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I N T R O D U C T I O N
The Toxicology Section of the Technology Branch of the 
Communicable D isease  Center conducts laboratory, field, and 
clin ical studies to determine the toxic hazards to man that are 
involved in the use of economic poisons in public health and 
agriculture. The sub jects of clin ical study include: ( 1) persons 
with occupational exposure — including malaria-control spraymen, 
farmers, orchardists, spray pilots, pest control operators, and 
others with heavy occupational exposure; (2) volunteers who take 
part in strictly  experimental investigations of pestic id es under 
controlled conditions; and (3) patients who are sick  a s  a resu lt of 
accidental over-exposure to p estic id e s. F a c ilit ie s  available  for 
this work include the main laboratory at Atlanta, Georgia, and 
field stations at Wenatchee, Washington, and Phoenix, Arizona. 
Special study c a se s  may be admitted to Public Health Service 
H ospitals in accordance with D ivision of H ospitals Operations 
Manual Part B , Chapter 1, Section 21.1, which was issu e d  under 
authority of Section 301(f), Public Law 410. Additional fac ilitie s  
for the study of volunteers have been made available generously 
by other institutions.
This Handbook replaces the “ C lin ical Memoranda on Economic 
P o iso n s,”  which were first issu ed  in March 1950 a s  separate 
re lea se s  on several new in sectic id es. Additional compounds were 
d iscu ssed  in subsequent editions. No attempt has been made in the 
Memoranda or in the Handbook to cover a large number of com­
pounds. Attention has been given to those m aterials that are 
manufactured in large amounts, that are known to have caused 
poisoning relatively frequently, or that are of specia l interest for 
some other reason. In general, the pestic id es introduced before 
DDT have been omitted because information on them is  readily 
available in textbooks of pharmacology. However, section s have 
been devoted to arsenic, thallium, phosphorus, and kerosene 
because they are leading cau se s of deaths asso c iated  with 
pestic id es.
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The Handbook is  based  on research of the Toxicology Section 
as well a s  reports from other sources. No credit or reference is  
given un less it is  felt that such a reference i s  reasonably avail­
able to most readers and would be of some real use to the physi­
cian in the management of his patient. The Handbook is  prepared 
primarily for the guidance of physicians in the d iagn osis and 
treatment of persons who may have had extensive or intensive 
exposure to economic poisons; however, it contains general infor­
mation that may be of interest to others a lso .
Form of  the H a n d b o o k
T h is Handbook is  arranged under several main headings such 
a s “ Organic Phosphorus In sec tic id e s,”  “ Chlorinated Hydrocarbon 
In sec tic id e s,”  and “ R odenticides.”  In order to conserve space , 
statem ents that apply to a ll members of a c la s s  of p estic id es have 
been placed immediately under the main heading for that c la s s  and 
have not been repeated in the sections on the individual com­
pounds. Synonyms for the different pestic id es have not been listed  
in the text, but some are given in the index.
A part of each section is  devoted to a description of the 
chemical nature, formulations, and u se s of the compound under 
consideration. T his portion is  intentionally a very brief resume of 
the sub ject matter and is  intended to guide the attending physician 
in questioning the patient on his exposure to economic poisons or 
their solvents. It must be understood clearly that, e specia lly  for 
the newer organic poisons, very much more is  known now regarding 
their chemical nature, formulations, and u se s than is  known about 
treatment or even the d iagn osis of acute or chronic poisoning by 
them in man.
The remainder of each section i s  devoted to medical consider­
ations including mode of action, d iagn osis, and treatment. T his 
part is  developed in greater detail than the first, although it  is  on 
these medical considerations that research is  most urgently 
needed. In many in stan ces, the suggestions for treatment are based
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on general medical principles and on animal experimentation 
because  many of the forms of poisoning have never been observed 
in man.
Attention is  called  to the analytical serv ices offered to physi­
c ian s in connection with c a se s  of poisoning. Directions for the 
collection and shipping of sam ples are given a s  appendices to 
this Handbook. (Only those sam ples that cannot be processed 
adequately by local or State laboratories should be submitted.) 
Other appendices contain a convenient form for the collection of 
data in c a se s  of suspected poisoning and directions for giving 
artific ia l respiration.
i n te rp re ta t ion  of  Tox ic i t y
Any compound may be toxic if it is  absorbed to an ex cessiv e  
degree. The sim plest way of expressing the toxicity of a compound 
i s  by means of an LD5Q -value. Such a value is  a s ta tistica l e sti­
mate of the dosage necessary  to kill 50 percent of a very large 
population of the te st  sp ec ie s  under stated  conditions (e .g ., single 
oral dose of aqueous solution).
Caution is  necessary  in the interpretation of LD 5Q-values.
F irst, hazards presented by any compound depend more on how 
it is  used than on how toxic it is .  In this country, the majority of 
the fatal and nonfatal accidents caused by solid  or liquid sub­
stan ces involve relatively nonpoisonous m aterials, available to a 
great number of people and sometimes used with reck less care­
le s s n e s s . T h is fact does not reduce the tragedy of needless injury. 
A lso, highly toxic substan ces do present a relatively greater 
hazard if used under comparable conditions.
Second, it is  known that toxicity may vary with sp e c ie s , age, 
sex , nutritional state , and formulation of poison, a s  well a s with 
the route of administration. By n ecessity , LD 5Q-values are given 
for anim als. They can be applied only with reservation to man.
Third, an LD -value is  a sta tis t ic  which, in itse lf, g iv es nou  U
information on the dosage that will be fatal to a very small pro­
portion of a large group of anim als. Although values such a s  the
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LD5 or L D j may be determined for laboratory animals, they are 
(for s ta tis tica l reasons) le s s  precise than the corresponding LD5Q- 
value and, therefore, even more d ifficult to apply to man.
Fourth, LD^0 -values are usually expressed  in terms of single  
d osages only. Thus, these values give little  or no information 
about the p o ssib le  cumulative e ffects of a compound.
In sp ite  of these necessary  qualifications, LD5Q-values are 
useful in making an objective comparison of the inherent toxicity 
of different compounds. Some m aterials are so poisonous that 
known exposure to a few drops on the skin is  reasonable ju stifica­
tion for diagnosing consistent illn e ss  a s  poisoning. On the con­
trary, other compounds are so  relatively harmless that a sm all dose 
maybe ingested without causing any harm. A s a very general guide, 
the probable lethal oral dose for a grown person may be estimated 
a s  follows:
Acute  oral for Probable lethal oral dose of
any animal (mg./kg.)  technica l  material for a human adult
L e s s  than 5 
5 to 50 
50 to 500 
500 to 5,000 
5,000 to 15,000
a few drops
“ a pinch”  to 1 teaspoonful 
1 teaspoonful to 2 tablespoonsful 
1 ounce to 1 pint (1 pound)
1 pint to l  quart (2 pounds)
It has been found that occupational poisoning with nonfumi­
gant pestic id es shows a very much closer correlation with acute 
dermal L D 50-values than with oral toxicity.
Su gg es t ion s  for  C l in i ca l  S tudy
In certain c a se s , the life of the patient has been saved 
because  the physician suspected  poisoning and began vigorous 
treatment promptly. R esponse to therapy may help to e stab lish  the 
d iagn osis. However, proof of adequate exposure to a poison should 
be obtained after the c r is is  i f  not before. The compound or a me­
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tabolite may be present in the excreta. For at le a st 24 hours 
after onset, all vomitus, urine, and feces should be saved 
system atically .
The history of each case  is  of the greatest importance'. If the 
fact of exposure to a toxicant is  clearly established , it is  then 
necessary  to know what poison or poisons were involved (including 
the solvents and other adjuvants); the concentration and amount of 
the contaminating material; the type, duration, and frequency of 
exposure; and the period from exposure to the onset of symptoms. 
Not only is  the most recent exposure important, but a ll preceding 
known instances should be listed . To facilitate  the taking and 
recording of an adequate toxicologic history, a form (Appendix A) 
has been devised and copies are available upon request from the 
Toxicology Section.
A careful neurologic examination is  e ssen tia l because the 
syndromes asso ciated  with many pestic id es are predominantly 
neurologic.
The physician will perform only those te sts  and administer 
only those treatments that he be lieves are indicated. On the other 
hand, to learn more about poisoning and treatment, it i s  desirable 
to co llect comparable data from a number of patients. To that end, 
it is  respectfully requested that the te sts  listed  below be con­
sidered and performed if there is  no medical or administrative 
contraindication. T e s ts  that are abnormal should be rechecked to 
rule out laboratory error. Confirmed abnormalities should be studied 
in detail. Reports of all te sts  should include a statement of the 
method and of the normal range for that te st  in the laboratory where 
it was made. Most of the te sts  suggested  are nonspecific in regard 
to any particular toxicant. Although the clin ical m anifestations of 
poisoning in man with many of the newer groups of p estic id es are 
primarily neurologic in origin, repeated d osages of the chlorinated 
hydrocarbon in sectic id es may produce pathologic changes in the 
liver and kidney without sign s referable to these organs (as they 
do under appropriate conditions in experimental anim als). For this 
reason, special attention should be given to liver and kidney 
function te s ts  in man in order that urgently needed data may be
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collected with reference to the p o ssib le  effects of p estic id es on 
these organs in man. The following clin ical and laboratory te sts  
are suggested:
Complete blood count including:
Red cell count 
Reticulocyte count 
White cell count 
Differential count 
Hemoglobin (in grams percent)
Hematocrit
U rinalysis
Serologic te st  for syphilis
Lumbar puncture with cerebrospinal fluid an aly sis  if there 
i s  any neurosymptomatology 
Phenolsulfonphthalein kidney te st
Q n je c t 1.0 ml. (6 mg.) of dye intravenously and 
co llect a specimen of urine every 15 minutes for
2 h o u r s j  
Mosenthal te st
Nonprotein nitrogen of the blood 
Icterus index
Urobilin in the urine (Schlesinger’ s  test)
Brom sulfalein liver function te st  (in ject 5 m g./kg. and 
make a reading at 45 minutes).
Cephalin flocculation 
Blood pressure (at le a st daily)
X-ray of chest
B a sa l metabolic rate (BMR)
Electrocardiogram
Electroencephalogram, if equipment is  available 
Certain other specific  te sts  (including tissu e  biopsy or 
examination of stomach contents, excreta, or blood) 
listed  under “ Laboratory F indings”  for each particu­
lar economic poison. (Directions for taking and 
shipping biopsy specim ens form Appendix B . Direc­
tions for preparing and shipping blood sam ples for
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Cholinesterase determination form Appendix C. 
Directions for shipping stomach contents form 
Appendix D.)
G en era l  Suggest ions for Treatment
In many c a se s  of poisoning, the nature of the toxic agent is  
not known. The treatment is , therefore, symptomatic and may 
include:
(1) Removal of the toxic agent.
(a) E m esis or gastric  lavage if poison has been taken 
internally. A s a first aid measure after ingestion of a 
nonirritant poison, vomiting may be produced by put­
ting a finger down the patient’ s  throat or by giving a 
child 20 ml. of syrup of ipecac plus water to mobilize 
the poison. Do not repeat the dose of ipecac a s  a 
first aid measure. Never try to make a stuperous or 
unconscious person vomit. Never use fluid extract 
of ipecac.
(b) Evacuation of the gut (avoiding oily laxatives where 
it is  possib le  that an organic solvent or a halogenated 
insecticide is  involved).
(c) Thorough washing of the eyes or body if there has 
been external contact with the poison.
(d) Removal of the patient to fresh air if poisoning has 
resulted from exposure to a contaminated atmosphere.
(2) Supportive therapy.
(a) Sedatives. Sodium pentobarbital is  preferred for acute 
poisoning because of its rapidity of action. Phénobar­
bital is  useful in maintaining a prolonged level of
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sedation to combat persisting hyperexcitability or 
recurring convulsions.
(b) Stimulants. In treating vasc ul ar  co l l ap se,  substances  
such as adrenalin should be used only after careful  
consideration; these stimulants are contraindicated in 
poisoning by the halogenated hydrocarbon in se c t i ­
c id es ,  even though the patient may be in severe de­
pression or coma.
(c) T ransfusions. Patients in shock, for whatever reason, 
may be helped by transfusion un less pulmonary edema 
or some other contraindication is  present. If blood is 
not readily available  or if  simple dehydration is  
present, 5% glucose or normal saline infusions are 
indicated. Intravenous fluids should not be continued 
long without a careful laboratory evaluation of the 
acid-base balance.
(d) Artificial Respiration. (For a suggested  method see  
Appendix E .) It is  more important to provide a free 
respiratory p a ssag e  and, if  necessary , artificial resp i­
ration to an anoxic patient than it is  to move him to a 
doctor or hospital. Frequently, the physician is  in 
telephone contact with the patient’ s  family or a s so c i­
a tes quite early. The physician should inquire about 
the victim’ s  breathing and color. If anoxia seem s to be 
present or imminent, a warning should be given again st 
moving the patient, and someone trained and equipped 
for giving emergency mechanical artificial respiration 
(usually  the fire department) should be called . If 
necessary , the person initiating the telephone call 
should be instructed in artificial mouth-to-mouth 
respiration to be carried out while the physician goes 
to the patient.
(e) Oxygen therapy. Oxygen should be administered to 
patients showing cyan osis or severe respiratory diffi­
culty. Patients with pulmonary edema require oxygen 
under positive pressure a s  well a s postural drainage
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and dehydration therapy until the condition is  
corrected.
T h ese  suggestions for symptomatic treatment are intentionally 
brief and emphasize early treatment. More detailed information may 
be found in the following recommended books:
von Oettingen, W.F.: Poisoning, A Guide to Clin­
ica l D iagnosis and Treatment, Second Edition, 
Philadelphia, W.B. Saunders C o., 1958.
G leason, M.N.; G osselin , R .E .; and Hodge, H .C.:
C lin ical Toxicology of Commercial Products,
Acute Poisoning (Home and Farm), Baltimore,
Williams and Wilkins C o., 1957.
It is  understood that, if  the nature of the toxic agent is  known, 
the physician may be able to use a sp ecific  antidote to supplement 
the general treatment. Where an antidote i s  known, it i s  described 
in the section on “ Treatment”  dealing with each pesticide. In any 
event, the importance of general medical care in c a s e s  of poisoning 
should not be underestimated. Even when a recognized antidote is  
properly administered, the general care of the patient may do as 
much or more to insure his survival.
Additional information on a pesticide frequently may be ob­
tained from the medical department of the company which manu­
factures the compound in question. For emergency consultation, 
physicians or hospital representatives may a lso  ca ll the nearer of 
the following representatives of the Public Health Service:
Dr. Wayland J .  H ayes, J r . Dr. Griffith E . Quinby
Atlanta, Georgia (AC:404) Wenatchee, Washington (AC:509)
Office: 634-5131 Office: 662-5506
Home: 373-7158 Home: 663-6175
9
Reporting
In c a se s  of pesticide poisoning, no matter how mild, physi­
cians and others are urged to notify promptly the nearest of the 
following laboratories:
T h is direct notification i s  not to be confused with or intended to 
be a substitute for the morbidity reports usually sent local and 
State departments of health or poison control centers.
Reports are solicited  not only on c a se s  that involve clearly 
established  poisoning but a lso  on c a se s  that present a diagnostic 
problem, even after thorough study. However, p ast experience has 
shown that the following caution is  necessary : Before chronic 
poisoning is  reported, be sure that exposure to a pesticide has 
occurred.
The narrative report that i s  requested for each c a se  of poison­
ing should be more complete than the average clin ical summary, 
for it will frequently be im possible to refer to the original chart. 
T h ese  ca se  h istories form one important source of information for 
this booklet, so  that the experience of one person may help many. 
All information received will be kept confidential so far a s  the 
identity of the patient is  concerned.
Communicable D isease  Center 
Atlanta 22, Georgia 
Attn: Toxicology Section
U. S. Public Health Service 
P . 0 . Box 73 
Wenatchee, Washington
U. S. Public Health Service 
4402 North Seventh Street 
Phoenix 12, Arizona
10
Prevention of Poisoning
In the United S tates pestic id es kill more children than adults. 
It is  probable that nonfatal poisoning a lso  occurs predominantly in 
children. T hese c a se s  in children could be virtually eliminated if 
(a) pestic id es were alw ays stored under lock and key, (b) care 
were taken that children could not reach the poisons while they are 
in u se , and (c) empty containers were d isposed of sa fe ly . Some of 
the compounds are extremely persistent. Poisoning has occurred 
from contact with a cup used a year before for measuring a 
pesticide.
Strangely enough most deaths caused by pestic id es are still 
a sso c ia ted  with arsenic, phosphorus, and other poisons that were 
available before the introduction of DDT and newer m aterials. 
Great care should be used with all poisons — including those that 
are so  familiar that some people forget their undiminished danger.
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O R G A N I C  P H O S P H O R U S  IN S E C T IC ID E S
Introduction: The organic phosphorus in sectic id es are character­
ized by ( 1) similar chemical structure (they may all be considered 
derivatives of phosphoric acid) and (2) sim ilar primary mode of 
action. T h ese  in secticides differ widely in their inherent toxicity 
and differ at le a st  to some extent in their rate of absorption, point 
of maximal action following absorption, and rate of destruction or 
excretion. The acute oral and dermal LD 50-values to rats of certain 
organic phosphorus in sectic id es including those mentioned in this 
Handbook are given in the table on page 13.
Routes of Absorption: Organic phosphorus in sectic id es are ab­
sorbed by the skin a s  well a s  by the respiratory and gastrointesti­
nal tracts. Absorption by the skin tends to be slow, but, because 
the in sectic id es are difficult to remove, such absorption is  fre­
quently prolonged. Skin absorption is  somewhat greater at higher 
temperatures and is  much greater in the presence of dermatitis. 
Thus, dermatitis may lead to serious poisoning following exposure 
that would ordinarily cause  no inconvenience.
Pharmacologic Action: The organic phosphorus poisons act a s 
more or le s s  irreversible inhibitors of the enzyme cholinesterase 
and thus allow the accumulation of large amounts of acetylcholine. 
The cholinesterase content of various t is su e s  is  not equally af­
fected in the same poisoned animal, and the level in all tissu e s  
including even the brain can be lowered markedly from the pre­
poisoning level without seriously  affecting normal function, espe­
cially  if the reduction is  gradual. Almost as important a s the 
degree of cholinesterase depression is  the rate at which it occurs. 
A sudden sligh t depression resulting from a sm all dose that is  
rapidly absorbed may lead to incapacitating acute illn e ss , though 
not to fatal illn e ss . A sudden marked depression from a sufficient 
dose leads to critical and frequently fatal poisoning. However, the 
blood cholinesterase of men and animals maybe gradually depressed
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A C U T E  O R A L  A N D  D E R M A L  L D s o - V A L U E S  O F  
O R G A N I C  P H O S P H O R U S  I N S E C T I C I D E S  F O R  
M A L E  A N D  F E M A L E  W H I T E  R A T S *
C O M P O U N D
O R A L  L D 50 ( M G ./ K G .) D E R M A L  L D 50 ( M G ./ K G .)
M A L E S F E M A L E S M A L E S F E M A L E S
Carbophenothion 30 10.0 54 27
Ch lorth io n 880 980 < 4500 4100
C o - R a l 41 15.5 860 -
D D V P 80 56 107 75
D e ln a v 43 23 235 63
Demeton 6.2 2.5 14 8.2
D ia z in o n 108 76 900 455
Dicapthon 400 330 790 1250
Dimethoate 215 - 400 -
D i-S ysto n 6 .8 2.3 15 6
E P N 36 7.7 230 25
Eth ion 65 27 245 62
Fenthion 215 245 330 330
Guthion 13 11 220 220
Malathion 1375 1000 > 4444 > 4444
Methyl parathion 14 24 67 67
Methyl Tr ith io n 9 8 120 215 190
N P D - - 2100 1800
Parath ion 13 3.6 21 6.8
Phorate 2.3 1.1 6.2 2.5
P h o s  drin 6.1 3.7 4.7 4.2
Phospham idon 23.5 23.5 143 107
Ronnel 1250 2630 - -
Schradan 9.1 42 15 44
T E P P 1.05 - 2.4 -
Tr ich lo ro fo n 630 560 > 2000 >  2000
*With the e xce p tio n  of the dermal L D ijq for dimethoate, th e se  v a lu e s  were 
determined by the T o x i c o l o g y  Sect io n  under stand ard ize d  co n d it io n s .
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to a very low level (<0.2 A ph/hr in man) by repeated sm all ex­
posures to organic phosphorus compounds without n ecessarily  
producing serious symptoms or even any symptoms whatever. Thus, 
a very low blood cholinesterase is  not always proof that a clin ical 
illn e ss  represents poisoning, but critical poisoning usually does 
not occur in man or laboratory animals in the absence of such 
enzyme lev els. In every c a se , the exposure history, symptoms, and 
clin ical findings must be considered carefully, no matter what the 
cholinesterase level may be.
It is  known now that some effects of organic phosphorus 
in sectic id es (e .g ., headache and irritation of the urinary tract both 
caused by paranitrophenol) are not always related directly to the 
inhibition of cholinesterase, but the relative importance of differ­
ent p ro cesse s in determining the clin ical outcome is  not estab­
lished . In any event, recovery is  apparently complete if a poisoned 
animal or man has time to re-form his critical quota of cholinester­
a se . Experiments with rats show that gradual depression of the 
blood cholinesterase by repeated, sm all, tolerated doses does not 
make the animals significantly more susceptib le  to a challenge 
dose. F ie ld  experience su ggests  that the same is  true of man. 
Thus, there is  a physiological adjustment to the s tre ss  of repeated, 
sm all, tolerated doses that is  at le a st  partially independent of the 
blood cholinesterase p e r  s e .  On the contrary, repeated d oses which 
produce any detectable clin ical injury in rats tend not only to 
reduce cholinesterase levels progressively but to produce cumula­
tive clin ical injury a lso . Thus, i f  a sm all second dose of poison is  
administered before physiological adjustment is  complete, the 
effect i s  partially additive. Following clin ical recovery after 
illn e ss  caused  by one or a few d o se s, physiological adjustment 
may be safe ly  presumed complete only after the activity of the 
blood cholinesterases has returned to normal. Depending on the 
degree of depression and other factors, the recovery may require 
about three months. T his does not mean that workers who have 
been poisoned may not return to work much sooner than three 
months providing the attending physician is  sa tisfie d  that his 
patient is  clin ically  normal and able to carry out all safe ty  m eas­
ures under the conditions of his employment.
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Some unmetabolized organic phosphorus in sectic id es are able 
to inhibit cholinesterase and are said  to have a direct action; 
many other compounds are not active until they have been altered 
either by chemical or enzymatic change, and, therefore, are called 
indirect inhibitors. Direct inhibitors tend to have more prominent 
local e ffects and to produce system ic poisoning more rapidly.
Signs and Symptoms of Poisoning in Man: Signs and symptoms are, 
at le a s t  to a very great extent, secondary to cholinesterase inhibi­
tion. The usual symptoms include: headache, g iddin ess, nervous­
n e ss , blurred vision, w eakness, nausea, cramps, diarrhea, and 
discomfort in the chest. Signs include: sw eating, m iosis, tearing, 
salivation  and other excessiv e  respiratory tract secretion, vom­
iting, cyan osis, papilledema, uncontrollable muscle twitches, 
convulsions, coma, lo s s  of reflexes, and lo s s  of sphincter control. 
The la s t  four signs are seen only in advanced c a se s  but do not 
preclude a favorable outcome if energetic treatment is continued.  
Poisoned animals show various degrees of heart block, and cardiac 
arrest may occur. Following a m assive oral dose asso ciated  with 
murder or suicide, death has occurred in 5 minutes or le s s  after 
ingestion. Following sm aller doses swallowed accidentally, onset 
of illn e ss  was sometimes delayed an hour or more. In occupational 
c a se s , illn e ss  i s  frequently delayed several hours so that the 
worker may first become sick  at home after supper. (However, if  
symptoms begin more than 12 hours after the la s t  known exposure 
to in secticide , illn e ss  is  probably due to some other cause.) 
Furthermore, in occupational c a se s , relatively incapacitating symp­
toms of nausea, cramps, discomfort in the chest, muscular twitch­
ing, e tc ., often follow the initial g iddin ess, blurred vision, and 
headache only after a period of 2 to 8 hours, but the onset of 
serious symptoms may be more rapid. It seem s that in the p ast 
undue em phasis has been given to m iosis a s a d iagn ostic sign. 
M iosis may appear late; in fact, the opposite condition, m ydriasis, 
may be present, perhaps a s  a nonspecific reaction to the discom­
fort and apprehension asso ciated  with poisoning. Treatment of 
sign ificant illn e ss  following ex cessiv e  exposure to these com­
pounds should not be delayed merely because m iosis i s  absent.
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There have been at le a st  3 c a se s  in which artific ia l respira­
tion was required but was inadequate, so  that the patient survived 
temporarily but showed severe brain injury a s  a result of the 
anoxia. The reason for inadequacy of artificial respiration in 
different instances was delay in reaching the victim or resistance 
of the airway or other difficulty that could not be overcome by well- 
trained and well-equipped physicians. The patients gradually re­
covered from the specific  sign s of poisoning but remained comatose 
and tended to continue to have inadequate spontaneous respira­
tion. Two of them showed temporary hyperthermia after the acute 
episode presumably as a result rather than a cause of brain injury. 
Death occurred 6 days to 4 weeks after onset. Extensive necrosis 
of the brain was present in those c a se s  that came to autopsy.
Laboratory Findings: Leukocytosis and moderate albuminuria, ace- 
tonuria, and glycosuria are frequent and hemoconcentration may 
occur.
By sp ec ia l techniques, the cholinesterase level of the blood 
or serum may be shown to be greatly reduced. At autopsy, the 
sam e may be demonstrated for the cholinesterase level of the 
brain or other t is su e s  provided fresh unfixed tissu e  is  employed. 
Blood is  usually adequate for examination if taken within a few 
days of death. Directions for collecting and shipping blood sam­
ples form Appendix C.
The most extensive single study of cholinesterase values of 
normal persons without exposure to organic phosphorus in secti­
cides employed the Michel method ( J .  Lab . Clin. Med. 34:1564; 
1949) and revealed the following values:
Cholinesterase Activity (ApH/hr) of Normal Human Blood*
♦The m e a n s  ( b u t  n o t  t h e  r a n g e s )  a r e  fo r  p e o p l e  40  y e a r s  o l d .  On t h e  a v e r a g e ,  t h e  p l a s m a  c h o l i n e s t e r a s e  of  m en  I n c r e a s e s  a b o u t  0 .0 2  p e r  d e c a d e  a nd  t h a t  o f  w o m e n  i n c r e a s e s  a b o u t  0 .0 4  p e r  d e c a d e .  T h e  e n z y m e  a c t i v i t y  o f  r e d  c e l l s  d o e s  n o t  c h a n g e  w i t h  a g e .
Red c e lls  — range
mean ± s.d
Men 
0.39 -  1.02 
0.766± 0.081
Women 
0.34 -  1.10 
0.750± 0.082
Plasm a — range
mean ± s.d,
0.44 -  1.63 0.24 -  1.54
0.953± 0.187 0.817± 0.187
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Other studies have shown that values exceeding the ranges 
in the table are encountered in normal people, but only very 
rarely.
It is  believed that cholinesterase values of 0.5 or le s s  for 
either ce lls  or plasm a represent abnormal depressions for most 
individuals. N evertheless, people may experience far greater 
depressions (to 0.2 or le s s )  without the onset of clinical signs 
or symptoms; this situation is  e specia lly  true of workers who are 
exposed daily over a period of weeks but whose exposure a t any 
one time is  kept at a minimum. On the contrary, a considerable 
absorption of an organic phosphorus insecticide may occur in one 
or a few exposures without producing any measurable reduction of 
blood cholinesterase. For practical purposes, exposure to organic 
phosphorus or carbamate in sectic id es is  the only cause of sign ifi­
cant depression of cholinesterase activity . Certa^. is e a se s  o f the 
liver cau se  a reduction of the enzyme in the plasm a, but these 
d ise a se s  are not consistent with active work.
It is  a lso  possib le  to estim ate absorption of some of the or­
ganic phosphorus in sectic id es by an aly sis  for their metabolic 
products in urine. Urinary levels of paranitrophenol have been 
used in this way to provide an estim ate of parathion exposure. 
Other methods are available for other compounds. There is  a broad 
correlation between the excretion of biotransformation products 
and the occurrence of illn e ss . However, there are great individual 
d ifferences in susceptib ility .
Bradycardia, A-V block and d issociation , exaggeration and 
inversion of the T wave, and disappearance of the P wave have 
been observed in experimental animals poisoned by T E P P , and are 
likely to be encountered with other organic phosphorus in secticides 
under su itable  conditions.
Pathology: No significant g ross or m icroscopic pathology is  to be 
expected except that a sso ciated  with pulmonary or cerebral con­
gestion or changes secondary to convulsions.
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Differential Diagnosis: In the absence of laboratory fac ilitie s for 
cholinesterase determinations, brain hemorrhage, heat stroke, heat 
exhaustion, hypoglycemia, gastroenteritis, and pneumonia or other 
severe respiratory infection have been confused at times with 
poisoning by these compounds. Mild poisoning must frequently be 
distinguished from asthma and from simple fright with various 
psychosom atic m anifestations, particularly among the a sso c ia te s  
of known poisoning c a se s . In recent years, a number of c a se s  have 
been provisionally diagnosed a s  poisoning by one of the le s s  toxic 
organic phosphorus in secticides before a complete investigation 
of the exposure history and clin ical course changed the diagnosis 
to poisoning by more toxic in sectic id es, mercury fungicides, or 
so lvents, or even to d ise a se  unrelated to pestic id es.
Treatment:
I. In very severe c a se s , the order of treatment should be a s
follows:
(1) A R T I F I C I A L  R E S P I R A T I O N ,  if required, preferably by 
mechanical means. See Appendix E .
(2) A T R O P I N E  S U L F A T E ,  2 to 4 mg. (1/30 to 1/15 grain)
intravenously as soon a s  cyan osis is  overcome. Repeat
at 5- to 10-minute intervals until sign s of atropinization 
appear (dry, flushed skin and tachycardia a s  high a s  140 
per minute).
(3) 2-PAM, S L O W L Y ,  intravenously, 1 g. for adults and 0.25 g. 
for infants.
(4) D E C O N T A M I N A T I O N  of the skin, stomach, and eyes 
a s indicated.
(5) S Y M P T O M A T I C  T R E A T M E N T .
II. In the more usual ca se , proceed a s  follows:
(1) A T R O P I N E  S U L F A T E ,  1 to 2 mg. (1/60 to 1/30 grain),
if symptoms appear. If e x cessiv e  secretions occur, keep
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the patient fully atropinized. Give atropine su lfate  every 
hour up to 25 to 50 mg. in a day.
(2) D E C O N T A M I N A T I O N  of the skin, stomach, and eyes a s 
indicated.
(3) 2-PAM, S L O W L Y ,  intravenously, if the patient fa ils  to 
respond satisfactorily  to atropine su lfate . D ose of 1 g. for 
adults, 0.25 g. for infants.
(4) S Y M P T O M A T I C  T R E A T M E N T .
It will be noted that the recommended dosage of atropine su lfate  is  
greater than that conventionally employed for other purposes but i s  
within sa fe  lim its. Atropine su lfate  relieves many of the d istressin g 
symptoms, reduces heart block, and dries secretions of the respira­
tory tract. People poisoned by anticholinesterase organic phospho­
rus compounds have an increased tolerance for atropine sulfate. 
Furthermore, a single dose of a s  much a s  10 mg. of atropine sulfate 
has been inadvertently administered intravenously to normal adults 
without endangering life , although it  h as, of course, produced very 
marked sign s of overdosage. In the presence of severe anticholin­
e ste ra se  poisoning, 40 mg. of atropine su lfate  may be given in a 
day without producing symptoms attributable to atropine su lfate . 
The effects of intravenous atropine su lfate  begin in 1 to 4 minutes 
and are maximal within 8 minutes. A mild degree of atropinization 
should be maintained in all c a se s  for 24 hours, and in severe c a se s  
for at le a s t  48 hours.
The tenacity of the chemical bond between cholinesterase and 
one of the various organic phosphorus compounds depends on the 
compound. For some, the bond is  irreversible under ordinary condi- 
tim es. However, it has been found that certain derivatives of hy- 
droxamic acid or oximes may promote release  of the enzyme even 
when the bond is  otherwise practically  irreversible.
Three derivatives (one available in at le a st 3 forms) have 
proved outstanding:
(a) 2-Pyridine aldoxime methiodide (2-PAM iodide or 
pralidoxime iodide).
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2-Pyridine aldoxime methochloride (2-PAM chloride or 
pralidoxime chloride)
2-Pyridine aldoxime methyl methanesulfonate (P2S)
(b) D iacetyl monoxime (DAM)
(c) 1,1-Trimethylene-6is-(4-formyl pyridinium bromide) 
dioxime. (TMB-4).
One of these drugs, used in conjunction with atropine su lfate , will 
protect experimental animals from much larger doses of organic 
phosphorus compounds than is  p o ssib le  by the use of the drug or 
atropine su lfate  alone. Of the three drugs, the first is  b e s t  known. 
T e sts  carried out with 2-PAM on more than 40 people accidentally 
poisoned by parathion are most encouraging. The dosage used has 
usually been 1 g. for adults with proportionally smaller d oses for 
infants. However, one patient severely poisoned by parathion re­
ceived 40.5 g. of 2-PAM over a period of 6 days. In most c a se s , a 
single dose was sufficient to produce dramatic improvement within 
30 minutes. In poisoning resulting from one or a few large d oses of 
parathion, 2-PAM cau se s a marked reactivation of red ce ll cholin­
e stera se  but much le s s  effect on the plasm a enzyme. Side effects 
have been minimal in normal su b jects and practically  nonexistent 
in people who were poisoned. A few patients given the iodine 
preparation complained of a ta ste  that no doubt resulted from the 
iodine moiety of the molecule. The other s a l t s  have the advantage 
of being more soluble and producing no ta ste . 2-PAM is  rapidly ex­
creted, chiefly in the urine. The half-life in the blood is  about 
1 hour.
2-PAM chloride is  now available a s  an investigational drug 
under the Federal Food, Drug, and Cosm etic Act. The drug may be 
bought by qualified physicians from Campbell Pharm aceuticals, Inc. 
(121 E a s t  24th Street, New York 10, N. Y.) after they f i le  the 
necessary  forms with the company. 2-PAM may a lso  be obtained 
from and used under the supervision of the Public Health Service
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by qualified physicians who contact the medical officers listed  on 
page 9.
M iosis and headache may p ersist after recovery from poisoning 
by organic phosphorus in sectic id es i s  otherwise largely complete. 
In some c a s e s ,  the system ic administration of atropine su lfate  is  
followed by partial or temporary dilatation of the pupils. M iosis re­
sponds more dependably to 2-PAM. If further system ic treatment is  
not n ecessary , the m iosis and a sso c ia ted  headache will respond to 
the instillation of 1/ 2% to 1% atropine su lfate  solution or 1/ 2% 
atropine su lfate  ointment into the eyes.
Never  give morphine, theophyll ine,  or theophyll ine-ethylene-  
diamine (Aminophyll ine).  Do not g ive  atropine to a cyanotic patient;  
give artificial respiration first and then give atropine sulfate. Large 
amounts of intravenous fluids are generally contraindicated be­
cau se  o f ex c ess iv e  fluid in the respiratory tract.
T r an qu i l i z er s  should be used with great caution; they are 
seldom indicated at a ll. In fact, there are some indications that use 
of a phenothiazine-substituted drug to overcome anxiety and rest­
le s s n e s s  may have been a contributing cau se  in the fatal outcome 
of a c a se  in which the side  e ffects of the drug were apparently 
mistaken for persisting sign s of poisoning by organic phosphorus 
in sectic id es. Promazine and chlorpromazine increase mortality in­
experimental anim als poisoned by parathion.
If pulmonary secretions have accumulated before atropine 
su lfate has become effective, they should be removed by suction 
and a catheter. If the stomach i s  distended, empty it with a Levin 
tube.
If the patient has not yet shown symptoms or they have been 
allayed by treatment, he must be completely and quickly decontami­
nated. Remove the patient’ s  clothing, and, with due regard for his 
condition at the moment, bathe him thoroughly. Remove any v isib le  
in secticide gently with lo ts of water and soap or other detergent, if 
availab le . Avoid abrasion. When the skin appears clear, bathe or 
swab with ethyl alcohol. Parathion and many of the other organic 
phosphorus in sectic id es are very much more soluble in alcohol
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than in water, and significant amounts can be washed from skin 
that has been scrubbed several times with soap and water.
If there i s  any suspicion that the poison has been ingested or 
inhaled and if  the patient is  still responsive, induce vomiting, give 
some neutral material such a s  milk or water, and induce vomiting 
again. The reason for mentioning inhaled material i s ,  of course, 
that a large portion of such material may be deposited in the upper 
respiratory tract and subsequently carried to the pharynx and 
swallowed. N ausea may be anticipated, of course, on the b a s is  of 
the system ic action of organic phosphorus compounds, but if vomit­
ing i s  not profuse, gastric lavage may be used. Experiments have 
indicated that vomiting induced immediately or even 1.5 hours after 
ingestion i s  more effective than gastric  lavage in removing poison.
Atropine sulfate does not protect again st muscular w eakness. 
The usual mechanism of death appears to be respiratory failure. 
The use of an oxygen tent or even the use of oxygen under slight 
positive pressure i s  advisable and should be started early. Watch 
the patient constantly,  s ince the need for art i f i cia l  respiration may 
appear suddenly.  Equipment for oxygen therapy and for artificial 
respiration should be placed by the patient’ s  bed in readiness 
while the patient i s  on his way to the hospital. C yanosis should be 
prevented by the most suitable means, sin ce  continued anoxia 
aggravates the depression of the respiratory center caused directly 
by the poison. Complete recovery may occur even after many hours 
of artificial respiration have been n ecessary .
If there is  any reason to think that the eyes may have been 
contaminated, irrigate them with physiological saline or water. The 
absorption of some of the organic phosphorus in sectic id es by the 
eye is  remarkably rapid.
The acute emergency la s t s  24 to 48 hours, and the patient 
must be watched continuously during that time. Favorable response 
to one or more doses of atropine su lfate , frequently given a s  a 
first aid measure, does not guarantee again st sudden and fatal 
relapse . Medication must be continued during the entire emergency.
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Any person who is ill  enough to receive  a s ing le  dose of atropine 
sulfate should remain under medical  observation for 24 hours,  
because the atropine sulfate may produce only a temporary rel ief  of 
symptoms in what may prove to be a ser ious case  of poisoning.
Atropine sulfate should never be administered for preventive pur­
poses to persons who have not become sick . 2-PAM is  not used a s 
first aid, and one dose of it is  frequently adequate. However, re­
peated administration may be required in severe c a se s , and the 
patient alw ays must have continuous observation.
Following exposure heavy enough to produce symptoms, further 
organic phosphorus insecticide exposure of any sort should be 
avoided. The patient may remain susceptib le  to relatively small 
exposures to the sam e or any other organic phosphorus compound 
until regeneration of cholinesterase is  nearly complete.
Prevention: Poisoning in those who work with the more toxic 
organic phosphorus in sectic id es may be prevented in three general 
ways: (1) constant, thoughtful care on the part of every worker;
(2) mechanical aids such as protective clothing, m asks, and factory 
safety  ventilation; and (3) regular inspection of working condi­
tions. It is  practical to te st  routinely the plasm a and erythrocyte 
cholinesterase levels of factory or agricultural workers who may 
be subject to significant exposure to organic phosphorus com­
pounds. The interpretation of individual values in asymptomatic 
persons is  difficult. It is  clear, however, that a single very low 
enzyme value for one worker or a low average value for a group of 
exposed workers is  an indication of the need for improved personal 
care or better mechanical protection or both. In a sim ilar way, 
poisoning may be minimized by proper evaluation of the amount of 
urinary excretion of biotransformation products, such a s para- 
nitrophenol.
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C h forth ion
Chemical Name: 0 ,0-dimethyl O-(m-chloro-p-nitrophenyl) 
phosphorothioate:
Chemical Formula: Cl
CH,-Ck S / = = \
c „ , > O N0'
Formulations: Chlorthion i s  available a s  an approximately 50% 
em ulsifiable concentrate, 25% water-wettable powder, and 3% dust.
Uses: Chlorthion is  used in control of roaches and adult and larval 
m osquitoes. It is  approved for use in dairy barns for fly control.
Toxicology: No c a se s  of human poisoning are known. Studies of 
the acute oral and dermal toxicity of Chlorthion to experimental 
animals indicate a low toxic hazard. By both oral and dermal 
routes, the toxicity of Chlorthion is  le s s  than that of DDT and much 
le s s  than that of certain other of the organic phosphorus group of 
in sectic id es. From animal stud ies, one might expect some cholin­
e stera se  depletion in persons having very heavy repeated expo­
sures to Chlorthion. Taking dosage into account, the toxicology of 
Chlorthion is  sim ilar to that of the organic phosphorus in secticides 
generally. See pages 12 to 23.
C o -R a
Chemical Name: 0 ,0-diethyl 0-(3-chloro-4-methyl-2-oxo-2E-l- 
benzopyran-7-yl)phosphorothioate.
, ,  , I P  , c 2h 5-o s
C h e m ic a l F o rm u la : Np
c 2h ,- o
P-O 0 s S iO
Cl
CH,
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Formulations: Co-Ral is  available in the form of a 25% wettable 
powder and 0.5% dust.
Uses: Co-Ral is  a system ic insecticide for control of arthropod 
p arasite s of animals by external application. Sprays and dips of
0.25% and 0.5% concentration are used to control cattle  grubs a s 
well a s  external parasites of cattle, sheep, goats, dogs, and 
chickens.
Routes of Absorption: Co-Ral can be absorbed through the skin as 
well a s  by other routes.
Pharmacologic Action: See page 12. Co-Ral differs from manyother 
organic phosphates in that the toxicity  a s  a resu lt of oral adminis­
tration is  delayed and more prolonged.
Toxicology: The dermal toxicity of Co-Ral is  low. No toxic symp­
toms due to the use of Co-Ral have been observed in man. How­
ever, excessiv e  exposure has been shown in a few c a se s  to lower 
blood cholinesterase values. The ingestion of significant quanti­
tie s  would be expected to produce poisoning. Taking dosage into 
account, and with the possib le  exception of its  delayed action, the 
toxicology of Co-Ral is  sim ilar to that of the organic phosphorus 
in sectic id es generally. See pages 12 to 23.
D D V P
Chemical Name: 0 ,0-dimethyl 2,2-dichlorovinyl phosphate. 
Chemical Formula: CH} -0^(j)
.p-o-ch=cci2
CHj -O
Formulations: Technical, ba its, concentrates, and aeroso ls are 
availab le .
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U ses: DDVP is  used for control of houseflies, phorid flie s  (in 
mushroom cultures), Mediterranean fruit f lie s , and cigarette beetles 
(in warehouses).
Routes of Absorption: DDVP is  easily  absorbed by the skin a s 
well a s  by other routes. Although inherently le s s  poisonous than 
parathion or T E P P ,it  has a much greater vapor pressure, and toxic 
concentrations of DDVP may be produced in specia l chambers in 
the laboratory. Measurements show that dangerous concentrations 
of vapor are not produced under practical conditions of use in 
warehouses, but fogs or aeroso ls may be dangerous.
Pharmocologic Action: In general, the action is  sim ilar to that of 
other organic phosphorus in sectic id es, but the compound is  a 
direct inhibitor of cholinesterase, and it is  detoxicated relatively 
quickly. At le a st  in anim als, recovery from acute poisoning is  
rapid and the range of tolerated dosage is  wide. Although a dietary 
concentration of DDVP a s  low a s  50 ppm produces definite lower­
ing of the plasm a and red cell cholinesterase lev e ls of rats, yet 
these animals withstand a dietary level of 1,000 ppm for 90 days 
without showing any signs of intoxication.
Dangerous Single and Repeated Doses to Man: Two laborers in 
another country died after spilling concentrated DDVP on their 
arms. No details are available.
In another instance, the sp illage  of only about 4 ounces o f a 
3% oil solution of DDVP on a man’ s  lap resulted in poisoning 
which apparently would have been fatal had it not been for unusu­
ally  vigorous treatment. There was no previous exposure and no 
effort to remove the poison until the man noticed a burning of the 
skin about half an hour after the accident. Even then, washing was 
very superficial and a bath w as delayed another hour.
In still another c a se , a man spilled  a smaller amount of the 
sam e k3% formulation on his arm. He removed his shirt at once and 
washed with soap and water a s  soon a s p o ssib le , about 15 minutes 
later. He developed d izz in ess and nausea a s  the only symptoms.
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T e sts  have shown that men can withstand brief exposure to 
air concentrations at le a st  a s  high a s  6.9 ( ig ./ l .  without clin ical 
effect or depression of blood cholinesterase; intermittent exposure 
totaling 5 hours daily at a concentration of 0.5 | !g . / l .  produces no 
clin ical effect and no effect on red cell cholinesterase, but does 
cause  a gradual, moderate reduction of plasm a cholinesterase.
Signs and Symptoms of Poisoning in Man: In the serious, nonfatal 
ca se  mentioned above, the victim developed slurred speech and 
drow siness slightly more than an hour and a half after the acci­
dent. He collapsed  suddenly after reaching a hospital. Prompt 
use of oxygen, a total of 15 mg. o f atropine su lfate  (mostly intra­
venously), and supportive treatment saved him. He appeared to be 
recovering uneventfully when he developed periodic hallucinations 
and violent com bativeness during the fourth and fifth day after the 
accident. B ecau se  of certain factors peculiar to this c a se , it was 
not p o ssib le  to tell whether these complications were related 
directly to DDVP. In any event, the patient finally recovered 
completely.
Laboratory Findings and Other Toxicology: See page 16. , The first 
sample of blood for cholinesterase determination in the serious, 
nonfatal ca se  mentioned above w as taken the day after the acc i­
dent. The enzyme activity, though reduced, was surprisingly high 
in view of the near-fatal outcome. Animals show a rapid recovery 
of cholinesterase activity, e specia lly  of the plasm a, following 
poisoning with DDVP. The same may occur in man. For other 
points of toxicology, see  pages 12 to 23.
Demeton
Chemical Name: 0 ,0-diethyl 0-[2-(ethylthio)ethyl[]phosphorothioate 
(I) and 0,0-diethyl S-[2-(ethylthio)ethyQphos- 
phorothioate(II) in a ratio of approximately 2 to 1 .
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Chemical Formulae:
C ,H ,-0. S 2 5  \  hp-o-c2h 4-s-c2h 5
c 2h ,- o
C2H5- Q 0>c 2h 5-o^ p -s-c2h 4-s-c2h ,
I. Thiono Isomer II. Thiol Isomer
Formulations: Demeton is  available  a s  an approximately 24% 
em ulsifiable concentrate.
Uses: Demeton is  a system ic insecticide in plants; that i s ,  the 
compound i s  translocatable from one part of a living plant to 
another. Thus, demeton will control certain plant p e sts  on all 
parts of the plant, even though it  may be applied to only one part. 
The compound i s  used on cotton, ornamentals, seed crops, and 
some food plants.
Routes of Absorption: Demeton is  -readily absorbed through the 
skin, a s  well a s by other portals.
Pharmacologic Action: See page 12.
Dangerous Single and Repeated Doses to Man: L ittle  is  known 
regarding the acute and repeated d osages that would be dangerous 
to man. However, the minimum acute lethal oral dose for man is  
believed to be approximately equal to that of parathion. The com­
pound is  only slightly le s s  toxic by the dermal route. In the female 
rat, a dietary intake at the rate of 0.16 m g./kg./day produced slight 
cholinesterase depression. An intake of 2.6 m g./kg./day caused 
sign s of poisoning that tended to diminish as feeding continued. 
Men tolerated 3.75 mg. daily for 24 days (approximately 0.05 m g./ 
kg./day) with only about 15% depression of plasma cholinesterase 
and no significant change of red cell enzyme.
Signs and Symptoms of Poisoning in Man: At le a st  four fatal, 
several severe nonfatal, and a number of mild c a se s  of demeton 
poisoning have been reported. Persons poisoned with demeton
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have shown the typical symptoms of organic phosphorus poisoning 
described on page 15.
Pathology: One autopsy revealed congestion in the v iscera, a 
bloody exudate in the lungs, and a unique odor of the contents of 
the peritoneal cavity.
Treatment and Other Toxicology: See pages 12 to 23.
Chemical Name: 0 ,0-diethyl 0-(2-isopropyl-4-methyl-6-pyrimidinyi) 
phosphorothioate.
Chemical Formula:
90% pure), a s  a 25% wettable powder, 2% to 4% dust, 25% emulsifi- 
able concentrate, 20% solution, and a s  a poison bait. For fly 
control, the addition of sugar (2.5 parts sugar to 1 part of toxicant) 
has been used.
Uses: Diazinon is  effective again st flie s  and roaches a s  well a s 
many in sect p e sts  of fruits and vegetab les. In addition to the more 
usual formulations, i t  may be used to impregnate cords for fly 
control.
Routes of Absorption: Diazinon i s  readily absorbed through the 
skin a s  well a s  through other portals.
Dangerous Single and Repeated Doses to Man: Eight men drank 
only part of a bottle of Diazinon d isso lved  in xylene or a xylene-
CHj
Formulations: Diazinon is  available  in the technical form (about
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like material in the belief that the liquid was wine. Three of them, 
with an average age of 73 years, died.
Diazinon, formulated a s  an ointment, caused sweating, abdomi­
nal pain, nausea, and, in one instance, coma when 80 mg. of active 
ingredient was applied experimentally twice to the skin of each of 
two men for the treatment of creeping eruption. It is  not possib le  
at this time to state  whether the unexpectedly great dermal absorp­
tion w as caused by the formulation or the dermatitis, or both.
The spraying of an oil formulation on floors and bedclothing 
caused near-fatal poisoning of 3 children.
Slight asymptomatic cholinesterase depletion occurs in spray­
men a s  a result of extensive occupational exposure to Diazinon. 
T his fact and the c a se s  mentioned show that Diazinon must be 
used with care even though its  toxicity i s  relatively low in com­
parison with many other organic phosphorus in sectic id es.
Signs and Symptoms of Poisoning in Man: Typical symptoms (listed  
on page 15 ) occurred in the c a se s  of Diazinon poisoning. M iosis, 
bradycardia, diarrhea, increased respiratory tract secretions, coma, 
and convulsions were seen in one or more c a se s , including those 
that survived. The illn ess tends to be somewhat more protracted 
than poisoning by most other organic phosphorus compounds.
Laboratory Findings and Other Toxicology: Serious illn ess  is  
a sso c iated  with verymarked inhibition of blood cholinesterase. For 
treatment and other asp ects of toxicology, see  pages 18 to 23.
Guthion
Chemical Name: 0 ,0-dimethyl S-(4-oxo-l,2,3-benzotriazin-3 
(4H)-ylmethyl)phosphorodithioate.
Chemical Formula: C H 3-0  S
/ P  
C H j - O
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Formulations: Guthion i s  available  a s  an approximately 18% emul- 
sifiab le  concentrate, a s 25% wettable powder, and a s  3% dust.
Uses: Guthion is  currently used in controlling a wide variety pf 
in sects on fruit, nuts, cotton, and some vegetables.
Routes of Absorption: Guthion can be absorbed through any body 
portal.
Dangerous Acute and Repeated Doses to Man: There i s  little 
direct knowledge of the acute and chronic dosages that would be 
dangerous to man. Although the acute oral toxicity is  sim ilar to 
that of parathion, the dermal toxicity is  considerably lower than 
that of most other highly toxic organophosphorus pestic id es. T his 
difference may account for the better safety  record of Guthion. 
Dogs that were fed d iets containing 20 ppm of Guthion for 12 
weeks exhibited no toxic symptoms, although their red blood cell 
cholinesterase was depressed to about 80% of normal.
Signs and Symptoms of Poisoning in Man: No fatal c a se s  of poison­
ing with Guthion are known. People with occupational exposure 
have an excellent safety record sim ilar to that of people using 
malathion.
Other Toxicology: The toxicology of Guthion is  similar to that of 
the organic phosphorus compounds generally. See pages 12 to 23.
Malathion
Chemical Name: 0 ,0-dimethyl S - ( l ,2-dicarbethoxyethyl) 
phosphorodithioate.
Chemical Formula: CH3-O S Ç
/P-S-CH-C-O- C2H,
CH3-O I ^
c h 2-c -o - c 2h ,
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Formulations: Malathion is  available a s  technical grade material, 
wettable powder (25%), dusts, solutions, poison b a its, and emulsi- 
fiable concentrates.
Uses: Malathion is  used in the control of certain p ests  of fruits, 
vegetables, and ornamentals. A s a public health pesticide, it  has 
been employed for the control of house f lie s , m osquitoes, and lice . 
For fly control, malathion i s  used in liquid and dry b a its.
Routes of Absorption: Malathion i s  absorbed by all portals, but 
skin absorption i s  inefficient (see  below).
Pharmacologic Action: Much of the malathion taken into the mam­
malian body i s  broken down, chiefly in the liver, into harmless 
m aterials, but some i s  converted into compounds that inhibit cho­
lin esterase  and, therefore, may produce the characteristic s ign s 
and symptoms caused by other organic phosphorus compounds (see  
page 15). M assive doses of malathion produce temporary muscular 
w eakness in chickens, which, like man, are susceptib le  to this 
kind of effect. Affected chickens continue to show this paresis  for 
up to three weeks after full recovery from the ordinary signs of 
malathion poisoning. Moderate d oses produce no such effect, and 
the compound i s  practical for the control of ectoparasites of 
chickens. The mechanism by which the muscular w eakness is  pro­
duced i s  not known, but it  i s  clearly not identical to that responsi­
ble for other poisoning. The muscular w eakness, such a s  that seen 
in chickens, has not been seen in human c a se s  (perhaps because of 
dosage); it s  relationship to the coma and flaccidity  seen in some 
human c a se s  i s  not known.
Dangerous Single and Repeated Doses to Man: A dose of only about
4 g. of malathion produced severe but nonfatal illn ess  in a child 
who drank it, and a dose of 14 g. had a sim ilar effect on a woman. 
On the contrary, an amount estim ated at 5 g. led to the death of a 
75-year-old man about 1.5 hours after ingestion. A second fatality 
resulted from an estimated 56.7 g. of malathion. All confirmed 
c a se s , whether fatal or not, have involved proved or possib le  in-
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gestion as determined by history or the finding of malathion in 
stomach washings, or both. F ive c a se s  reported a s  malathion 
poisoning presumably involved dermal or respiratory exposure. 
T h ese  c a se s  show little clin ical resemblance to confirmed c a se s  
or to one another. An oral dose of 58 mg. taken experimentally 
produced no clin ical effect and 23% of the dose was recovered in 
the urine. A total of 1106 mg. was recovered from the urine of a 
man who barely recovered following attempted suicide.
The repeated dosage of malathion necessary  to produce clini­
cal illn e ss  in man i s  unknown. Experiments have shown that people 
can eat 16 mg. of malathion daily without significant depression 
of cholinesterase or any clin ical effect. A dosage of 24 mg. per 
day for 56 days produced a maximal reduction of 25% in both plasm a 
and red blood cell cholinesterase. Ten percent malathion powder 
was applied daily to essen tially  all the human skin, and an average 
of 2% of the available dose was recovered in the urine. When this 
dosage was repeated daily, an average daily excretion of 51.5 mg. 
of malathion-equivalent was recovered. The maximal rate of ex­
cretion measured in this way with no clin ical side effects was 
229 mg. per day. The rate of malathion absorption was undoubtedly 
somewhat greater than the rate of recovery of malathion-equivalent 
in the urine. Very extensive use of malathion has not led to de­
pletion of blood cholinesterase in applicators. The threshold limit 
value for malathion in air is  15 mg./M3.
Signs and Symptoms of Poisoning in Man: Broadly speaking, the 
s ign s and symptoms observed in poisoning by other organic phos­
phorus compounds have been seen in poisoning by malathion. 
However, sudden coma (characterized by unconsciousness and 
marked flaccidity of the limbs, but without cardiovascular co llapse 
and with minimal interference with respiration) occurred in several 
c a se s  that went on to uneventful recovery. (A sim ilar flaccidity 
with minimal interference with respiration has been reported more 
rarely in people poisoned by parathion.) In at le a st  one c a se  of 
malathion poisoning, coma was recurrent. Involuntary defecation 
and urination occurred during coma in several in stan ces. Some
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patients seemed to respond promptly to atropine su lfate , while 
others showed le s s  response than might be expected. Choiinester- 
a se  w as only moderately depressed when illn e ss  was severe, but 
w as severely depressed in a fatal c a se  in which the measurement 
was made. Thus, there i s  more than a hint that poisoning by mala- 
thion i s  characterized in man by “ side  e ffe c ts”  not seen in poison­
ing by inherently more toxic organic phosphorus compounds. In any 
event, it  i s  clear that a relatively large dose of malathion is  re­
quired to produce illn ess  and that the chances of recovery from 
this i l ln e ss  are better than might be judged from the clin ical ap­
pearance of the patient.
Laboratory Findings: In the few c a se s  in which blood cholinester­
a se  was measured, the red cell and plasm a enzymes were about 
40% to 50% of normal, which was higher than the clin ical severity 
of the c a se s  would have led one to predict.
Treatment and Other Toxicology: See pages 18 to 23.
Methyl parathion
Chemical Name: 0 ,0-dimethyl O-(p-nitrophenyl) phosphorothioate.
Chemical Formula: CH3-0 S / = = \
> ° - ( \  > N ° .
CHj-O ^ __ /
Formulations: Methyl parathion i s  available  a s  70% solution, 24% 
to 51% em ulsifiable concentrates, and 25% dust concentrate. It is  
applied in the form of dilute sprays or dusts (1.5% to 5%).
Uses: Control of agricultural p e sts .
Routes of Absorption: Methyl parathion may be absorbed by any 
route.
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Toxicology: The dangerous dose i s  not known. An oral dosage of 
7.0 mg. daily  for 24 days (approximately 0.1 m g./kg./day) produced 
no significant effect on red cell cholinesterase and only about 15% 
inhibition o f the plasm a enzyifre of volunteers. All confirmed c a se s  
of human poisoning have had substantial exposure. In what may 
have been the only fatal ca se , the compound was recovered from 
the stomach and must have been ingested. Animal experiments 
indicate a somewhat lower dermal toxicity than that for parathion. 
This finding may be a factor in explaining the relatively good 
occupational safety  record of methyl parathion. For treatment and 
other a sp ects  o f toxicology, see  pages 18 to 23.
Parathion
Chemical Name: 0 ,0-diethyl O-(p-nitrophenyl) phosphorothioate. 
Chemical Formula: C2H,-Q S / = >’h ’ -on s  / = \
Formulations: Parathion i s  currently used a s  dilute sprays, which 
are prepared by the operator from 15% or 25% wettable powders or 
from em ulsifiable concentrates o f 50% or le s s .  D usts are used a lso . 
They may be purchased ready mixed in concentrations of 5% or 
le s s .  Technical parathion, which i s  a deep brown to yellow liquid 
and approximately 98% pure, may be encountered under industrial 
conditions and in formulating establishm ents. Aerosol formulations 
containing up to 10% parathion may be used in greenhouses. Cords 
impregnated with parathion for fly control contain about 100 mg. per 
linear foot.
Uses: Parathion finds alm ost it s  entire use in agriculture including 
nurseries, greenhouses, etc. Persons exposed occupationally to 
parathion may be engaged in synthesizing the compound, formula­
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ting and packaging it , applying it, or working among residues. Even 
those workers whose only contact has been with fresh residues 
have occasionally  been poisoned. This has been noted among such 
crop workers a s  thinners, harvesters, and irrigators. Accidental ex­
posure o f children to open or even “ empty”  containers has been a 
major and dramatic source of fatal poisonings.
Under practical field conditions, agricultural workers may have 
approximately concurrent exposure to two or more organic phos­
phorus pestic id es. The patient may recall only the most recent use 
of the most advertised formulation; a careful history is  necessary  
to reveal the facts.
Routes of Absorption: Absorption takes p lace readily through any 
portal. F a ta l human poisoning has followed ingestion, skin ex­
posure, and a lso  inhalation with varying degrees of skin exposure. 
The vapor pressure of parathion i s  so low that respiratory exposure 
alone i s  not considered important a s  a cause  of serious poisoning 
from wet sprays. Respiratory exposure to finely particulate dust is  
hazardous; complete respiratory protection has reduced illn e ss  
among formulating plant workers. Aerosol preparations are known 
to be highly dangerous.
Pharmacologic Action: See page 12.
Dangerous Single and Repeated Doses to Man: Death has followed 
splashing of the body and clothing of one worker with technical 
parathion (approximately 95% pure). The amount was sufficiently 
small that the worker was not soaked or at any rate did not follow 
the simple instructions for changing clothes and bathing. Several 
operators have died after rather extensive skin contact with -dilute 
agricultural sprays or dusts. Children 7 to 9 years old were killed 
by bathing in a tub in a house that had been sprayed several days 
earlier with 10% parathion intended for ornamental plants in a 
greenhouse. Other children died after swinging on a parathion con­
taminated bag suspended by a rope. Both children and adults have 
been poisoned by parathion applied with the intention of controlling 
head lice  or other lice.
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In  a number of fatal c a se s  of human poisoning by parathion, 
the dosage which the victim received orally was known to be 
exactly 900 mg. In one carefully studied c a se , the ingestion of 
120 mg. led rapidly to death of a man. Children 5 to 6 years old 
were killed by eating 2 mg. of parathion, a dosage of about 0.1 
m g./kg. In instances in which parathion contaminated food eaten 
by people of different age s, death occurred mainly or exclusively 
among children.
A daily oral dose of 7.2 mg. produced a 33% fall in whole 
blood cholinesterase of adult volunteers in 42 days. A dose of
3 m g./day produced no effect. The established  threshold limit for 
parathion in air is  0.1 mg./M3.
Laboratory Findings: See page 16. Under certain circum stances, 
parathion may be iso lated  from exhumed bodies a s  well a s fresh 
necropsy specim ens.
Treatment and Other Toxicology: See pages 18 to 23.
Phorate
Chemical Name: 0 ,0 -diethyl S-(methylthio-ethyl)phosphorodithioate.
Chemical Formula: C2H5-0 S
/P-S-CH2 -S-C2H5
c 2h 5-o
Formulations: Carbon impregnated with 44% phorate.
Uses: Seed treatment of cotton and legum es.
Dangerous Single and Repeated Doses to Man: The dangerous dose 
of phorate for man is  unknown but obviously sm all.
Signs and Symptoms of Poisoning in Man: The sign s and symptoms 
described on page 15 have occurred in c a se s  associated  with
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phorate. One patient suffered occasional convulsions and a severe 
fall in blood pressure. He required artificial respiration but ulti­
mately recovered.
Treatment and Other Toxicology: See pages 18 to 23.
Phosdrin
Chemical Name: alpha isomer of 2-carbomethoxy-l-methylvinyl 
dimethyl phosphate.
Chemical Formula: CH3-0 <J) CH3 (¡)
/P-O-C = CH-C-O-CHj 
CH3-0
Formulations: Technical Phosdrin contains not le s s  than 60% of 
the alpha isomer listed  above, the remainder being insecticidally  
active related compounds. It is  available a s approximately 25% 
and 50% concentrates, 25% water-soluble solutions, 1% and 2% 
d usts, 1% and 2% granules, and 20% to 25% wettable powders.
Pharmacologic Action: Phosdrin is  a direct inhibitor of cholines­
terase . It, therefore, shares with T E P P  the unusual property of 
causing m iosis in the presence of mild or even no system ic illn e ss . 
It i s  a lso  distinguished by its  ability to cause other local effects 
and by its  high toxicity and rapid onset of system ic symptoms.
Dangerous Acute and Repeated Doses to Man: The dangerous dose 
of Phosdrin for man is  unknown. However, animal experiments and 
human c a se s  show that it is  very sm all. The tentative threshold 
limit value for Phosdrin in air is  0.1 mg./M3.
Signs and Symptoms of Poisoning in Man: Most observed c a se s  
have been occupational in origin. In general, the sign s and symp­
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toms described on page 15 have been seen , but presence of v isual 
disturbance and rapidity of onset have been noteworthy and are 
probably asso ciated  with direct inhibition of Cholinesterase. Illn e ss  
has begun within 15 minutes of sp illage  of the insecticide and 
within 45 minutes of first exposure.
Treatment and Other Toxicology: See pages 18 to 23.
S ch ra d a n
Chemical Name: octamethylpyrophosphoramide
Formulations: Sprays and aerosol bombs (7%). Concentrations a s 
high a s  42% are available.
Uses: Schradan is  a system ic in secticide absorbed by plants and 
translocated to all parts for the control of sucking in sects.
Dangerous Single and Repeated Doses to Man: Apparently, human 
illn e ss  a s  the result of exposure to schradan has not been re­
ported. The ingestion of lm g. of schradan per day caused a gradual, 
asymptomatic depression of blood cholinesterase (especially  red 
cell enzyme) in 24 volunteers. The depression was maximal (25% 
in whole blood) after about 40 days. The ingestion of 4.2 mg. of 
schradan per day by one sub ject caused a maximal depression of 
whole blood cholinesterase (67%) after about 60 days of the 74-day 
exposure period. Patients with myasthenia gravis have been main­
tained on d o ses of 7 mg. every 12 hours for months with apparent
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benefit and on d oses of 15 mg. every 12 hours with some sign s of 
intoxication.
Treatment and Other Toxicology: See pages 18 to 23.
TEPP
Chemical Name: tetraethyl pyrophosphate.
Chemical Formula: C2H ,-0. q  Q / O C2H5
P - ° - P
c 2h 5-ck x m : 2h .
Formulations: Formulations (all expressed  a s technical T E P P *) 
include concentrates (solutions of the organophosphates and emul­
sifiers in an organic solvent) ranging up to 50% or more and field- 
use emulsions ranging from 0.025% to 0.4%, aeroso ls from 0.5% to 
4%, and dusts from 0.5% to 2.0%. A mixture of 4.7% T E P P  and 
10.7% lindane has been used for fly control after dilution with a 
solution of m olasses which serves a s  a bait.
Uses: T E P P  is  used a s  a substitute for nicotine in the control of 
aphids, m ites, and other soft-bodied arthropods. Its  use in the con­
trol of in sects of public health importance has been limited almost 
entirely to fly control.
Routes of Absorption: T E P P  is  absorbed readily through all por­
ta ls . In the rat the relation between the L D sq by subcutaneous, 
oral, and percutaneous administration i s  1 : 2.5 : 3.5.
Dangerous Single and Repeated Doses to Man: F ata l accidents in­
volving T E P P  have apparently a ll involved suicide or gro ss care-
♦ The t e c h n i c a l  g r a d e  m a t e r i a l  i s  4 0 %  T E P P  a n d  6 0%  r e l a t e d  e t h y l  p h o s p h a t e s ,  
w h i c h  a r e  a l s o  a c t i v e .
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le s sn e ss , such a s  taking the compound by mouth or spilling a 
concentrate of it on the skin. The d osages in such c a se s  are, of 
course, unknown. Several persons, including children, have died 
after spilling the concentrated material on their skin. A number of 
nonfatal accidents have been reported among agricultural workers 
and airplane pilots who were making agricultural application of the 
insecticide. Some experience has been had in man in connection 
with the treatment of myasthenia gravis. A single dose of 5 mg., or
3.6 mg. daily for 2 days, or 2.4 mg. daily for 3 days parenterally; 
or 7.2 mg. every 3 hours orally for 3 to 5 d oses, produced symptoms 
in normal sub jects a s  did slightly larger d oses in myasthenia 
gravis patients receiving atropine sulfate. Symptoms at these 
relatively low dosages included localized  fascicu lations, anorexia, 
nausea, sweating, abdominal cramps, salivation , giddin ess, rest­
le s sn e ss , insomnia, paresth esias, and dreaming. Symptoms ap­
peared suddenly about 30 minutes after the final dose.
Evidence has been obtained that 5 mg. intramuscularly or 25 
mg. orally would cause severe symptoms. Likew ise, it is  believed 
that 20 mg. intramuscularly or 100 mg. orally would cause death. 
It will be noted that the single oral dose of 25 mg. per man men­
tioned above represents a dosage of only about 0.35 m g./kg.
The threshold limit value for T E P P  in air is  0.05 mg./M3.
Signs and Symptoms of Poisoning in Man: In addition to the sy s­
temic poisoning effects listed  on page 15, the following local 
e ffects should be mentioned. Since T E P P  is  a direct inhibitor of 
cholinesterase, it  may produce ophthalmic and possib ly  pulmonary 
sign s and symptoms without accompanying system ic illn e ss . The 
picture produced by ophthalmic instillation  of 0.1% technical T E P P  
in peanut oil consisted of e x c e ss  lacrimation, rhinitis, burning, 
mild blurring of vision, mild headaches, sensations of pressure in 
the eyeballs or over the frons and, within 20-30 minutes, pin-point 
pupils with accompanying increased accommodation and diminished 
light perception. Most of these sign s and symptoms disappeared in 
a few hours, but considerable m iosis persisted  for 24 hours and the 
effects were not all gone after 48 hours. When instillation was 
limited to one eye, resulting in unilateral m iosis, the volunteers
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complained of disturbance of depth perception even though they 
p assed  standard te sts  of static  depth perception. This complaint 
was due to the production of the Pulfrich phenomenon brought on by 
the unequal light in the two eyes. Similar effects, e specia lly  
m iosis, have occurred in agricultural workers, including p ilots, who 
were exposed in the course of their work.
There is  evidence, e specia lly  with d u sts, that there may be
signs of T E P P  poisoning restricted to the respiratory system . 
Rhinitis and a sensation of tightness in the chest may be due
entirely to the localized  effect of the T E P P . Local e ffe c ts  from
parathion or demeton are le s s  apparent.
Laboratory Findings: See page 16.
Treatment and Other Toxicology: See pages 18 to 23.
T richlorofon
Chemical Name: 0 ,0-dimethyl,2,2,2-trichloro-l-hydroxyethyl 
phosphonate.
Chemical Formula: CH3-0<J) OH
^P- CH-CClj 
CH3-0
Formulations: Trichlorofon is  available a s  a 1% dry bait for fly 
control. Other formulations are 50% wettable powder, 5% dusts and 
granules, and fly d isk s each of which contains 0.1 g.
Uses: This material is  used in dairy barns and milk processing 
rooms a s  a poison bait for fly control. It is  a lso  used for control of 
roaches and a variety of in sect p ests of field crops and ornamen­
ta ls . More recently the compound has been used, either a s  an oral 
dose or spray for control of cattle grubs, horse bots, screw worms, 
various arthropod ectoparasites, and several nematode worms.
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Routes of Absorption: Trichlorofon is  readily absorbed through the 
skin a s  well a s by other routes.
Pharmacologic Action: See page 12. Trichlorofon is  a weak direct 
inhibitor of cholinesterase. It differs from other compounds in this 
group with respect to the very rapid recovery from symptoms of sub- 
lethal poisoning noted in experimental animals.
Dangerous Single and Repeated Doses to Man: A highly purified 
trichlorofon formulation given in two doses of 7.5 m g./kg. on suc­
ceeding days to 15 volunteers (a total dose of 1,050 mg. for a 70 
kg. man) produced nausea, co lic , and sweating in one and no ill­
n e ss  in the others. The affected person recovered after a single 
dose of atropine su lfate . The plasm a cholinesterase level fell to 
below 10% of normal, and the red cell cholinesterase fell to about 
50% in all the sub jects. Later, this same dosage was used ex­
tensively for the treatment of intestinal worms with infrequent 
and mild side effects.
Other Toxicology: Taking into account the high dosage of tri­
chlorofon necessary  to produce poisoning in man or anim als, and 
a lso  taking into account the rapidity of recovery, the toxicology of 
trichlorofon i s  otherwise similar to that of the organic phosphorus 
in sectic id es generally. For treatment and other asp ects of toxi­
cology, see  pages 18 to 23.
43
C A R B A M A T E  INSECTICIDES
C a rb a ry l
Chemical Name: 1-naphthyl-N-methylcarbamate 
Chemical Formula: Q
Formulations: Carbaryl i s  manufactured a s  a 98% concentrate which 
is  formulated for use a s  dusts (1.75% to 10%), w ettable powders 
(50% to 80%), and flowable formulations (40% to 50%).
Uses: Carbaryl is  a wide spectrum insecticide effective again st 
in sect p e sts  of fruits and nuts, vegetables, forage crops and cotton, 
and forest and range land.
Routes of Absorption: Carbaryl is  absorbed by all portals including 
the skin.
Pharmacologic Action: The carbam ates are reversible inhibitors 
of cholinesterase. The reversal is  so rapid that, unless special 
precautions are taken, measurements of blood cholinesterase of 
people or animals exposed to carbam ates are likely to be inaccurate 
and always in the direction of appearing to be normal. The com­
pound is  rapidly metabolized. The naphthalene moiety is  excreted 
a s  1-naphthol, largely in a conjugated form. Concentrates may 
cause skin irritation a s well a s  system ic poisoning.
Dangerous Acute and Repeated Doses to Man: A single, carefully- 
measured oral dose o f 250 mg. (approximately 2.8 m g./kg.) resulted
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in moderately severe poisoning of an adult. The sm allest dosage 
that will produce illn e ss  in man following prolonged exposure is  
not known. B ecau se  of the rapid metabolism, the dangerous re­
peated dose may be only slightly smaller than the dangerous single 
dose. Workers exposed to carbaryl dust, sometimes at concentra­
tions a s  high a s  40 mg./M 3 under abnormal conditions but usually 
at lower concentrations, showed a slight depression of blood 
cholinesterase but no illn e ss . Dogs were acutely poisoned when 
exposed in a chamber at a concentration of 75 mg./M 3 for 5 hours.
In the male rat, the oral LDjo  is  850 m g./kg. and the dermal 
L D jo  is  >4,000 m g./kg. Carbaryl was fed to'm ale and female rats 
for 92 days at levels a s high a s  225 to 237 m g./kg ./day  without 
significant effect on food consumption, rate of growth, or level of 
plasma or red cell cholinesterase. Single oral d o se s at the highest 
level depressed the plasm a and red cell cholinesterases but the 
activ ities of these enzymes came back to normal within 16 hours.
Signs and Symptoms of Poisoning in Man: A 19-month old infant 
developed constriction of the pupils, salivation , and muscular in­
coordination in spite of gastric  lavage within half an hour after 
ingestion of an unknown amount o f carbaryl. A single 0.3 mg. dose 
of atropine su lfate  was effective, and recovery was apparently 
complete in 12 hours. The man who swallowed 250 mg. o f carbaryl 
had a very sudden onset of violent epigastric pain 20 minutes after 
the dose. A little  later he began to sw eat profusely. A 1 mg. dose 
o f atropine su lfate produced little  improvement although he was 
s till able to continue work. He gradually developed great lassitu de  
and vomited twice. One hour after ingesting carbaryl, and following 
a total of 3 mg. of atropine su lfate , he w as feeling better. After one 
more hour he w as completely recovered and enjoyed lunch.
Laboratory Findings: Blood cholinesterase is  inhibited; it should 
be measured by a technique that minimizes reactivation. 1-Naph- 
thol, a compound normally present only in traces, is  excreted in 
the urine following absorption of carbaryl. A specimen collected 18 
hours after poisoning from the infant mentioned above contained a
689679 0 - 6 3 - 4
concentration of 31.4 ppm. Healthy men with occupational ex­
posure have been found to excrete conjugated plus free 1-naphthol 
at a rate of 10 ppm or slightly higher, while unexposed men excrete
1.5 to 4.0 ppm.
Treatment: Depending on the severity of the ca se , a ll the methods 
used for treating poisoning by organic phosphorus compounds are 
useful with one exception: 2-PAM  and other oxim es are not recom­
mended for routine use. Animal stud ies indicate that the use o f 2- 
PAM might be harmful. Although people might not show the same 
reaction, no oxime should be used for treating poisoning by a 
carbamate insecticide except on an investigational b a s is .
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C H L O R IN A T E D  H Y D R O C A R B O N  INSECTICIDES
Introduction: The chlorinated hydrocarbon in secticides have in 
common the chemical composition implied in the group name. 
However, beyond this broad sim ilarity, the compounds vary widely 
in chemical structure and activity . Although much i s  known about 
the pharmacology of these m aterials, the b a sic  mode of action is  
not known for a single one of them. It is  entirely possib le  that 
chlorinated hydrocarbon in sectic id es of significantly different 
chemical structure have different modes of action; i t  i s  certain 
that there are qualitative a s  well a s  quantitative differences in 
their pharmacologic action.
The acute oral and dermal LD -v a lu e s  to rats of certains o
chlorinated hydrocarbon in sectic id es and derivatives including 
those treated in this Handbook are given in the table (page 48).
The following description, based  largely on DDT, is  appli­
cable to the chlorinated hydrocarbon in sectic id es a s  a group. The 
actions known to be peculiar to specific  compounds are described 
in the separate section s.
Pharmacologic Action: The chlorinated hydrocarbon in sectic id es 
act on the central nervous system , but the exact mechanism of 
this action either in man or in animals has not been elucidated. 
Large doses a lso  induce nausea and/or diarrhea. On repeated dos­
age, the compounds produce microscopic changes in the liver and 
kidneys in some experimental anim als. T his has not been demon­
strated clearly in man in connection with uncomplicated poisoning. 
Somewhat different lesion s may be produced in man or animals by a 
single fatal dose.
The compounds and/or certain degradation products are stored 
in fat. Such storage resu lts either from a single  large dose or from 
repeated sm all d o se s. The m aterials stored in the fat appear to be 
largely inactive, since the total amount stored in an experimental 
animal often may be greater than the lethal dose i f  given at one 
time. The in sectic id es (or their derivatives) usually may be demon-
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A C U T E  O R A L  A N D  D E R M A L  L D 5„ - V A L U E S  O F  
C H L O R I N A T E D  H Y D R O C A R B O N  I N S E C T I C I D E S  F O R  
M A L E  A N D  F E M A L E  W H IT E  R A T S
C O M P O U N D
O R A L  L D 50 (M G ./ K G .) D E R M A L  L D S0 ( M G ./ K G .)
M A L E S F E M A L E S M A L E S F E M A L E S
A ld r in 39* 60* 98* 98*
Chlordane 335* 430* 840* 690*
C h lo ro b e n zi la te 1040* 1220 — —
D D A  + 740* 600 — —
D D E  + 880* 1240* - -
D D T 113* 118* — 2510*
D ie ld r in 46* 46* 90* 60*
D ila n - - 6900* 5900*
Endrin 17.8* 7.5* — 15*
Hep tach lor 100 162 195 250
Isodrin 15.5* 7.0* 35* 23*
Kelthane 1100* 1000* 1230* 1000*
L in d a n e 88 91 1000 900
Methoxychlor (6000.0)** - - >  6000*
Perthane >  4000* >  4000* - —
T D E  (D D D ) (3400)** - - -
Th io d a n 43 18 130 74
To xaph en e 90* 80* 1075 780
* T h e s e  v a lu e s  were determined by the T o x i c o l o g y  S e ct io n  under 
s ta n d a rd ize d  co n d it io n s .
** S e x  not s p e c i f ie d .
+  Metaboli te  of D D T .
strated in milk and urine. The compounds stored in the fat are 
eliminated only very gradually when further dosage i s  discontinued.
Laboratory Findings: Laboratory findings are usually negative and 
alw ays nonspecific except that the insecticide or its  derivatives 
may be demonstrated in stomach contents, urine, or t is su e s , e s ­
pecially  fat. See Appendices B and D.
Pathology: In experimental animals killed by large d o se s of chlori­
nated hydrocarbon in sectic id e s, dilatation of blood v e s se ls  and
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even small petechial hemorrhages secondary to convulsions may be 
encountered. The outstanding changes following repeated DDT 
feeding in rodents are found in the liver. T h ese  changes con sist of 
centrolobular hypertrophy, margination of cytoplasmic granules, 
fatty infiltration, and lipospheres formed by proliferation of smooth- 
contoured endoplasmic reticulum. Similar changes occur in combi­
nation following exposure to other chlorinated hydrocarbon in secti­
cides and occur separately following a wide variety of toxicants. 
T h ese  changes have not been found in the higher animals nor in 
man. All sp ec ie s show liver cell necrosis but only at very high 
lev els of dosage. Here again the changes are in no way specific .
Differential Diagnosis: Nervous symptoms and convulsions entirely 
sim ilar to those of chlorinated hydrocarbon insecticide poisoning 
may be induced by a variety of economic poisons a s  well a s  by 
even le s s  specific  neurologic d ise a se . If maximal symptoms are 
not reached within a matter of a few hours after acute exposure, 
then another d iagn osis or some complicating factor should be 
sought. Even if  it  is  known that an insecticide has been taken, the 
effect of the solvent should be carefully considered. (See section 
on solvents, page 114.)
Treatment: Depending on the condition of the patient, attention 
should first be given to sedation or to the removal of poison which 
may have been taken internally. Syrup of ipecac, gastric  lavage, 
and saline laxatives may be used. Oil laxatives should be avoided, 
for they promote absorption of these in secticides and of many 
organic solvents. Removal of poison from the skin is  important 
a lso ; it is  done b est with soap and water.
While antidotes discovered in animal te sts  can be expected to 
provide protection-for poisoned human beings, it is  not always easy  
to draw conclusions regarding human dosage from such te sts . In 
general, the dosage of antidotes employed su ccessfu lly  in animals 
exceeds that considered safe  in human practice. The following 
recommendations are n ecessarily  based  on the resu lts obtained 
from the administration of likely antidotes to warm-blooded animals
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(including monkeys) previously dosed with lethal amounts of 
in secticide:
Phenobarbital, which has been used in d oses up to 0.7 
g. per day in epilepsy , and pentobarbital (0.25 to 0.5 g.) 
are the barbiturates known to control convulsions of 
central origin. The object of sedation is  not to induce 
sleep  but to restore a relative calm; however, the proper 
dosage in the presence of poisoning may be so  large that 
it would induce an esth esia  if poisoning were not present.
Calcium gluconate has been used le s s  than the other 
antidotes. It is  reported to control convulsions caused by 
chlorinated hydrocarbon in secticides in experimental 
animals, and it has seemed helpful in a few human c a se s . 
Since its  mechanism of action is  entirely different, it may 
be used in addition to sedatives.
Epinephrine is  contraindicated. It se n sitize s  the heart, 
predisposing to serious arrhythmias and thus to death.
BHC
Chemical Name: 1,2,3,4,5,'6-hexachlorocyclohexane.* 
Chemical Formula: c l
C l
Formulations: In addition to the technical grade m aterial,* solu­
tions, em ulsions, wettable powders, d usts, and poison ba its  are
* T h e  c o m m e r c i a l  p ro d u c t  h a s  a b o u t  th e  fo l lo w in g  i s o m e r ic  c o m p o s i t io n :  a lp h a ,  65%  to  
70% ; b e t a ,  6% to  8% ; g am m a , 12% to  15%; d e l t a ,  2% to  5% ; e p s i lo n ,  3% to  77o; o th e r  
is o m e rs  a n d  r e l a t e d  c o m p o u n d s , 2% to  3% .
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available. Lindane* is  used in many formulations, especially  
those for household use.
Uses: BHC is  widely used in the control of cotton in sects. A s a 
t1% powder lindane is  used for the control of body lice  which are 
resistan t to DDT. BHC has been used for the control of other 
in sects of public health importance particularly in the countries 
under British influence, and it has found some use for this purpose 
in the United S tates. Some household preparations contain BHC or 
lindane, and it has been used to some extent for the control of 
D D T-resistant flie s  and m osquitoes. In some areas, lindane i s  
extensively used for termite control.
Routes of Absorption: BHC may be absorbed through any portal 
including the skin. The material i s  a local irritant, but this property 
i s  inversely proportional to the purity of the sample.
Pharmacologic Action: The several isom ers of BHC have different 
actions. The gamma and alpha isom ers are stimulants to the cen­
tral nervous system , the principal symptom being convulsions. The 
beta and delta isom ers are depressants of the central nervous 
system .
Dangerous Single Dose to Man: The dangerous single dose of the 
technical mixture has been estimated at about 30 g. and the danger­
ous dose of lindane at about 7 to 15 g. T hese estim ates may be too 
high, for a young man suffered serious illn e ss  including a convul­
sion following a single carefully-measured dose of 45 mg. of lin­
dane intended a s  a vermifuge. He was one of 15 patients treated 
with a highly dispersed emulsion at an intended dosage of 45 mg. 
(30 mg. for the la s t  of the se r ie s) three times a day for 3 days. Of 
the 15 patients, 6 showed some toxic symptoms. It is  true, that in 
similar stud ies of the potential use of benzene hexachloride a s  a 
drug, other persons have withstood larger d oses, e specia lly  of
* L in d a n e  i s  th e  a c c e p t e d  com m on  n am e  fo r  e s s e n t i a l l y  p u re  g am m a is o m e r  o f b e n z e n e  
h e x a c h lo r id e .
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undissolved or poorly dispersed material, apparently without seri­
ous effect. These observations are summarized in the table be­
low. In these stud ies, it was found that a mixture of isom ers 
burned the tongue and the unpurified mixtures were highly irritative.
The fatal poisoning of a 5-year-old girl weighing about 55 
pounds was caused by the accidental ingestion of 4.5 g. of BHC a s  
a 30% solution in an unspecified organic solvent. T h is represents 
a dosage of 180 m g./kg. In sp ite  o f evacuation of her stomach and 
therapy to restore failing circulation, she died.
Formulation 
(Percent Gamma 
Isomer)
Dosage Effect
10 -3 0 4 0  m g . / d a y ,  
10 da ys
D ia r r h e a  a f t e r  8th  d a y .
6 0 - 8 5
4 0  m g . / d a y ,  
14 d a y s
N o  e f f e c t - o b s e r v e d .
110  m g . / d a y ,  
re p e a te d
D i a r r h e a  a f t e r  6 th  d a y .
4 0  m g . / d a y ,  
14 d a y s
N o  e f f e c t  o b s e r v e d .
100 4 5  m g. t . i . d . ,  3 d a y s ,  
( 2 0  p a t i e n t s )
N o  e f f e c t  o b s e r v e d .
180 m g . / d a y ,  
re p e a t e d
D i z z i n e s s  an d  d i a r r h e a  
a f t e r  s e v e r a l  d a y s .
A number of children have been poisoned by eating a s  little a s  
a part of one (0.33 g.) tablet of lindane intended for use in thermal 
vaporizers. At le a st three 1.4 to 1.5-year-old children have been 
killed by eating larger amounts of lindane intended for this purpose. 
The dosage in one ca se  was thought to be 7 g. In one other ca se , it 
was an unknown multiple of 0.8 g. (the weight of one tablet).
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The use of thermal vaporizers with lindane has caused some 
clear-cut in stances of respiratory poiso ’H’ig. For example, two 
refreshment stand operators suffered se v e r3 headache; nausea; and 
irritation of eyes, nose, and throat shortly after exposure to lindane 
vapors from a dispenser in which the in sectic ide  apparently became 
overheated. The symptoms abated 2 hours after the device was 
removed. Overheated Lindane i s  more apt to cause  respiratory d is­
tre ss  than i s  lindane vaporized at lower temperatures. T h is is  true 
because  the greater heat "releases more of the compound and a lso  
cau se s some splitting of the molecule into highly irritating decom­
position products.
It i s  interesting to note that lindane shows a marked difference 
in toxicity to different sp e c ie s . Its  toxicity to laboratory animals 
i s  le s s  than that o f DDT, but for several domestic anim als, notably 
ca lv es, lindane i s  more toxic than DDT or even dieldrin.
Dangerous Repeated Dose to Man: There are no confirmed c a se s  of 
system ic poisoning in man a s  a resu lt of repeated exposure to BHC.
It is  interesting to note that in laboratory animals the gamma 
isomer has by far the greatest acute toxicity, but i t s  relatively 
rapid excretion by the kidneys does not permit extensive accumu­
lation in the body, and the gamma isomer shows the low est toxicity 
on repeated exposure. The highest toxicity  following repeated 
dosage and the low est acute toxicity are shown by the beta isomer, 
which has no in secticidal importance but forms a part of those 
formulations prepared from technical grade BHC. The use of Lin­
dane, therefore, i s  favored not onLy because it i s  the most effective 
form of BHC for killing in se c ts , but a lso  because  it probably pre­
sents a relatively low toxicity to workers who have long, intensive 
exposure.
Dermatitis and perhaps other m anifestations based  on sen si­
tivity have been observed in human beings. Dermatitis has been 
reported in workers who came in contact with BHC and its  pre­
cursors during manufacture without proper hygienic precautions.
Shortly after a lindane vaporizer was installed  in her p lace  of 
employment, a 35-year-old woman developed urticaria. The dermati­
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tis  improved during weekends, but recurred when she returned to 
work. Patch te s ts  were positive. Complete elimination of exposure 
resulted in permanent recovery. For a more extended d iscussion  
see  articles by the A.M.A. Committee on P estic id e s: Health haz­
ards of electric vaporizing devices for in sectic id e s. J.A.M .A. 149: 
367-369, May 1952; Health problems of vaporizing and fumigating 
dev ices for in sectic id es; a supplementary report. J.A .M .A. 152: 
1232-1234, Ju ly  1953; and Abuse of in secticide fumigating devices, 
J.A .M .A. 156:607, October 1954.
The threshold limit value for lindane in air i s  0.5 mg./M 3.
Signs and Symptoms of Poisoning in Man: In 3 of the fatal c a se s , 
symptoms began 1 to 2 hours and death followed 12 hours or le s s  
after BHC was ingested. In another c a se , symptoms began 3.3 hours 
and death occurred 80 hours after ingestion. I lln e ss  w as character­
ized by repeated, violent, clonic convulsions, sometimes super­
imposed on a continuous tonic spasm . Respiratory difficulty and 
cyanosis secondary to the convulsions were common. In some 
c a se s , the victim screamed during convulsions a s  if in terrible 
pain. In at le a st  one case , the rectal temperature reached 103° F. 
Insofar a s records are available, heart and respiratory failure ap­
peared to be simultaneous. In the nonfatal c a se s , sign s of hyper­
irritability have differed only in degree.
Men acutely exposed to high air concentrations of lindane 
and its  decomposition products show headache, nausea, and irrita­
tion of eyes, nose, and throat.
Urticaria has followed exposure to lindane vapor in rare in­
stan ces. Unlike the signs and symptoms already mentioned, this 
allergic manifestation occurs only in su sceptib le  individuals, 
apparently only after a period of sensitization .
Blood d yscrasias have been attributed to BHC rarely. How­
ever, they probably have been attributed more frequently to it  than 
to any other modern pesticide including those used in greater 
tonnage. About half the reported c a se s  happened in one European 
country. It is  possib le  that the occurrence of traces of impurities 
or some other differences of formulation account for the peculiar 
distribution of alleged c a se s . The same may be said  about c a se s  of
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nervous disorder in men working with BHC in another European 
country. The relationship between these disorders of the blood and 
the nervous system and BHC is  not fully established  even in con­
nection with large d oses.
Laboratory Findings: In one c a se , the following concentrations of 
lindane were found at autopsy: fat, 343 ppm; liver, 88 ppm; stool, 
478 ppm; and stomach contents, 105,000 ppm.
Pathology: In the c a se  of a 1.5-year-old boy who ingested lindane 
with no solvent or other toxicant present, the gross findings in­
cluded congestion of the lungs and kidneys, distention of the 
intestinal tract, and a reddish yellow appearance of the liver. 
M icroscopically, the lungs showed edema, congestion, and broncho­
pneumonia. The liver exhibited fatty metamorphosis, and the kid­
ney tubules revealed degenerative changes. There were tiny 
hemorrhages in the brain associated , at le a st in some instances, 
with necrosis in the w alls of the small blood v e sse ls . The change 
in the lung appeared to be consistent with aspiration pneumonia. 
The liver changes were more prominent than those seen in labora­
tory animals under sim ilar conditions. The findings were similar 
in two other c a se s  in which pathology was reported.
Chlordane
Chemical Name: l,2,4,5,6,7,8,8-octachloro-3a,4,7,7a-tetrahydro-4,7 
methanoindane.*
♦ T h e  t e c h n ic a l  g ra d e  c h lo rd a n e  c o n s i s t s  o f  th e  A  a n d  B c h lo r d a n e ,  h e p t a c h lo r ,  a n d  t r ic h lo r  
in  a d d i t io n  to  r e l a t e d  m a te r i a l s  a n d  a  s m a l l  p e r c e n ta g e  of h e x a c h lo r o c y c lo p e n ta d ie n e .
Chemical Formula:
H
C l
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Formulations: Chlordane is  commercially available a s  wettable 
powders, em ulsifiable concentrates, oil solutions, low percentage 
d u sts, and technical chlordane. Technical chlordane is  available in 
two grades -  refined and agricultural. Both grades appear e ssen ­
tially  equal in their in secticidal properties. The agricultural grade 
may be used wherever the staining of treated surfaces is  not a 
problem. The refined grade i s  generally used for the control of 
household insect p e sts .
Uses: Chlordane has been found useful in agriculture. I t  w as used 
rather extensively for control of flie s and mosquitoes in Italy, 
Sardinia, and Greece until resistan ce  developed. It is  found in a 
number of household formulations sold in th is country, either alone 
or in combination with other in sectic id es.
Routes of Absorption: Chlordane is  readily absorbed through the 
skin a s well a s through other portals.
Pharmacologic Action: Chlordane is  a stimulant to the central 
nervous system ; its  exact mode of action is  unknown. Animals 
poisoned by this and related compounds show an extremely marked 
lo s s  of appetite about the same time that they show neurological 
symptoms. See a lso  page 47.
Dangerous Single and Repeated Doses to Man: Convulsions fol­
lowed by recovery occurred in an infant following a dosage of about 
10 m g./kg. and in an adult following 32 m g./kg. The fatal dose for 
man has been estim ated to be between 6 and 60 g ., and clin ical 
experience indicates that this is  e ssen tia lly  correct. One person 
receiving an accidental skin application of 25% solution amounting 
to something over 30 g. of technical chlordane developed symp­
toms within about 40 minutes and died before medical attention was 
obtained. In one patient known to be an alcoholic, death followed 
exposure to a low oral dosage of chlordane (2-4 g .) . Microscopic 
examination of the t issu e s  revealed severe chronic fatty degenera­
tion of the liver, characteristic of chronic alcoholism . Although
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this fatality  cannot be attributed exclusively  to chlordane, it is  
consistent with previous observations that the toxicity of some 
chlorinated hydrocarbons is  much enhanced in the presence of 
chronic liver damage.
A woman who ingested 6 g. (104 m g./kg.) of chlordane in talc 
with su ic id al intent suffered chemical burns of the mouth, severe 
g a stritis , enteritis, diffuse pneumonia, lower nephron syndrome, 
and central nervous system excitation with terminal mania and 
convulsions. Death occurred after 9.5 days. The most important 
autopsy findings were those of severe necrotizing bronchopneu­
monia, and desquamation and degeneration of the renal tubular 
epithelium. The dangerous repeated dose i s  unknown. The thresh­
old limit value for chlordane in air is  2.0 mg./M 3.
Signs and Symptoms of Poisoning in Man: One person poisoned by 
chlordane developed convulsions within 40 minutes of gross skin 
contamination and died, apparently of respiratory failure, before 
medical aid could be obtained. Convulsions and coma may begin 
a s  little  a s  30 minutes after ingestion, but these signs do not 
preclude complete recovery.
Acutely poisoned experimental animals show sim ilar sign s. 
Experimental animals exposed to repeated sm all d oses exhibit 
hyperexcitability, tremors, and convulsions, and those which sur­
vive long enough show marked anorexia and lo s s  of weight. Symp­
toms in animals frequently occur within an hour of the administra­
tion of a large dose, but death often is  delayed for several days 
depending on the dosage and route of administration. In any event, 
symptoms are of longer duration with chlordane than with DDT 
under sim ilar conditions.
Laboratory Findings: See page 48.
Pathology: See page 48.
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Chemical Name: 2,2,&is(j?-chlorophenyl)l,l,l-trichloroethane. 
Chemical Formula:
Formulations: DDT is  available a s  a technical grade material, a s  
em ulsifiable concentrates of 50% or le s s ,  a s wettable powders of 
25% to 75%, a s  aerosol bombs, a s  solutions, a s  em ulsions, and as 
dusts of various concentrations. Em ulsions and wettable powder 
suspensions of 5% are commonly used in residual spray operations. 
D usts frequently contain 10% of DDT. Many commercially avail­
able formulations contain, in addition to DDT, a variety of other 
in sectic id es and one or more solvents or carriers. Increasing use is  
being made of various syn ergists in combination with DDT to over­
come the resistan ce developed to it by some in sects. Many house­
hold insecticide sprays co n sist of a 5% solution of DDT in purified 
kerosene. All the ingredients of these preparations contribute to 
their toxicity.
Uses: DDT is  probably the most widely used insecticide now avail­
able. It is  used for a variety of purposes in agriculture, for the 
control of in sects of public health and p est sign ificance, and for 
various household u se s . A 10% dust is  employed for the control of 
human lice . B ecau se  of its  very wide use, DDT is  more Likely to 
be encountered than any other single  insecticide.
Routes of Absorption: DDT is  absorbed from the intestinal tract 
and, if it occurs in the air in the form of a very fine aerosol or 
dust, it  may be taken into the alveoli of the lung from which it is  
absorbed readily. DDT is  not, however, absorbed through the skin 
unless it  is  in solution. Solutions are absorbed through the skin 
and, by the sam e token, emulsions are absorbed to some extent.
Cl-C-Cl
C l
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Likew ise, fats and o ils  from whatever source increase the absorp­
tion of DDT by the intestine.
Pharmacologic Action: See page 47.
Dangerous Single Dose to Man: The oral dosage  of DDT necessary  
to produce illn e ss  in man has become rather accurately known. A 
single ingestion of 10 m g./kg. produces illn e ss  in some but not all 
su b jects, even though no vomiting occurs. Smaller dosages gener­
ally  produce no illn e ss , although a dosage of 6 m g./kg. produced 
perspiration, headache, and nausea in a man who was already 
sick ly  and who was hungry at the time of eating the compound. 
Those who have shown illn e ss  following ingestion of 10 m g./kg. 
have not shown convulsions. Convulsions have frequently occurred 
when the dosage level w as 16 m g./kg. or greater. D osages at le a st 
a s  high a s  285 m g./kg. have been taken without fatal resu lt. How­
ever, even somewhat smaller dosage lev els lead to prompt vomiting, 
so  that the amount retained is  not determinable. After a single 
dose, the excretion of DDA in the urine reaches i t s  height within a 
day or two and continues at a lower level for several days 
thereafter.
Animal studies indicate that DDD and Perthane are somewhat 
le s s  toxic than DDT. Methoxychlor i s  significantly • le s s  toxic 
than DDT.
Dangerous Repeated Dose to Man: The minimal daily dosage pro­
ducing illn e ss  in man is  not known. Experiments with the most 
susceptib le  animals would su ggest that some individuals might 
show mild illn e ss  at a dosage ranging from 2.5 to 5 m g./kg ./day. 
Although dogs withstand 10 m g./kg ./day  for years without any 
adverse effect, the fact that some human su b jects are made i l l  by 
a single dose at this rate shows that man is  more su sceptib le  to 
DDT than the dog. In stud ies of volunteers, 40 ate 35 mg. per man 
per day (about 0.5 m g./kg./day), 17 for a s  long a s  21 months, 
without producing any adverse effect. A dosage of 0.5 m g./kg./day  
is  about 200 times the daily rate at which the average citizen in 
the United S ta te s receives DDT in his diet. T h ese  volunteers on
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the higher dosage level stored from 101 to 466 ppm of DDT after 12 
months and 105 to 659 ppm after 21 months. Periodic physical and 
laboratory examinations revealed no indication of any clin ical 
effect of the DDT. An average concentration of about 50 ppm of 
DDT in the total dry diet would be required to produce a dosage of 
0.5 m g./kg ./day . The actual concentration of DDT in prepared 
m eals is  in the order of 0.25 ppm (dry b a sis ) , and the consequent 
dosage is  calculated to be about 0.0026 m g./kg ./day .
T his dietary DDT is  undoubtedly the major source of DDT and 
DDE stored in the fat of persons in the general population. E sse n ­
tially  all sam ples from people in the United States show some 
storage. The highest concentrations of DDT-derived material stored 
in anyone in recent years with no known occupational exposure 
were: DDT, 16 ppm; DDE, 31 ppm. The average storage level for 
DDT is  le s s  than 10 ppm and for DDE le s s  than 15 ppm.
A higher content of DDT and its  derivatives was found in 
workers who had occupational exposure. Even concentrations of 
DDT a s  high a s  648 ppm and of DDE a s  high a s  434 ppm in the fat 
of a man who had formulated DDT for 5 years were not a sso c iated  
with any detectable injury from DDT. Careful hospital examination 
of the workers who had very extensive exposure and who volun­
teered for examination revealed no abnormality which could be 
attributed to DDT. Much higher lev els than have been found in man 
have been observed in the fat of experimental animals which were 
apparently asymptomatic.
DDT stored in the fat is  eliminated only very gradually when 
further dosage is  discontinued.
The threshold limit value for DDT in air i s  1.0 mg./M3.
Signs and Symptoms of Poisoning in Man: In acute poisoning, the 
time of onset depends on the dose; it maybe a s  little  a s  30 minutes 
after a dose of 20 grams, but is  usually 2 to 3 hours, and may be 
even longer. The onset is  characterized by paresthesia  of the 
tongue, lip , and part of the face. In more severe poisoning, the 
paresthesia  may a lso  be detected in the extrem ities, the proximal 
extent of the involvement depending on dosage. The patient soon
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suffers from a sen se  of apprehension, a disturbance of equilibrium, 
d izz in ess, confusion, and — most characteristic — tremor. In severe 
poisoning, convulsions may intervene, and there may be paresis  of 
the hands. General symptoms include m alaise, headache, and 
fatigue. Very large doses are followed promptly by vomiting, which 
apparently depends on an irritant action of the compound. Delayed 
vomiting with or without diarrhea may a lso  follow, but the mecha­
nism s of these actions are not clear. Careful medical examination 
during the period of severe symptoms indicates that the pupils are 
dilated. Except in severe poisoning the pupils react normally to 
light and accommodation, and the eyes show no nystagmus. Sensi­
tivity to touch and pain are exaggerated in the areas in which the 
patient fee ls paresthesia, and proprioception and vibratory sen sa­
tion may be lo st in the fingers and toes but not in the more proxi­
mal portions of the arms and leg s. T e s ts  to demonstrate coordina­
tion are performed poorly, but the reflexes are normal except when 
the dosage has been very large. The pulse may be quickened in 
mild poisoning, probably a s  a nonspecific reaction to discomfort 
and apprehension. The pulse is  irregular or abnormally slowed 
(45-60/min.), or both, in severe poisoning. Blood pressure and 
temperature remain essen tia lly  normal. Transient jaundice following 
a dosage of about 70 m g./kg. was reported by one observer but has 
not been seen by others even with higher dosage lev e ls. Except in 
the most serious c a se s , recovery has always been well advanced or 
complete in 24 hours. Three persons, who were estim ated to have 
eaten 20 g. of DDT each, still showed a residual w eakness of the 
hands after 5 weeks.
There i s  no well-described ca se  of fatal, uncomplicated DDT
poisoning. In one instance, death followed the taking of an unstated 
amount of DDT powder with su icidal intent, but the p o ssib le  in­
volvement of other poisons was not excluded. A number of deaths 
have been reported following the ingestion of DDT solutions. In 
these in stan ces, the clin ical picture has frequently been character­
ist ic  of solvent poisoning.
Signs and symptoms of chronic poisoning in man are unknown, 
although, judging from experimental anim als, liver and kidney dys-
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functions should be looked for a s  p o ssib le  complications of a 
d ise a se  entirely similar to acute poisoning.
The primary irritancy of DDT to the skin is  practically  nil, 
and it has little or no tendency to produce allergy . Dermatitis 
a sso c ia ted  with DDT has occasionally  been reported. Some c a se s  
involved physical irritation by flying chips, but local or system ic 
allergy should be expected to occur in rare in stances, and the 
possib ility  should be considered and carefully studied. In no ca se  
should a dermatitis or other d ise a se  of allergic origin be ascribed 
to DDT without a careful effort to rule out other cau se s and without 
some direct demonstration that DDT is ,  in fact, involved.
Laboratory Findings: Laboratory findings are e ssen tia lly  negative 
except for the presence of DDT and its  m etabolites, which may be 
quantitatively measured by sp ecia l methods. In any c a se s  of acute 
DDT poisoning, the urine should be examined for the presence of 
DDA Q&is-(p-chlorophenyl) acetic acid^l (See Appendix D). Follow­
ing the ingestion of a single dose of DDT at the rate of 11 m g./kg., 
the highest concentration of DDA reached in the urine of a volun­
teer was 2.24 ppm. Daily ingestion of DDT at the rate of 0.05 
m g./kg ./day  for 270 or more days produced concentrations of 0.02 
to 1.98 ppm, while 0.5 m g./kg ./day  gave 0.36 to 10.56 ppm of DDA. 
The single availab le  report indicates a high concentration of DDT 
in human organs (but not n ecessarily  fat) following fatal poisoning.
Pathology: See page 48.
Dieldrin
Chemical Name:
l,2,3 ,4 ,10,10-hexachloro-6,7-epoxy-l,4 ,4a,5,6,7,8,
8a-octahydro-l,4-en</o,earo-5,8-dimethanonaphthalene.
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Chemical Formula:
Formulations: Dieldrin formulations are available a s  wettable pow­
ders (25% to 75%), dust concentrates (25% to 50%), em ulsifiable 
concentrates (18%), solutions (0.5%), impregnated pellets (1% to 
15%) and a s  low percentage dusts (alone or in combination with 
other in secticides).
Uses: Dieldrin has been used extensively since 1952 for the con­
trol of a variety of agricultural in sects and forest p e sts , e specia lly  
in situations where a long-lasting residual effect is  advantageous. 
It also has been used in several foreign countries a s  a residual 
house spray for control of d ise a se  vectors, but has been registered 
for limited treatment only of homes in this country to control some 
household p ests . Dieldrin a lso  is  of value in the control of several 
sp ecie s of m osquitoes, tick s, chiggers, and sand flie s.
Routes of Absorption: Dieldrin is  absorbed readily through the skin 
a s  well a s  through other portals.
Pharmacologic Action: Dieldrin like many other chlorinated hydro­
carbons acts a s a stimulant to the central nervous system ; see 
page 47. Three syndromes (determined largely by the size  and 
number of d oses) may be recognized: ( 1) A few large doses produce 
increasing stimulation of the central nervous system  culminating, 
if the dosage is  sufficiently high, in one or more convulsions. If 
death does not occur, there is  relatively prompt recovery without 
significant weight lo ss  or other permanent injury. (2) A larger 
number of moderate-sized doses may produce without warning a 
condition marked by complete lo ss  of appetite, weight lo s s , and
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convulsions. Without treatment, death is  apparently inevitable. 
(3) Many relatively small doses may produce one or a few convul­
sions with le sse r  accompanying symptoms that may recur even 
though exposure is  discontinued. Types 1 and 3 have been observed 
repeatedly in man; the occurrence of type 2 in man is  unconfirmed, 
although it  i s  easily  produced in animals. Electroencephalograms 
indicate injury to the brain stem.
Dangerous Single Dose to Man: Those persons with the greatest 
opportunity for exposure to dieldrin may also  have contact with 
related compounds, notably aldrin. The effects of dieldrin and 
aldrin are sim ilar both quantitatively and qualitatively in animals, 
and this appears to be true for man a lso . Persons exposed to oral 
d osages which exceed 10 m g./kg. frequently become acutely ill. 
A dosage of about 44 m g./kg. led to convulsions in a child. Symp­
toms may appear within 20 minutes, and in no instance has a latent 
period of more than 12 hours been confirmed in connection with a 
single exposure.
The most thoroughly described related ca se  involved an at­
tempted suicide by ingesting aldrin at an estim ated dosage of
25.6 m g./kg. There have been at le a st  two deaths caused  by the 
ingestion of undissolved dieldrin and several caused by drinking 
emulsions or solutions. The dosage in these c a se s  is  unknown.
In anim als, the acute dermal toxicity of dieldrin in xylene is  
roughly 40 times that of DDT. T e sts  with certain other solvents 
indicate a factor of only about s ix . An important difference i s  that 
undissolved DDT is  not absorbed from the skin but undissolved 
dieldrin i s  readily absorbed.
Dangerous Repeated Dose to Man: Little  is  known quantitatively 
about the toxicity o f repeated doses of dieldrin for man. However, 
in different countries 2% to 40% of men applying 0.5% to 2.5% su s­
pensions or emulsions at the rate of about 1 g./M  2 have developed 
poisoning within 2 weeks to 24 months after first exposure. Most 
of the c a se s  were not complicated by contact with in sectic id es 
c lo sely  related to dieldrin. Some of the men were exposed to no 
other insecticide while some were previously exposed to DDT,
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BHC, or chlordane. However, no relevant d ise a se  has been re­
ported following similar exposure to these latter three compounds 
alone or in combination.
Animals have shown convulsions a s  much a s 120 days follow­
ing the la s t  dermal dose of dieldrin, indicating that dieldrin or its 
derivatives and/or residual toxicant-induced injury may persist in 
the body for a long time once severe poisoning has occurred. 
Entirely sim ilar recurrent illn ess  has been observed repeatedly in 
man.
The threshold limit values for aldrin and dieldrin in air are 
each 0.25 mg./M3.
Signs and Symptoms of Poisoning in Man: Early symptoms of acute 
poisoning include headache, nausea, vomiting, general m alaise, 
and d izzin ess. With more severe poisoning, clonic and tonic con­
vulsions ensue or they may appear without the premonitory symp­
toms ju st  mentioned. Coma may or may not follow the convulsions. 
Hyperexcitability and hyperirritability are common findings. Follow­
ing repeated exposure some spraymen developed a condition in­
distinguishable from epilepsy — the number of c a se s  being much 
greater than could be explained on the b a s is  of idiopathic d ise a se . 
Seizures recurred in some men even though they were removed from 
exposure. Poisoning characterized by a combination of convulsions, 
complete lo s s  of appetite, and severe weight lo s s  has not been 
confirmed in man but would probably occur under certain conditions 
of exposure. About 6 hours after ingesting dieldrin, a baby suddenly 
lo st con sciou sn ess, became dyspneic and then convulsed. Finally 
the convulsions were stopped by treatment, but she remained un­
conscious; the temperature rose to 104° F ., cyan osis and tachycar­
dia increased, and the child died 20 hours after exposure.
Aldrin i s  reported to have caused erythemato-bullous dermati­
tis  in a single ca se .
Laboratory Findings: Findings may be e ssen tia lly  normal except 
for the E E G , the presence of in secticide  in the t is su e s , and the 
excretion of dieldrin-derived material in the urine. However, the
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mere finding of insecticide is  not proof of poisoning, for the com­
pound or derivatives have been demonstrated in the blood and 
urine of spraymen who were asymptomatic. To be sure, there was a 
general parallelism  in the resu lts of b io assay s  on blood and the 
presence of poisoning; workers who had had convulsions tended 
to show high concentrations of dieldrin in their blood.
Aldrin absorbed into the body is  converted to dieldrin and 
stored in that form. In one c a se  of acute aldrin poisoning with 
complete recovery, dieldrin w as found in the fat in a concentration 
of 40 ppm. Earlier reports based  on older analytical methods indi­
cated lower concentrations in other c a se s .
In the ca se  in which aldrin was ingested at the estim ated rate 
of 25.6 m g./kg., laboratory te sts  indicated transient kidney damage 
and questionable liver involvement. The patient responded well to 
supportive therapy and showed no residual effects except for 
border-line abnormalities of the electroencephalogram. Later elec- 
troencephalographic studies of a se rie s  of patients showed specific  
changes: bilateral synchronous sp ik es, spike and wave com plexes, 
and slow theta w aves.
Treatment: In addition to the information on page 49, the following 
is  of importance. Animal experiments indicate that it maybe n eces­
sary to give phenobarbital in large d oses over a period of 2 weeks 
or more in connection with the syndrome characterized by complete 
lo s s  of appetite and severe weight lo ss . The dosage required to 
keep poisoned animals from showing hyperexcitability or convul­
sion s and to enable them to eat and behave normally is  often a 
dosage that would induce sleep  or even an aesth esia  in a normal 
animal of the same sp e c ie s . In human beings the dosage should be 
adjusted to the symptoms.
Prevention: Workers applying dieldrin residual sprays indoors or 
workers who are otherwise exposed extensively to dieldrin for 
relatively long periods of time should be told clearly about the 
danger which ca re le ssn e ss  may involve. They should be thoroughly 
trained in proper methods of handling dieldrin, and they should be 
provided with industrial safeguards or protective clothing suitable
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to the conditions of work. Work should be limited to 40 hours per 
week. Periodic electroencephalographic examinations may offer a 
valuable method for detecting subclin ical intoxication.
Chemical Name: mixture of 2-n itro-l,l-6is  (p-chlorophenyl) 
propane (1 part) plus 2-nitro-l,l-Z>is (p -  
chlorophenyl) butane (2 parts).
Chemical Formula:
/ \ci
2-n itro-l,l-ô is 
(p-chlorophenyl) propane 
Prolan (1 Part)
Formulations: Dilan is  available a s  an 80% liquid concentrate, 
and a s  dusts.
Uses: Dilan has been recommended for use in fly control for strains 
resistan t to other chlorinated hydrocarbons. (Following spraying 
directly on skin of cattle, Dilan is  excreted in milk in amounts 
intermediate between DDT and methoxychlor and, therefore, is  not 
recommended for use on dairy cattle .)
Dilan is  used to some extent a s  a substitute for pyrethrum 
powder in control of agricultural p e sts .
, Routes of Absorption: Toxicity te sts  in lower animals indicate 
that it can be absorbed from the digestive tract. Dilan d oes not 
seem to be absorbed to an appreciable extent through the skin.
2-n itro-l,l-6es 
(p-chlorophenyl) butane 
Bulan (2 Parts)
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Toxicology: In the absence of reported poisoning, the dangerous 
dose to man is  unknown. R esu lts with animals indicate that the 
mixture i s  considerably le s s  toxic than DDT. In anim als, the 
sign s and symptoms resemble those caused by the other chlorinated 
hydrocarbons.
Laboratory Findings: None available.
Treatment: See page 49.
Endrin
Identity: l,2,3,4,10,10-hexachloro-6,7-epoxy-l,4 ,4a,5,6,7,8,8a- 
octahydro-l,4-enc?o-e/ic?o-5 ,8- dimethanonaphthalene.
Formula:
Formulations: Endrin is  available a s  dusts (1.5%), granules (1%), 
water-wettable powders (a s  high a s  75%), em ulsifiable concentrates 
(19.5%) and baits (0.75%).
Uses: Endrin i s  used for so il in sects and foliage in sects (with 
limitations to prevent residues in the food of man or anim als); it 
i s  a lso  used for seed treatments and for the control of mice in 
orchards.
Pharmacologic Action: See dieldrin, which has the same action.
Routes of Absorption: Endrin is  absorbed by the skin a s  well a s 
by the respiratory and gastrointestinal system s.
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Dangerous Single and Repeated Doses to Man: An outbreak of 
poisoning was caused by the contamination of sacked flour during 
shipment in a railway car in which endrin had leaked two months 
earlier. Endrin in a concentration of 150 ppm was found in the re­
mains of a loaf of bread that had caused illn ess  in one person. 
The severity of illn e ss  was proportional to the amount of bread 
eaten; 3 or 4 s l ic e s  or 2 or 3 rolls were usually sufficient to pro­
duce a convulsion, and a man who ate nearly a whole loaf had 
repeated convulsions in quick su ccession  for about an hour. Com­
putations based  on these observations indicate that the dosage 
n ecessary  to produce a single convulsion in man is  about 0.20 to 
0.25 m g./kg., and the dosage necessary  to produce repeated fits 
probably i s  about 1 m g./kg. A child who died an hour and 10 
minutes after ingesting endrin is  estim ated to have taken about 30 
m g./kg. Animal experiments suggest that a much sm aller dosage 
a lso  could be fatal.
There is  no direct evidence on the repeated dosage that must 
be absorbed in order to produce illn e ss . Endrin poisoning has oc­
curred among formulators and applicators. Endrin i s  more toxic 
than dieldrin and, by analogy, endrin would be expected to require 
somewhat sm aller dosages to produce poisoning following daily 
exposure.
The tentative threshold limit value for endrin in air is  0.25 
mg./M 3.
Signs and Symptoms of Poisoning in Man: In the contaminated 
bread episode, mild illn ess  involved d izz in ess , weakness of the 
leg s, abdominal discomfort, and nausea but usually not vomiting. 
Several patients were temporarily deaf, and some were slightly 
disoriented or aggressive. Insomnia was common. More serious 
illn ess  involved convulsions and occurred in about 30 people. The 
time of onset was irregular, but usually 2 to 4 hours in those who 
ate contaminated bread only once. People who ate 2 or more meals 
frequently showed no acceleration of onset after the la s t  dose, but 
in some in stan ces onset was a s  Little a s  half an hour after the 
meal. The fits were sudden and without warning. They were epi­
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leptiform in character with frothing at the mouth, facial congestion, 
and violent convulsive movements of the limbs, sometimes leading 
to dislocation of the shoulder or other injury. The fits  lasting 
several minutes were followed by sem iconsciousness for 15 to 30 
minutes. Recovery was well advanced by the next day in most 
patients but a few complained of headache, d izz in ess, lethargy, 
w eakness, and anorexia for 2 to 4 weeks. E xcept for abnormal 
electroencephalogram s, neurological findings were normal soon 
after a convulsion.
In fatal c a se s , the onset may be a s  little a s 20 minutes, and 
death about an hour after ingestion. Convulsions may become 
alm ost continuous. Hyperthermia (107 °F . or more) was asso ciated  
with endrin poisoning in two children, 1 and 2.5 years o ld . The 
high fever was followed by decerebrate rigidity in both instances. 
The hyperthermia may have been a specific  effect o f endrin. Other 
findings in one of the c a se s  strongly suggested  injury to the brain 
stem. The same conclusion is  ju stified  by electroencephalographic 
stud ies.
Laboratory Findings: The insecticide has been found in the fat of 
man (a s  high a s  400 ppm by b ioassay ) and other t is su e s  (a s  high 
a s  10 ppm). The concentrations consistent with health or d ise a se  
in man are not yet estab lished . Electroencephalogram s may show 
bilateral synchronous sp ik es, spike and wave com plexes, and 
slow theta w aves. The EEG  usually returns to normal within 3 to 6 
months after exposure i s  stopped.
Treatment: See dieldrin, page 66.
Preventions: See dieldrin, page 66.
Heptachlor
Chemical Name: l,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro- 
4,7-methanoindane.
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Chemical Formula:
Formulations: Heptachlor is  available  a s em ulsifiable concentrates 
(24%), 2.5% dusts, 25% wettable powders, and granular formula­
tions containing from 2.5% to 25% heptachlor. Heptachlor is  a lso  
formulated with some fertilizer mixtures for the control of soil 
p ests.
Uses: Heptachlor is  used again st flie s , m osquitoes, and a variety 
of household p e sts . It is  a lso  used in controlling agricultural p e sts , 
e specia lly  so il in sects .
Toxicology: It has been estimated that the minimal dermal dose 
required to produce symptoms in man is  46 g. for a single dose and 
1.2 g. per day for repeated exposure. In anim als, heptachlor cau ses 
sign s of poisoning sim ilar to those caused by aldrin and dieldrin 
(see  page 62). Ju s t  a s  aldrin is  converted in the body to its 
epoxide (dieldrin), so  heptachlor is  converted to its  epoxide and 
stored largely in that form.
The threshold limit value for heptachlor in air is  0.5 mg./M3.
Laboratory Findings: See page 48.
Treatment: See dieldrin, page 66.
Toxaphene
Identity: A chlorinated camphene whose approximate empirical
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formula is  C 10H 10C lg, representing a chlorine content of between 
67% and 69%.
Formulations: Toxaphene is  marketed a s  the technical grade mate­
rial; a s  a 40% dust concentrate; a s  dilute d usts; a s a wettable 
powder; a s  impregnated pellets; a s  42% to 73% em ulsifiable con­
centrates; a s  44% to 80% concentrates in oil; a s  a 5% bran bait; 
and as a cotton dusting formula (toxaphene 20%, sulfur 40%, inert 
material 40%).
Uses: Toxaphene is  used for the control of grasshoppers, soil 
p e sts , and many in sects that attack forage crops, cotton, and 
certain vegetables. It is  a lso  used to control the ectoparasites of 
livestock.
Routes of Absorption: Toxic and in some instances lethal amounts 
of toxaphene can enter the body through the mouth, lu n g s, and 
skin. Enteric absorption of the insecticide is  increased  by the 
presence of d igestib le o ils , and liquid preparations of the in secti­
cide penetrate the skin more readily than do dusts and wettable 
powders.
Pharmacologic Action: In general, toxaphene resem bles chlordane 
and to some extent camphor in it s  physiological action. Toxaphene 
cau se s diffuse stimulation of the brain and spinal cord resulting 
in generalized convulsions of a tonic or clonic character. Death 
usually resu lts from respiratory failure. Detoxification appears 
to occur in the liver.
Dangerous Single and Repeated Doses to Man: Toxaphene has an 
irregular range of toxicity with the minimal acute lethal oral dose 
for man estimated to be 2 to 7 g. Its  chronic oral toxicity in the 
dog (an animal susceptib le  to toxaphene) is  some 10 times that of 
DDT. In man a single dermal application of 46 g. or daily applica­
tions of 2.4 g. over a period of days is  very dangerous. Toxaphene 
cau se s moderate irritation of the skin but little or no sensitization .
At le a st  7 human deaths have been reported as due to toxa­
phene. All 7 c a se s  were children. In 5 instances the poison was
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swallowed and may have been swallowed in the other c a se s  a lso ; 
the dosage could not be determined. From other c a se s , it appears 
that 10 m g./kg. or le s s  leads to nonfatal convulsions in some per­
sons but to no d ise a se  at all in other persons.
Signs and Symptoms of Poisoning in Man: Nonfatal poisoning 
generally begins in 4 hours or le s s  after toxaphene is  ingested . In 
fatal c a s e s , severe symptoms have begun a s  early as half an hour 
after exposure, and death occurred in one instance in le s s  than 4 
hours from the time of exposure. In all reported c a se s , death has 
occurred or recovery has begun and been e ssen tia lly  complete in a 
period of 12 hours or le s s .  However, control of convulsions i s  not 
n ecessarily  d ecisive . In one c a se , convulsions had been controlled 
for some hours, and there were hopeful sign s of improvement for a 
time, followed by a sudden rise  in temperature, respiratory co llapse , 
and death. Nonfatal poisoning has been characterized by nausea, 
mental confusion, jerking of the arms and le g s , and by convulsions. 
In some in stan ces convulsions have begun suddenly without any 
warning sign s or symptoms. F a ta l poisoning has been characterized 
by frequent, repeated, violent convulsions and by cyan osis. In some 
instances the cyan osis may resu lt from mechanical interference of 
the convulsions with respiration. However, in one carefully ob­
served c a se , cyanosis appeared before convulsions.
Laboratory Findings: The only significant finding i s  the storage of 
compounds related to toxaphene. T his complex can be specifica lly  
identified.
Pathology: See page 48.
Treatment: See page 49.
73
B O T A N I C A L  INSECTICIDES
Chemical Name: The active ingredients in pyrethrum extract con­
s i s t  of a mixture of four compounds, pyrethrin I and II, and cinerin 
I and II. Pyrethrin I, the constituent p o sse ss in g  the greatest in sec­
ticidal activity , is  represented by the chemical formula shown 
below. Allethrin is  a synthetic pyrethrin analogue.
Chemical Formula:
Formulations: Pyrethrum and allethrin are available commercially 
in powder or dust form, in a variety of solvent extracts, and in 
em ulsifiabie preparations of various concentrations. The usual 
household spray contains about 0.5% active pyrethrum principles.
Uses: Pyrethrum and allethrin, alone or combined with syn ergists, 
are used extensively in du sts, sprays, and aeroso ls again st a wide 
variety of in sec ts . Allethrin has a lso  been used in vaporizers.
Routes of Absorption: Pyrethrum and allethrin may be absorbed 
from the gastrointestinal tract and by the respiratory route. They 
are not absorbed to a significant degree through the skin; however, 
allergic reactions may resu lt from this route of exposure.
CHj
>^ N _ C H 2 -CH =CH -C H = c h 2
IIc
CHj CH}
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Pharmacologic Action: The nervous symptoms produced by pyre- 
thrum and allethrin poisoning resemble those of veratrin intoxica­
tion, proceeding from excitation to convulsions to tetanic paraly sis, 
except that pyrethrins cause muscular fibrillation a s  well. Death i s  
due to respiratory failure. If recovery occurs, it i s  usually complete. 
Injury to man from pyrethrum has most frequently resulted from the 
allergenic properties of the material rather than its  direct toxicity.
Dangerous Single and Repeated Doses to Man: Under practical 
conditions, pyrethrum and allethrin are probably the le a st  toxic to 
mammals of a ll the in sectic id es currently in use. Pyrethrum has 
been used orally a s  an anthelmintic in some areas for many years 
with no apparent i l l  e ffects. The approximate oral L D 50 to white 
rats of pyrethrum is  200 m g./kg. and of allethrin, 680 m g./kg.
The occurrence of a rare individual hypersensitive reaction, 
e specia lly  following a previous sensitizin g exposure, is  a p o ss i­
bility. The death of a two-year-old child following the eating of 
one half ounce (15 g.) of pyrethrum concentrate was attributed to 
pyrethrum poisoning. The e sters constituting allethrin and pyre­
thrum mixtures are rapidly detoxified by hydrolysis in the gastro­
intestinal tract and to some extent in other t is su e s  of warm-blooded 
anim als. The chrysanthemum monocarboxylic acid formed is  ex­
creted in the urine. B ecau se  of their ready excretion, these com­
pounds exhibit little or no toxicity following repeated exposure.
The threshold limit value for pyrethrum in air i s  5 mg./M3.
Signs and Symptoms of Poisoning in Man: Pyrethrum toxicity may 
m anifest itse lf  in several forms in man. Contact dermatitis i s  by 
far the most common. The usual picture is  a mild erythematous, 
vesicu lar dermatitis with papules in moist areas, and intense 
pruritus. A bullous dermatitis may develop. Some individuals show 
m anifestations of pyrethrum sensitiv ity  sim ilar to those seen in 
p o llin osis, including sneezing, serous n asal d ischarge, and nasal 
stu ffin ess. A few c a se s  of extrinsic asthma due to pyrethrum mix­
tures have been reported. Some of the individuals involved had a 
previous history of asthma with a very broad allergic background.
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A severe anaphylactic reaction, including peripheral vascular col­
lap se  and respiratory difficulty, is  a rare accompaniment of the 
dermatologic reaction.
Laboratory Findings: P ositive  patch te sts  with pyrethrum are help­
ful in d iagn osis. Eosinophilia may accompany the acute allergic 
reaction. Examination of mucous nasal sm ears from individuals 
with vasomotor rhinitis reveals numerous eosinophils following 
exposure.
Treatment: The treatment for the various reactions to allethrin and 
pyrethrum is  symptomatic. Antihistimines are of value. If sufficient 
pyrethrum has been ingested to cause  nervous m anifestations, 
pentobarbital should be used. The diarrhea that occurs may be 
controlled with atropine sulfate.
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R O D E N T IC ID E S
Introduction: The rodenticides differ widely in their chemical 
nature. Strange to say, they also differ widely in the hazard which 
they offer under practical conditions, even though all of them are 
used to kill animals that are physiologically similar to man. Sodium 
fluoroacetate i s  one of the most hazardous rodenticides available. 
Warfarin i s  the most thoroughly studied of a group of new rodenti­
cides which present a minimal hazard.
With the exception o f arsenic, thallium, and phosphorus, the 
older rodenticides are not covered in this handbook, but their 
properties are listed  in standard texts on pharmacology. (Arsenic 
i s  d iscu ssed  under “ H erbicides”  because of its  relative impor­
tance a s an eradicative weed killer.)
Phosphorus
Identity: Elementary phosphorus occurs in two common forms: the 
relatively harmless red and the highly toxic white or yellow.
Formulations and Uses: White phosphorus i s  formulated as a 2% 
to 5%  paste for use against rats and roaches.
Routes of Absorption: Poisoning resu lts from ingestion. Contact 
of yellow phosphorus with the skin cau se s burns, but dermal absorp­
tion i s  not known to lead to system ic poisoning.
Dangerous Single and Repeated Doses to Man: A dose of 15 mg. 
may be severely toxic and 50 mg. may be fatal. The element is  
more toxic when ingested in solution or in a finely divided state  
than when taken in lumps. A daily dosage of 1 mg. given with 
therapeutic intent sometimes produced gastrointestinal disturbance, 
necrosis of the jaw , and rarely typical phosphorus poisoning. The 
threshold limit value for yellow phosphorus in air i s  0.1 mg./M 3.
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Signs and Symptoms of Poisoning in Man: Acute phosphorus poison­
ing is  peculiar because symptoms appear in two stag e s . During the 
first 24 hours, symptoms of severe gastrointestinal irritation occur 
as soon as one-half hour after ingestion. The victim may die of 
cardiovascular failure within 12 hours. T his first stage may be fol­
lowed by a latent period lasting from a few hours to a few days 
depending upon the amount ingested. The system ic stage i s  charac­
terized by abdominal pain, nausea, vomiting, hematemesis and 
other hemorrhagic m anifestations, jaundice, hepatomegaly, oliguria, 
toxic psychosis, convulsions, coma, and shock. There may be 
severe damage to the liver, heart, and kidney, and death may ensue 
at any time. Cirrhosis o f the liver has been reported after recovery 
from the acute state.
Formerly, chronic poisoning, characterized by necrosis of the 
mandible and maxillary bone, was caused by prolonged inhalation 
of phosphorus in industry.
Pathology: Fatty degeneration i s  striking in the liver, heart and 
kidney but may be found in all organs. Hepatic necrosis may be 
extensive with changes occurring first in the periphery of lobules.
Differential Diagnosis: If history of phosphorus exposure i s  un­
available, the initial symptoms may be confused with the gastro­
enteritis caused by agents such as arsenic. There is  a charac­
teristic odor o f garlic to the breath and vomitus in phosphorus 
poisoning. Luminescence in a darkened room of the gastric con­
tents, feces, or urine is  pathognomonic.
Laboratory Findings: U rinalysis may show albuminuria, cylindruria, 
and hematuria. Liver function te sts , including prothrombin time, are 
abnormal. Hypoglycemia may be severe; blood urea nitrogen and 
creatinine may be elevated. The phosphorus content o f the blood 
is  usually normal. EKG changes may be present with myocarditis. 
A nalysis for phosphorus may be done on tissu e  or gastric contents.
Treatment: Since there i s  no specific  therapy, the removal of 
phosphorus by vomiting or gastric lavage with large volumes of 
fluid is  of utmost importance. Potassium  permanganate, 0.1% solu­
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tion, or 2% hydrogen peroxide are used in preference to water since 
they may oxidize phosphorus to harmless phosphates. Two hundred 
ml. of mineral oil or 100 to 200 ml. of petrolatum, which prevents 
phosphorus absorption, can then be administered. However, absorp­
tion can be increased by other fats and o ils . The treatment of shock 
and acute hepatic or renal failure is  instituted when necessary . Ade­
quate carbohydrate intake i s  important. Shock has responded to 
vasopressor agents. The use of steroids resulted in dramatic im­
provement in one ca se  o f severe poisoning after the ingestion of 
825 mg. of phosphorus.
Sodium fluoroacetate
Chemical Name: sodium monofluoroacetate.
Chemical Formula: H q
I ❖F - C - C  
I \
H ONa
Formulations: Sodium fluoroacetate i s  a co lorless, odorless, water- 
soluble sa lt  having a purity of about 95%. An extremely dilute solu­
tion has a vinegar-like taste , at le a st  to some people. The sa lt  is  
d issolved in water in the proportion of 12 g ./g a l. (1:300). This 
solution is  used again st rats by filling %-ounce squat souffle cups 
(70 mg./cup) and by placing these at strategic locations in rat- 
infested areas. This solution is  often colored with a black dye. 
Sodium fluoroacetate is  also  mixed with common rat baits at the 
rate of 1 oz. of poison to 28 lb s. o f bait (1:500).
Uses: Sodium fluoroacetate is  a nonspecific poison which i s  used 
to kill rats, mice, other rodents, and predators in general.
Routes of Absorption: Sodium fluoroacetate i s  rapidly absorbed 
from the gastrointestinal tract. Oral doses of sodium fluoroacetate 
have approximately the sam e toxicity as those given subcutan­
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eously, intramuscularly, intraperitoneally, or intravenously. Sodium 
fluoroacetate i s  not readily absorbed through the intact skin, but it 
may be absorbed in the presence of cuts or dermatitis. D usts of the 
poison are efficiently absorbed in the pulmonary system. The poi­
son appears to be uniformly distributed in the t is su e s , including 
the brain, heart, liver, and kidney.
Pharmacologic Action: Following absorption, sodium fluoroacetate 
appears to act without being chemically changed. Through a direct 
interference with acetate metabolism by an ill-defined mechanism, 
sodium fluoroacetate has a strong effect on-either the cardiovascu­
lar or nervous system, or both, in all sp ecie s and on the skeletal 
m uscles in some sp ec ie s . Man g ives a mixed type response with 
the cardiac feature predominating. By a direct action on the 
heart, notably in the rabbit, contractile power i s  lo st, which leads 
to declining blood pressure. Premature ventricular contractions are 
seen in all sp ec ie s  and arrhythmias are marked in some sp ec ie s  
including man. The central nervous system, notably that of the dog, 
is  directly attacked by sodium fluoroacetate. In man, the action on 
the central nervous system produces epileptiform convulsive se i­
zures followed by severe depression. Cumulation of sodium fluoro­
acetate occurs to some extent, and some tolerance can be demon­
strated in the mouse and rat, and possib ly  in the rhesus monkey.
Dangerous Single Dose to Man: Judging from fatal and near-fatal 
c a se s , the dangerous dose for man i s  0.5 to 2 m g./kg. Other 
specie s vary considerably in their response to sodium fluoroace­
tate with primates and birds being the most resistant and carnivora 
and rodents being the most susceptib le. Most domestic animals 
show a susceptibility  falling between the two extremes.
The threshold limit value for sodium fluoroacetate in air is  
0.05 mg./M 3.
Signs and Symptoms of Poisoning in Man: In all sp ec ie s , there i s  a 
variable latent period ranging from 30 minutes to 2 hours or more 
between dosing and the appearance of symptoms. T his period is  
shortened but not eliminated by large amounts of sodium bicarbo­
nate, fumarate, or chloride. Both man and rhesus monkeys give a
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“ mixed response”  to fluoroacetate poisoning. In both fatal and 
nonfatal c a se s  in man, the first indication of poisoning was nausea 
and mental apprehension, generally followed by epileptiform convul­
sion s. After a period o f several hours, p u ls u s  a lt e r n a n s  may ex ist 
followed by ventricular fibrillation and death. Children appear to 
be more subject to cardiac arrest than to ventricular fibrillation. 
In rhesus monkeys convulsive se izures p a ss  from the facial 
m uscles to the ear and m asseter m uscles and then over the entire 
body, ending in violent jerks. Recovery from the seizure may occur 
only to be followed by a sudden attack of ventricular fibrillation 
and cardiac failure.
Laboratory Findings: In animals, in creases in the blood lev e ls  of 
certain constituents have been observed as follows: (1) g lucose  in 
rabbits and goats, (2) lactic  and pyruvic acids in the rabbit, (3) ace­
tate in the dog. Serum inorganic phosphate lev e ls  (probably from 
muscle) are increased in goats and rabbits; the concentration of 
plasm a potassium is  also  increased (from control lev e ls of 17 m g./ 
100 ml. to 25 mg./lOO ml.) in poisoned animals. A nalyses for fluo­
rine content of the organs of a fatally poisoned patient showed 
elevated values.
Pathology: The histopathologic changes in poisoning by fluoro­
acetate appear to contribute little  to the elucidation of its  action. 
Congestion of abdominal v iscera  and lungs, resulting from cardiac 
failure i s  seen in animals, with focal lung hemorrhage and gen­
eralized hemorrhage occurring in the rat and chicken, respectively.
Differential Diagnosis: In general, poisoning with sodium mono- 
fluoroacetate is  so acute and so violent that it has only to be 
distinguished from poisoning with other convulsant poisons.
Treatment: The treatment for sodium fluoroacetate poisoning is  
mainly symptomatic. Immediate em esis and gastric  lavage followed 
by oral doses of magnesium sulfate may be useful. Administration 
of certain compounds capable o f supplying acetate ions have shown 
antidotal effects in animals including monkeys; the choice drugs 
being monoacetin (glycerol monoacetate) (0.1 to 0.5 m l./kg. by 
deep intramuscular injection). A single dose of magnesium sulfate
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(800 m g./kg.) given intramuscularly as a 50% solution has saved 
the life of rats dosed with lethal amounts of sodium fluoroacetate. 
Complete quiet and rest are indicated, but barbiturates to the point 
of anesthesia have proved disappointing when used a s antidotes 
against this poison.
Prevention: Sodium fluoroacetate should be used by competent 
sp e c ia lis ts  and then only under very strict limitations.
Thall  ium
Identify and Formula: thallium su lfate , T1S04.
Formulation and Use: Thallium sulfate is  sold as the sa lt , as 
prepared rodenticides (0.5% to 3% food baits and 1.5% liquid baits) 
and as ant and roach poisons (0.05% to 3% baits). Some States and 
c itie s ban the general sa le  of formulations containing more than 
1% or 2% thallium sulfate.
Routes of Absorption: The oral route is  the most important in c a se s  
of poisoning, although dermal absorption may a lso  occur. Formerly, 
intoxication but no known deaths resulted from the application of 
ointment containing 3% to 7% thallium acetate for depilation.
Pharmacologic Action: Thallium is  a cellular toxin and resem bles 
arsenic in its  e ffects. However, sulfhydryl-containing enzymes are 
only slightly inhibited by thallium. Thallium is  distributed to all 
the t is su e s  of the body; there is  no tendency to accumulate in bone. 
Excretion is  mainly by the kidney and to some extent into the in­
testine. In humans, only about 3.2% of the thallium in the body is  
excreted each day.
Dangerous Single and Repeated Doses to Man: Thallium acetate was 
formerly used a s a depilatory in children at a single  oral dose of 
8 mg./kg. Lower d osages were unreliable in causing hair lo ss . 
Depilation i s ,  of course, a toxic effect. Even though dosage was 
carefully regulated, serious poisoning, including 6 deaths was
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found in 5.5% of 8,006 c a se s . No deaths were reported at lower 
d osages, but poisoning occurred in 1 c a se  from a dose of 4 m g./kg. 
of thallium acetate. Adults are susceptib le to lower d osages than 
children and thallium was administered therapeutically only to 
children under 10 or 12. Thallium acetate and sulfate are equiva­
lent in toxicity; both compounds are water-soluble and contain 
about 80% thallium.
Thallium is  a cumulative poison. The repeated dose necessary  
to produce toxicity is  not so  well known. The daily oral admini­
stration of thallium acetate to rats at le s s  than 1/50 of the single 
L D S0~dose caused depilation in 6 weeks and death in rats within
4 months. The threshold limit for thallium in air in 0.1 mg./M 3.
Signs and Symptoms of Poisoning in Man: The clin ical picture re­
sem bles arsenic intoxication. Signs and symptoms are referable 
mainly to the gastrointestinal tract and nervous system. After large 
d o se s, gastroenteritis is  evident in about 12 to 14 hours, while 
neurological symptoms may be delayed 2 to 5 days. G astrointestinal 
m anifestations include severe paroxysmal abdominal pain, vomiting, 
diarrhea, anorexia, stom atitis, salivation , and weight lo ss . Neuro­
logical m anifestations during the first days of illn ess  may include 
paresth esias, headache, cranial nerve damage, convulsions, deli­
rium, and coma. V ascular co llapse and death may occur in 24 to 
48 hours, but the course is  usually more prolonged. Death may be 
caused by respiratory paraly sis, pneumonia, or circulatory d is­
turbances. Peripheral neuropathy, particularly in the le g s , is  com­
mon with severe pain, paresth esias, muscle w eakness, and atrophy. 
L o ss  of hair begins after 1 to 2 weeks have elapsed. In the more 
protracted c a se s , ataxia, choreiform movements, dementia, depres­
sion, and psychosis may be prominent. A blue gingival line and 
dermatological abnormalities, including white bands in the nails 
may appear. Neurologic damage may be permanent. L iver damage 
occurs but is  not prominent clin ically. Kidney damage is  mani­
fested by proteinuria, cylindruria, and sometime oliguria and 
hematuria.
With the continued administration of smaller d o se s, symptoms 
may first be apparent in a week with progression for several more
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weeks. In chronic poisoning, symptoms can be nonspecific and 
thallium intoxication may not be suspected unless dépilation occurs. 
Although characteristic of thallium toxicity, hair lo ss  a lso  can re­
sult from poisoning with other metals and certain drugs.
Laboratory Findings: D iagnosis can be confirmed by analysis for 
thallium in urine, blood, or hair. Thallium does not occur normally 
in body fluids or tissu e ; however, its  presence in urine does not 
necessarily  mean intoxication. In fatal, acute and subacute c a se s , 
the concentration of thallium in tissu e  ranges from 5 to 100 ppm. 
Thallium can be found in the urine for a s long as 2 months after 
intoxication. Other laboratory determinations are not specific . 
The blood picture and the cerebrospinal fluid are usually normal. 
T e sts  of liver function have been abnormal in a few instances.
Pathology: Only hyperemia and punctate hemorrhages of the gastro­
intestinal tract and v isceral congestion may be found if death is  
soon after exposure. There may be fatty degeneration of the heart 
and liver, degeneration of kidney tubules, and edema and conges­
tion of the lungs. Degeneration occurs in peripheral nerves, and 
cortical v e s se ls  are engorged. Chromatolysis in neurones is  prom­
inent in the pyramidal tracts, basa l ganglia, and third nucleus.
Treatment: Gastric lavage should be done in acute c a se s . Acti­
vated charcoal and potassium iodide can be given orally to reduce 
thallium absorption. Sodium thiosulfate may be given intravenously 
to inactivate any thallium in the blood, but its  usefu lness has not 
been proved. In one study, dithizon, a chelating agent, was effec­
tive in 5 out o f 6 severely ill children in an oral dosage of 10 m g./ 
kg. twice a day for 4 days or longer. The mechanism of action was 
unknown. It is  generally felt that EDTA or BAL are not useful in 
the treatment of thallium intoxication. However, there are reports 
of improvement after the administration of BAL. In animals BAL 
has not been effective, while dithizon (diphenylthiocarbazone) was 
protective in rats after thallium administration. In one report, tri­
hexyphenidyl (Artane) caused a striking reduction of tremors.
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W  arfarin
Chemical Name: 3-(a-phenyl-ß-acetylethyl)-4-hydroxycoumarin.
The compound is  a lso  available  a s  the sodium 
salt.
Chemical Formula:
Formulations: Warfarin is  available in the form of a 0.5% powder. 
The diluent is  cornstarch suitable for mixing with additional bait 
such a s  corn meal, bread crumbs, meat, etc. A final concentration 
of 0.025% or le s s  is  recommended for bait, depending on the spe­
c ie s  of rodent to be controlled and upon other conditions. In addi­
tion to the concentrate, finished baits containing 0.025% warfarin 
are available  commercially. Warfarin sodium is  available  pharma­
ceutically  in capsu les and tab lets.
Use s: A s a rodenticide, warfarin is  used both for commensal rats 
and mice and for wild forms. It has proved to be very effective.
Routes of Absorption: Warfarin is  readily absorbed by the gastro­
intestinal tract; absorption of the sodium sa lt  in man requires about 
3 hours a s  indicated by a comparison of the rate of action of oral 
and intravenous d oses. Warfarin i s  not significantly absorbed 
through the skin. Its  absorption by the respiratory tract is  unknown, 
but there need be no circumstance in which sm all particles of dust 
could be inhaled, even in manufacture.
Pharmacologic Action: Warfarin has two actions: inhibition of 
prothrombin formation and capillary damage. There is  unconfirmed
85
evidence that these two actions are produced by the two moieties 
of the molecule. Thus, 4-hydroxycoumarin inhibits the formation of 
prothrombin and reduces the clotting power of the blood, while 
there is  some evidence that at sufficient dosage benzalacetone 
produces capillary damage and leads to bleeding upon the very 
sligh test trauma. Significantly enough, vitamin K has an antidotal 
action again st both actions of warfarin up to a certain point.
A single intravenous, therapeutic, dose of the sodium deriva­
tive (70-75 mg. or about 1 m g./kg.) in man may produce some in­
crease in prothrombin time within 2 hours, and usually produces a 
substantial increase within 14 hours. The average maximum re­
sponse is  on the fourth day. Spontaneous recovery to normal occurs 
about 8 days after a single therapeutic dose. Thus, significant 
clin ical depression of prothrombin level is  maintained for 3-6 days. 
In the treatment of thromboembolic d ise a se , a maintenance dose of 
about 10 m g./day or 50 mg. every 5 days i s  required to keep the 
prothrombin level between 10% and 30% of normal. Patients have 
been thus maintained for years.
All the pathology induced by warfarin is  reversible up to a 
certain point (See below).
Warfarin and some other anticoagulants are derived from cou- 
marin while others a s  well a s  the drug phenindione are indandione 
derivatives. The occurrence of agranulocytosis and hepatitis in 
some patients treated with phenindione su ggests the possib ility  
that phenindione compounds may have effects entirely unrelated to 
their anticoagulant properties.
Dangerous Single and Repeated Doses to Man: Serious illn e ss  was 
induced by the ingestion of 1.7 mg. of warfarin per kg. per day for 
six  consecutive days with su icidal intent. T his would correspond 
to eating almost 1 pound of bait (0.025% warfarin) each day for 6 
days. All s ign s and symptoms were caused by hemorrhage and, 
following multiple small transfusions and m assive doses of vitamin 
K, recovery was complete.
In Korea, a family of 14 persons lived for a period of 15 days 
on a diet consisting almost entirely of corn meal containing war­
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farin. The dosage of the different individuals was determined to 
vary from about 1 to 2 mg. of warfarin per kilogram per day. As a 
result of this exposure and without benefit of treatment, 2 of the 14 
persons died. A 19-year-old girl who w as in a state  of shock and 
severe hemorrhage 2 days after the warfarin diet was discontinued 
recovered following a blood transfusion and small daily  doses of 
vitamin K. The remaining 11 members of the family recovered 
within a week after exposure, although only sm all daily d oses of 
vitamin K were given, and although they all had shown marked 
sign s of poisoning when they first accepted treatment. Recovery of 
the 12 survivors was complete. The entire episode was made po s­
sib le  only by a se rie s  of unusual events and by the extraordinary 
apathy of the family, resulting in their totally ignoring unmistak­
able sign s of illn e ss .
The possib ility  of human poisoning by warfarin must be kept 
in mind. In sp ite  of one reported ca se  which su ggests  the p o ss i­
bility of hypersensitivity, the safety  factors and experience with 
use of the sodium sa lt  in medical treatment make it appear un­
likely that poisoning with this pesticide will occur except with 
su icidal intent or a s the result of g ross c a re le ssn e ss  and igno­
rance. Although numerous accidental ingestions by children and 
adults have been reported to the New York Poison  Control Center, 
no known injury from these ingestions has been observed.
The threshold Limit value for warfarin in air is  0.1 mg./M3.
Signs and Symptoms of Poisoning in Man: The in itial symptoms in 
an attempted suicide using warfarin were back pain and abdominal 
pain. The onset occurred one day after the sixth daily dose. A day 
after onset, vomiting and attacks of nose bleeding occurred. On the 
second day of illn e ss , when admitted to the hospital, the patient 
was observed to have a generalized petechial rash. The prothrombin 
time was greatly prolonged. The coagulation time was definitely 
increased by the Lee-White method and slightly increased by the 
capillary tube method. B leeding time was normal. Urine w as normal 
in appearance but contained many red c e lls  on microscopic exami­
nation.
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In the Korean c a se s , the first symptoms appeared 7 to 10 days 
after the eating of warfarin was begun. M assive bru ises or hema- 
tomata developed at the knee and elbow joints and on the buttocks 
in all c a se s . Extensive gum and nasal hemorrhage usually appeared 
about a day later and by the 15th day blood lo ss  was extensive.
Animals intoxicated with the compound exhibit increasing 
pallor and w eakness reflecting blood lo ss . Appetite and body weight 
are not specifica lly  affected. The blood lo s s  may be evident in the 
form of bloody sputum, bloody or tarry sto o ls, petechiae, or ex­
ternally v isib le  hematomata. Hematoma formation is  more common 
than free hemorrhage. If the hematoma is  superficial, it will be 
marked by sw elling and discoloration. However, in laboratory 
anim als, hematomata are frequently so  large in m uscle septa that 
the entire upper or lower leg is  grossly  swollen, even though the 
lesion  is  so deep that no color i s  evident beneath the skin. There 
i s  no typical location for hematoma formation, the location of 
bleeding being apparently a matter of chance. B leeding asso ciated  
with the central nervous system  may be of such location and ex­
tent a s  to cause  paraly sis of the hindquarters several days before 
death occurs.
Laboratory Findings: Of greatest specific  significance is  the 
markedly reduced prothrombin activity of the blood plasm a as 
measured by the method of Quick or its  m odifications. More deli­
cate te sts  may be made using both dilute and whole plasm a. How­
ever, a clin ical c a se  should show marked increase of the pro­
thrombin time of whole plasma.
A le s s  specific  te st  that will be abnormal in the presence 
of poisoning i s  the clotting time. The red count and hemoglobin 
gradually fall i f  bleeding continues. In terminal c a se s , a state  
of shock develops.
A chemical method for detecting the presence of warfarin 
is  available  but not practical for the hospital laboratory. Speci­
mens of the stomach contents suspected of containing warfarin 
should be shipped refrigerated to the Toxicology Section for chemi­
cal an a ly sis . See Appendix D.
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Pathology: Animals killed by warfarin show most extreme pallor 
of the skin, m uscles, and all the v iscera. In addition, evidence 
of hemorrhage maybe found in any part of the body but usually only 
in one location in a single autopsy. Such blood a s  remains in the 
heart and v e s se ls  is  grossly  thin and forms a poor clot or no clot.
Treatment: After blood has been taken for prothrombin and other 
differential diagnostic te s ts , vitamin K in a dose of 65 mg. should 
be given three times on the first day of treatment irrespective of 
symptoms. Smaller doses should be continued until the prothrombin 
time has reached normal. In a seriously  i l l  patient, a sm all trans­
fusion of carefully matched whole blood should be given initially 
and repeated daily until the patient has returned to normal. Such 
a patient should be given vitamin K a lso . If it  were ever necessary  
to treat a patient in shock from blood lo s s  resulting from warfarin 
poisoning, frequent small transfusions and a complete consider­
ation of the blood chemistry would be in order. Any large  hema- 
tomata should be the subject of a surgical consultation, but any 
surgical action should be taken only after the clotting power of 
the blood is  restored to normal.
The progress of the patient should be followed by the pro­
thrombin te st. T e s ts  should be made at le a st  twice daily until a 
return to normal i s  clearly estab lished .
It will be noted that the suggested  dosage of vitamin K i s  far 
in e x c e ss  of the 1.0 mg. dose recommended in the Pharmacopoeia. 
It i s ,  however, a sa fe  dosage and is  based  on that already used 
su ccessfu lly  for some years in the treatment of ex cessiv e  hypo- 
prothrombinemia in the course of medication with coumarin drugs.
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F U N G IC ID E S
Dith iocarbam ates
Identity: ferbam — ferric dimethyldithiocarbamate; ziram — zinc 
dimethyl dithiocarbamate; maneb — manganese ethylene bisdithio- 
carbamate; zineb — zinc ethylene bisdithiocarbamate; and nabam — 
disodium ethylene bisdithiocarbamate.
Chemical Formulae:
CHj
^ N - C - S  
C H , ^  §
ferbam
Fe
3
CHj
CHjX
:N -c-sils
ziram
Zn
2
CH2—N —C—S*
1 1H S \
CH2—N—C—S
M n
I
H
maneb
CH2—N —C—
CH
Sv i h \
H S \  
/
N —C—S '
ilH S
zineb
Na—S—C—N—CH2 — CHj - N - C - S - N a  
h I 2 2 I h
S H H S
nabam
Formulations: The several compounds are available a s solutions up 
to 76%,as dusts up to 20%, and a s  wettable powders.
Uses: All the dithiocarbamates are fungicides used mostly on fruit 
crops and tobacco but a lso  on vegetables and ornamentals.
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Toxicology: The acute oral toxicity of dithiocarbamates to rats 
is a s follows:
Compound L D 5 0  -Value 
(mg./kg.)
Ferbam 17,000
Ziram 1,400
Maneb 7,500
Zineb > 5,200
Nabam 395
The exact dosage necessary  to produce poisoning in man is 
not known for any of these compounds. Most applicators have con­
sidered the dithiocarbamates to be harmless and acted accordingly 
without experiencing anything more serious than mild derm atitis, 
pharyngitis, rhinitis, bronchitis, and conjunctivitis as a result of 
the rather heavy exposure. There is some evidence that much of 
the primary irritancy of formulations of these compounds may be 
due to the vehicle a s well a s  to the active ingredients.
O r g a n i c  m ercury compounds
Identity: Mercury is  bivalent in the organic compounds used as 
fungicides. As a rule, an alkyl (methyl, ethyl, methoxyethyl, etc.) 
or an aryl (phenyl, tolyl, etc.) mercury group is  combined with 
an inorganic or organic acid or amide. Typical examples are: ethyl 
mercury phosphate, phenyl mercury acetate.
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Most methyl mercury compounds appear to be more effective 
than other organic mercury compounds as fungicides. Some of the 
methyl compounds present a greater hazard to the user partly be­
cause of their higher volatility, although by simple L D 50 te sts  the 
methyl mercury sa lts  are not more toxic than the phenyl mercury 
sa lts .
Formulations: Both dusts and sprays are available. In some areas, 
there has been a trend to the use of sprays. Commercially treated 
seed generally are colored with a bright dye a s a warning.
Users: The organic mercury compounds are used a s  seed dressings 
for the prevention of seed-borne d ise a se s  of grains, vegetables, 
cotton, peanuts, soybeans, sugar beets, and ornamentals. They 
may be used for the control of fungus d ise a se s  of turf, fruits, cere­
a ls , and vegetables but not under conditions that will leave any 
measurable residue in the food of man or animals. At le a st in other 
countries, organic mercury compounds have been used for the pres­
ervation of wood and in the paper, p la stic s , and fabric industries.
Routes of Absorption: These compounds are absorbed by the skin 
and by the respiratory and gastrointestinal tracts. Some of the alkyl 
compounds are highly volatile , thus increasing the hazard of inhala­
tion.
Pharmacologic Action: Mercury, in whatever form, is  a general 
protoplasmic poison. Differences in toxic m anifestations of the 
organic mercury compounds and the better known inorganic com­
pounds are seen particularly in chronic poisoning and are correlated 
with the greater storage of the organic compounds in the liver, 
kidneys, and brain. Storage in the brain may indicate a greater 
ability of some of the organic compounds to p ass the blood-brain 
barrier but may represent only an equilibrium between blood and 
brain levels. At equivalent dosages of mercury, more is  excreted 
in the urine after repeated feeding with phenylmercuric acetate 
than after sim ilar feeding with mercuric acetate , but after injection 
more is excreted with the inorganic form. With repeated dosage, the
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organic compounds are more toxic. These facts have been offered 
as evidence of a greater initial absorption of the organic compounds 
(mercuric acetate v s. phenylmercuric acetate) from the gastroin­
testinal tract. Thus, the greater toxicity of the organic compounds, 
e specia lly  the alkyl ones is largely explained by their greater 
absorption and le sse r  excretion resulting in greater storage. 
Following daily oral dosage at the same rate, rats stored 
only traces of mercuric chloride or mercuric nitrate in the blood 
and brain; they stored more phenylmercuric acetate and much more 
cyano (methyl-mercuric) guanidine and methyl mercuric hydroxide 
in these t is su e s . A sim ilar relationship was true for the liver and 
kidneys (inorganic < aryl < alkyl), but the concentrations were 
larger, so  that the storage of even inorganic mercury was easily  
detected. The concentration of all three c la s s e s  in the different 
t issu e s  increased in the order; brain < blood < liver < kidneys. 
Inorganic mercury is transported mainly in the plasma while both 
alkyl and aryl mercury are largely bound to the erythrocytes. The 
excretion of mercury in man exhibits two phases following c e s ­
sation of exposure to ethyl mercury chloride, ethyl mercury phos­
phate or ethyl or phenyl mercury acetate. The first phase shows a 
slight rise  in urinary mercury concentration, which reaches a peak 
that is variable in both magnitude and the interval of time after 
exposure c e a se s . Following the peak level, a second uniformly 
downward trend occurs.
All compounds of mercury can damage the kidney. Mercury 
vapor, its inorganic sa lt s , and the lower alkyl compounds produce 
damage to the central nervous system . In the case of the methyl 
and ethyl mercury compounds, this damage can take the form of 
irreversible brain cell injury. Such changes may continue to pro­
gress for some .time after the exposure to mercury has ceased .
Dangerous Single and Repeated Doses to Man: The exact 
amount of any organic mercury compound necessary  to produce 
poisoning in man is  not known but is obviously sm all. The acute 
oral LDgQ-value for representative compounds in rats is approxi­
mately 30 m g./kg. The total dose of an organic mercury compound 
necessary  to produce chronic poisoning in cats is about the sam e,
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that is 6 to 24 m g./kg. expressed a s mercury. Acute poisoning by 
organic mercury has been reported infrequently in man, although 
such poisoning by methyl and other alkyl compounds has occurred. 
There have been many c a se s  of chronic poisoning involving both 
inorganic and organic mercury. Most chronic c a se s  caused by known 
organic chemicals were asso ciated  with repeated exposure in con­
nection with the manufacture of alkyl compounds, their use for 
treating seed , or the eating of treated seed . Other ca se s  were a s s o ­
ciated with the ingestion of seafood contaminated by industrial
waste. The threshold limit value for organic mercury compounds 
in air is 0.01 mg./M^.
Signs and Symptoms of Poisoning in Man: The acute symptoms 
associated  with irritation of the gastrointestinal system  and renal 
failure caused by inorganic mercury compounds are seldom observed 
in poisoning by organic mercury compounds and then almost exclu­
sively  in acute poisoning. Even the mild digestive disturbances 
and sore mouth seen in moderate, chronic, occupational poisoning 
by inorganic mercury are relatively rare. Instead, the nervous symp­
toms appear first, sometimes after relatively slight exposure and 
after months of latency. The patient may complain of headache; 
paresthesia of the tongue, lip s, fingers, and toes; and other non­
specific  dysfunction.
Early sign s include fine tremors of the extended hands, lo ss 
of side  vision, and slight lo ss  of coordination, especia lly  with the 
eyes closed as in the finger-to-nose-test. Incoordination is espec- 
illy notable in speech, writing, and gait. Incoordination may pro­
gress to the point of inability to stand or to carry out other volun­
tary movements. O ccasionally there is  muscle atrophy and flexure 
contractures. In other c a se s , there are generalized myoclonic 
movements.
There may be difficulty in understanding ordinary speech 
although hearing and the understanding of slow deliberate'speech  
often remain unaffected. Irritability and bad temper are frequently 
present and may progress to mania. O ccasionally the mental picture 
deteriorates to stupor or coma. E specia lly  in> children, mental 
retardation may be added to the symptoms of poisoning already 
mentioned.
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Patients frequently become gradually much worse after their 
illness is recognized and exposure is  stopped. Even in those c a se s  
in which recovery occurs in the course of months or years, there 
may be little or no real neurological improvement, only an adapta­
tion and reeducation. The duration of illn ess in fatal c a se s  has 
ranged from about a month to 15 years. Intercurrent infection, a sp i­
ration pneumonia, or inanition are the immediate cau se s of death.
The oiganic mercury compounds are strong irritants of the skin 
and may cause b listers or other dermatitis with or without a s s o ­
ciated system ic illn ess .
Laboratory Findings: The average excretion of mercury by normal 
people is  0.5 |ig. daily in the urine and 10 ng. daily in the feces. 
Although 'there i s  some disagreement about the concentration of 
mercury that can be excreted safe ly , there is  general agreement 
about the value of making the measurement. The most conservative 
view is  that the concentration in the urine should not exceed  15 
micrograms per liter ( | ig . / l . )  or slightly higher following exposure 
to alkyl mercury. Somewhat higher excretion can be tolerated fol­
lowing exposure to inorganic mercury, because any given level of 
excretion represents le s s  absorption a s  compared with an organic 
compound. Other investigators, who have presumably used more 
sen sitive  chemical methods (although they failed to recognize the 
po ssib ility  of exposure to inorganic mercury in association  with 
organic compounds), indicate that any operator exposed chiefly to 
alkyl compounds excreting more than 50 |ig. of mercury per liter of 
urine should be placed on a “ watch l i s t ”  requiring weekly urinaly­
s is  and that any operator excreting more than 100 M-g./l. should be 
removed from exposure. H ospitalized c a se s  may excrete 600 or more 
micrograms per 24 hours (300 to 400 p ,g ./l.) .
Pathology: Extensive and relatively characteristic pathology has 
been reported in man and experimental anim als. The most common 
findings are: (1 ) bilateral cortical atrophy around the anterior end 
of the calcarine tissue  with disappearances of the striation of 
Gennari (associated  with constriction of the v isual fields) and (2) 
gross atrophy of the folia in the depths of the su lc i of the lateral
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lobes and the declive of the cerebellum involving the granule cell 
layer (associated  with ataxia). The hypothalamus, midbrain, and 
basal ganglia may be involved. The changes in the brain involve 
g lio sis  a s  well as the abnormality and lo ss  of specific  neurones. 
The bodies of the Purkinje ce lls are spared although the axones 
are affected. Changes in the peripheral nerve and the posterior 
columns have been reported in anim als. D ecrease in anterior horn 
cells with demyelination of the lateral columns of the spinal cord 
(associated  with a ca se  said  to resemble amyotrophic sc le ro sis) 
has been reported; the difference may be related to the fact that 
a phenyl mercury compound was involved.
In fatal c a se s , the concentration of mercury in the organs has 
been in the following ranges: brain, 4.0 to 10.0 ppm; spinal cord,
3.5 to 40 ppm; liver, 14.0 to 20.0 ppm; kidney, 3.0 to 30.0 ppm; 
and lung, 2.0 to 4.0 ppm. More recent investigations have shown 
higher maximal values perhaps a s  a result of better analytical 
methods: brain, 21 ppm; liver, 71 ppm; kidney, 144 ppm. E xcessiv e  
mercury may be found in the hair a lso . Comparable values obtained 
by modern techniques do not seem  to be available  in connection 
with chronic poisoning by inorganic mercury.
Differential Diagnosis: Viral encephalitis, poisoning by certain 
other m etals, and some neurological disorders of unknown or here­
ditary cause must be considered. D iagnosis depends on a history 
of exposure and the measurement of mercury in urine and t is su e s .
Treatment: In poisoning by alkyl mercury compounds, BAL is 
considered of doubtful value or even harmful. It may be useful in 
treating sequelae of alkyl mercury poisoning perhaps because in­
organic mercury may be left in the t is su e s . EDTA has a lso  been 
used a s an antidote but its  value is  not established .
Prevention of Poisoning: If mercury compounds must be used in­
stead of le s s  poisonous fungicides, then the use of m asks, rubber 
g loves, and separate work clothing is necessary . More elaborate 
protective devices are recommended under manufacturing condi­
tions. Special closed machinery is  availab le  for applying dressing
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to seed  and should be used if possib le . Even if the best equipment 
is availab le , a ll clothing, including sh oes, must be changed after 
work. Smoking, chewing gum or tobacco, drinking, or eating are 
prohibited during work. Tobacco, gum, or candy must not be carried 
in work clothing. Scrupulous personal hygiene is  required. Workers 
should receive preemployment medical examination to exclude 
those with neurasthenia, nervous d ise a se , derm atitis, liver disorder, 
hypertension, or defective kidney function. Persons with repeated 
exposure should have periodical medical examination and frequent, 
regular an alysis of the urine for mercury.
P eniach lo rop hen o ■
Chemical Name: pentachlorophenol
Chemical Formula:
Formulations: Pentachlorophenol, a crystalline so lid , is  soluble in 
various organic solvents, including the petroleum o ils in which it 
is applied. It is  frequently used a s  the sodium sa lt , which is  freely 
soluble in water.
Uses: Pentachlorophenol is an insecticide, m oluscicide, herbicide, 
fungicide, and bactericide. It is  used to control termites and other 
wood in sects and various sn a ils , including those that carry sch isto ­
som iasis. It is used a s  a weed killer, cotton defoliant, and preserv­
ative for timber.
Routes of Absorption: Pentachlorophenol is absorbed by the skin 
as well a s after inhalation or ingestion.
Pharmacologic Action: The action of pentachlorophenol is  similar 
to that of the dinitrophenols (which see) and co n sists  of an in­
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crease in the metabolic rate leading to a marked increase in body 
temperature, co llapse , and death. The main action of the chemical 
is a rapid uncoupling of oxidation and phosphorylation cy cles. 
Although illness may be produced by the cumulative action of 
several d o se s, the onset of critical illn ess tends to be sudden and 
the course of the d ise a se  rapid. In 19 c a se s  for which the informa­
tion is available, the time from first symptoms to death ranged 
from 3 to 30 hours and averaged 14 hours.
Excretion occurs largely in the urine. In certain fatal c a se s , 
it seemed that the victim was unusually susceptible by virtue of 
renal deficiency. This hypothesis was supported by experiments 
which showed that rabbits made nephritic experimentally were very 
much more easily  poisoned by pentachlorophenol than were normal 
anima Is.
Dangerous Single and Repeated Doses to Man: The exact dosage 
necessary to produce illness is not known. It is clear that the 
largest dosage that produces no illn ess whatever is little le ss  
than the fatal dosage. It is  claimed that one man drank a g la ssfu l 
of 2% solution of the sodium sa lt  with no effect except a hangover. 
One man died after working 6 days a s  a mixer preparing 2.1% cotton 
defoliant from 40% concentrate. Nine died after dipping timber by 
hand and without any protection in 1.5% to 2% solution for periods 
varying from 3 to 30 days with an average of 13 days; this is  typ­
ical of several other situations in which accidents have occurred. 
The threshold limit value for pentachlorophenol in air is 0.5 
mg./M3.
Signs and Symptoms of Poisoning in Man: Nonfatal system ic poi.- 
soning is characterized by w eakness, by more or le ss  marked lo ss 
of appetite and weight, sometimes by a feeling of constriction in 
the chest and dyspnea on moderate exercise , and almost always by 
excessive  sweating. Headache, d izz in ess, nausea, and vomiting 
may be present.
In fatal c a se s  the temperature is frequently extremely high 
Cup to 108°F  (42.2°C)^], but may be only moderately elevated. 
Sweating, dehydration, and dyspnea are present and there may be
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pain in the chest or abdomen. The pulse is rapid. Coma appears 
early. There is frequently a terminal spasm .
Under some conditions of u se , pentachlorophenol causes 
irritation of the skin, conjunctiva, and upper respiratory tract even 
at dosages that do not produce system ic d ise a se . Dermatitis may 
be acneform or eczematous.
Pathology and Laboratory Findings: The pathology is not charac­
teristic except that the high temperature of the body may be noted 
if autopsy is performed within a few hours after death. The organs 
frequently show some congestion and there may be some cerebral 
edema. Degenerative changes in the liver and kidneys have been 
observed in a few c a se s . In one ca se  of fatal occupational poison­
ing, with autopsy three days after death, pentachlorophenol was 
found in the following concentrations: lung, 76 ppm; blood from 
lung, 97 ppm; liver, 62 ppm; blood from liver, 46 ppm; and kidney, 
84 ppm. A child who ingested the material showed the following 
concentrations: liver, 59 ppm; blood from liver, 53 ppmjkidney, 
41 ppm; and urine (post mortem), 28 ppm.
Nonfatal c a se s  have shown 3 to 10 ppm of pentachlorophenol 
in the urine and sometimes traces of albumin. Concentrations were 
55 and 96 ppm in urine taken at autopsy from adults. Early reports 
of concentrations a s  low as 7 ppm in fatal c a se s  may be in error.
Differential Diagnosis: The greatest danger is that poisoning by 
pentachlorophenol will be mistaken for poisoning by an organic 
phosphorus insecticide, which is a lso  characterized by sweating, 
difficulty in breathing, and pain in the chest and abdomen.
Treatment: The use of atropine sulfate is  absolutely contraindicated. 
Treatment is symptomatic and difficult. An effort must be made to 
maintain the fluid and electrolyte balance and to keep the body 
temperature within tolerable limits.
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Prevention: The first rule of prevention is  good general hygiene 
with emphasis on protection of the skin of workers. At le a st under 
field conditions, it is wise to alternate workers so  that repeated 
exposure is for a maximum of two weeks. During the preemployment 
examination, careful measurement of renal function should be made 
in order to exclude applicants with deficient function.
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HERBICIDES
Arsenic
Identity and Formulae: Elementary arsenic forms two oxides: the 
trioxide, A s 20 3, and the pentoxide, A s2O s. Arsenic trioxide (tri­
valent) reacts with water to form arsenous acid, H3A s0 3, which 
i s  known only in solution and forms three serie s of sa lt s : ortho- 
arsenites (e .g ., N a 3A s0 3), m etaarsenites (e .g ., N a A s0 2), and 
pyroarsenites (e .g ., N a4A s2Os). Arsenic pentoxide (pentavalent) 
reacts with water to form three acids that may be isolated : ortho­
arsenic acid, H3A s 0 4; metaarsenic acid, HAsOs ; and pyroarsenic 
acid, H A s 0  . T hese acids form the corresponding sa lts : ortho-’ 4 2 7
arsenates, m etaarsenates, and pyroarsenates. A few organic arsenic 
compounds are also  used a s pestic id es.
Although a great many arsen icals have had some use, the fol­
lowing are of most importance:
Name
A rsenic trioxide
Sodium arsen ite  
P a r is  green
L ead  arsen ate
Synonym
white arsen ic
copper aceto-m eta- 
arsen ite
acid  lead  arsen ate  
stan dard  lead  arsen ate  
dilead  arsen ate
Formula
AS2°3
Mixture, s e e  above  
Cu(CH 3 COO) 2. 3Cu( AsO 2 ) 2
PbH AsO 4
B a s ic  lead  arsen ate  lead  hydroxy- 
arsen ate
Calcium  arsen ate
D im ethylarsinic ac id  Arsan
caco d y lic  ac id
Disodium  methyl 
arsen ate
P b 4 (PbOH) ( A s 0 4 ) 3 .H 20
a  com plex mixture 
(C H 3 ) 2 AsO(OH)
N a 2 CH 3 A s 0 3 .6H 20
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Formulations and Uses: Arsenic trioxide in the form of a powder is  
used a s  a rodenticide. Arsenites are more soluble and more rapidly 
toxic than corresponding arsenates; therefore, arsen ites are used 
as rodenticides and herbicides, and in in secticidal baits. Sodium 
arsenite i s  usually sold a s  a solution. Dimethylarsinic acid and 
disodium methyl arsenate are herbicides. In some countries sodium 
arsenite was used to dry up potato tops in preparation for me­
chanical harvesting, but the practice is  very dangerous. P aris 
green, although an arsenite, may be applied to foliage but the 
arsenates are le s s  phytotoxic and, therefore, preferred. Lead  ar­
senate i s  usually used as a wettable powder, calcium arsenate a s 
a dust. P aris  green impregnated on vermiculite is  used to an in­
creasing degree a s a mosquito larvicide. The use of arsenical 
in sectic id es in agriculture has decreased greatly since the intro­
duction of DDT and later poisons, but the use o f arsenical 
herbicides has increased.
Route of Absorption: Arsenic is  absorbed chiefly by the respira­
tory and gastrointestinal tracts. However, some i s  absorbed by the 
intact skin, and system ic illn ess  may follow application of arseni­
cal ointment to eczematous skin.
Pharmacologic Action: Arsenic in whatever form is  a general pro­
toplasm ic poison. It binds organic sulfhydryl groups, thus inhibit­
ing a number of enzymes, notably pryuvate oxidase and the phospha­
ta se s , so that tissu e  respiration i s  reduced. The chief pharmaco­
dynamic action is  dilatation and increased permeability of the 
cap illaries. This action is  strongest in the in testines regardless 
of route of absorption. Arsine (hydrogen arsenite), is  a powerful 
hemolytic agent but it i s  unlikely to be found in connection with 
p estic id es. Most commercial arsenic formulations are irritant, at 
le a st  in part because of their impurities. Pure compounds are 
only weakly irritant but they slowly kill c e lls  on prolonged con­
tact, and by local action on cap illaries they cause congestion, 
s ta s is ,  thrombosis, ischem ia and necrosis. Such necrosis extends 
into the bone in some instances. It i s  generally stated that arsenic 
can cause cancer, e specially  of the skin, but the epidemiology is
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not clear. No c a se s  have been clearly traced to occupational or 
accidental contact with pesticides.
Dangerous Single and Repeated Doses to Man: A dose of 5 to 50 mg.
of arsenic trioxide i s  toxic. A dosage of 128 mg. has proved fatal 
but recovery has occurred after much larger d oses. The effective­
n ess o f arsenical rat poisons varies greatly with the grind of the 
powder; very fine powders approach the toxicity of solutions con­
taining an equivalent amount of arsenic. Thus the ease  o f absorp­
tion influences the toxicity to a marked degree. The repeated dose 
necessary  to produce poisoning i s  le s s  well known. The “ thera­
peutic”  dose of arsenic trioxide (1 to 2 mg. three times daily) that 
used to be employed a s a tonic frequently led to mild poisoning. 
The threshold limit for arsenic i s  0.5 mg./M 3, a value higher than 
that for lead because arsenic i s  more efficiently excreted.
Signs and Symptoms of Poisoning in Man: For many years, arsenic 
has been the most important single cause of accidental deaths 
associated  with pestic id es. In 1956, it caused 35% of such ca se s . 
Accidental poisoning by arsenic p estic id es is  almost always acute 
and often involves children (74% of these c a se s  in 1956 involved 
children 5 years old or younger). Abdominal pain and vomiting often 
start within an hour of ingestion, although the onset may be de­
layed particularly if foul play is  involved and the dosage is  con­
trolled. Death may result from a severe fall in blood pressure and 
co llapse  a s  in “ dry”  cholera. Generally death i s  delayed for 1.5 
to 3 days after onset and sometimes a s  much a s  14 days. In this 
event, death follows vomiting and profuse, painful diarrhea; the 
clin ical picture is  similar to cholera because of the character of 
the stoo ls and the great dehydration of the patient. If the patient 
survives the acute phase, exfoliative dermatitis or neuritis may 
appear. People with this polyneuritis have pain, burning, and ten­
derness of the affected limbs and trouble in walking. Chronic 
poisoning has not been a significant problem in pesticide appli­
cators; c a se s  reported in vineyard workers in Germany may have 
involved the drinking of contaminated wine. Chronic poisoning is
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well known from other sources. It usually involves the frequently 
insidious onset of lo s s  o f appetite, weight lo ss , w eakness, nausea, 
alternating diarrhea and constipation, colic, peripheral neuritis, 
dermatitis, some lo s s  of hair, g iddiness, and headache. Cyanosis 
of the face may be present. The dermatitis may be erythematous, 
pustular, or even ulcerative. Burning and itching may be present 
and there may be serous discharge. With most arsenic compounds, 
the skin lesion s tend to be most marked in the area of greatest 
contact. They are considered mainly the result of direct toxic 
action. The action may involve the face, eyelids, conjunctivae, or 
even cornea. There may be irritation of the nose, pharynx, and 
trachea. Perforation of the nasal septum has occurred. In le s s  
acute c a se s , hyperkeratosis, hyperhidrosis, or m elanosis may oc­
cur. White transverse bands in the n ails frequently accompany 
polyneuritis. The bands gradually migrate to the free edge of the 
nails as the result of growth of the n ails. A highly characteristic 
dermatitis confined to the scrotum, inguinal area, and nasolabial 
folds may follow moderate occupational exposure to P aris  green. 
The lesion s begin with erythema, frequently become eczematous 
and weeping, and may start to heal with the formation of a black 
scab. A sensitization reaction may be involved because the d is­
tribution does not correspond to the distribution of in secticide on 
the skin, and the dermatitis generally occurs in the absence of 
typical poisoning.
Laboratory Findings: Normal people may excrete arsenic in the 
urine at rates as high as 0.17 ppm (as As2 0 3 ). Blood levels as high 
as 1 ppm have been reported in normal people as the result of a rse­
nic in ordinary food and water. Concentrations in other so ft tissu es 
may be a s  high as 7.6 ppm; the hair may have 10 to 15 ppm. Asymp­
tomatic chemical workers may show arsenic at a concentration of 
100 ppm in the hair and 0.82 ppm or more in the urine. Serious but 
nonfatal c a se s  showed urinary excretion a s high as 6.2 mg. per 
24 hours or between 4 and 6 ppm. Victims of acute poisoning 
showed 148 and 150 ppm of arsenic in the liver. Values from the 
kidneys in fatal c a se s  have ranged from 9.2 to 91 ppm.
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Electrocardiographic changes may be present. In arsine poi­
soning (unlikely in connection with pestic id es), severe anemia is  
found in the presence of a normal bone marrow; the urine shows 
hemoglobin and sometimes albumin.
Autopsy Findings: In acute poisoning, erosion arid inflammation 
of the stomach and upper intestinal tract may be marked. The liver 
may show degenerative lesion s and in chronic poisoning these can 
lead to cirrhosis. U nless death i s  very rapid, the severe dehydra­
tion produced by acute poisoning g iv es the body an emaciated 
appearance even though a normal amount o f fat remains. The ali­
mentary canal shows a large amount of fluid, shreds of mucous, 
and fa lse  membrane in the absence of marked corrosion -  a picture 
sim ilar to that in cholera. The body may decay more slowly than 
would be expected in the same amount of time at the same 
temperature.
Treatment:If ingestion i s  suspected, the stomach should be emptied 
by vomiting and lavage with warm water followed by a saline ca­
thartic. BAL (Dimercaprol) i s  a specific  antidote; it should be 
given intramuscularly at the rate o f 3 mg./kg. every four hours for 
the first two days, every six  hours on the third day, and twice daily 
thereafter until recovery i s  complete. The drug is  available as a 
10% solution in peanut oil with 20% benzyl alcohol. Dehydration 
should be combatted with saline infusions guided, where po ssib le , 
by laboratory studies. The diet should be liquid. BAL i s  indicated 
in the various forms of chronic poisoning as well as in acute 
poisoning.
Prevention: Most accidental c a se s  of poisoning by arsenical p esti­
cides would be prevented if formulations were alw ays kept in the 
original, labeled containers and the containers were stored so that 
they were absolutely in accessib le  to children.
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Chi o ro p h e n o x y  herbicides
Identity: 2,4-D — 2,4-dichlorophenoxyacetic acid
2,4,5-T -  2,4,5-trichlorophenoxyacetic acid 
MCPA -  2-methyl-4-chIorophenoxyacetic acid
Chemical Formulae:
Cl
MCPA
Formulations: The acids them selves are sometimes used but the 
sa lts  or e sters are more widely applied as weed k illers. The 
alkyl amine sa lts  of 2,4-dichlorophenoxyacetic acid (e .g ., tri- 
ethylamine, triethanolamine) have largely replaced the inorganic 
sa lts  (sodium or ammonium) a s herbicides. A wide range of simple 
alkyl e sters (e .g ., isopropyl and butyl) are used when relatively 
high volatility i s  desired; other esters (e .g ., butoxyethanol, tetra- 
hydrofurfuryl) are used when low volatility  is  required. A similar 
array of derivatives of 2,4,5-T and of MCPA are available. Other 
related hormone-type herbicides include 3,4-D,p-chlorophenoxy- 
acetic acid, various phenoxyproprionic acids and various phenoxy- 
butyric acids. In general, each of these may be prepared as the 
acid, inorganic s a lt s , amine sa lt s , or e sters. T hese compounds are 
sold a s dry sa lt s , p a ste s, em ulsifiable concentrates, water- 
wettable powders, and dusts varying in strength of active ingred­
ients from 2% to 98%. A wide variety of solvents have been used 
with them including kerosene, Stoddard’ s  solvent, xylene, and
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methylated naphthalenes. The active ingredients are applied at 
final dilutions as low as 3 ppm and a s high a s 25% (250,000 ppm) 
depending on the use.
Uses: As herbicides, 2,4-D-type compounds are used for selective 
weed control in many crops on over 50 million acres. These com­
pounds are used widely as eradicative herbicides in industrial 
weed control. They are a lso  used in very high dilutions a s  hor­
mone sprays to prevent the early dropping of fruit.
Routes of Absorption: These compounds may be absorbed if taken 
by mouth or presumably if inhaled. Skin absorption i s  slight.
Pharmacologic Action: 2,4-D and related compounds act a s
growth hormones in plants. They have no hormonal action in ani­
m als, but the mechanism of their toxic action i s  poorly understood.
Dangerous Single and Repeated Doses to Man: The acute oral 
toxicity of representative compounds to the rat is  as follows:
Compoun d *-^5 0 -Valoe  (mg./kg.)
2,4-D — acid 375
— sodium sa lt 666 -  805
— mixed butyl esters 620
— isopropyl ester 700
2,4,5-T — acid 500
— mixed butyl esters 481
— isopropyl ester 495
MCPA -  acid 700
— amine sa lt 1,200
The oral dose required to produce symptoms in man is  probably 
3 to 4 g. One man consumed 500 mg. of purified 2,4-D per day for 
21 days without ill effect. When 2,4-D acid was investigated a s  a 
possib le  treatment for disseminated coccidiodom ycosis, the patient 
had no side effects from 18 intravenous doses during 33 days; each 
of the la s t  12 d oses in this se rie s  was 800 mg. or more; the la s t
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being 2,000 mg. (about 37 m g./kg.). A nineteenth and final dose of 
3,600 mg. produced acute illn ess  described below. An oral dose of 
not le s s  than 6,500 mg. led to death in a case  of suicide.
Animals fed 2,4-D or 2 ,4 ,5-T tolerate for months daily doses 
only slightly smaller than those which cause toxic effects when 
given only once. Thus, cumulative effect is  minimal. Recovery 
from poisoning is  complete.
The threshold limit value for 2,4-D in air is  10 mg./M 3, and 
the tentative value for 2 ,4 ,5-T is  the same.
Signs and Symptoms of Poisoning in Man: The patient given 3,600 
mg. of 2,4-D acid intravenously suffered coma, fibrillary twitching 
of some m uscles, hyporeflexia, and urinary incontinence. Seven 
hours after infusion the patient could be roused but lapsed back 
into deep sleep. Twenty-four hours after dosage he was eating well 
but s till complained of profound muscular w eakness; within an ad­
ditional 24 hours he had apparently recovered from all effects of 
the plant hormone. In what was presumably attempted su icide, 
ingestion of an unknown amount of 2,4-D resulted in “ prolonged 
stupor”  followed by recovery. The body of the man who committed 
suicide showed signs of convulsions prior to death.
Animals killed quickly by large d oses o f 2,4-D are thought to 
die o f ventricular fibrillation. If death is  delayed, myotonia, stiff­
n ess of the extremities, ataxia, paraly sis, and coma are seen. 
Repeated d oses that may or may not eventually lead to death pro­
duce lo s s  of appetite, lo s s  of weight, vomiting, depression, rough­
n ess of coat, and general ten sen ess and muscular w eakness. It 
may be significant that the myotonia characteristic of poisoning 
by 2,4-D in animals has not been reported in man.
Three c a se s  of “ peripheral neuritis”  among men very recently 
exposed to 2,4-D were seen at one clin ic in a single month. No 
valid toxicological or epidemiological evidence was given to sup­
port a causal relationship. Although more than 700,000,000 pounds 
of 2,4-D and related compounds have been manufactured and used, 
no similar c a se s  have been reported.
As with other chem icals, 2,4-D may be a cause of contact
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dermatitis, but this effect in man is  neither so common nor so 
severe as animal experiments would suggest.
Laboratory Findings: Animal studies have not indicated any use­
ful laboratory te sts .
Pathology: Experimental animals killed by 2,4-D show irritation 
of the stomach (or the abomasum of ruminants), minor liver and 
kidney injury, and sometimes congestion of the lungs. Nonspecific 
hyperemia of the lungs, liver, and brain were found in the case  of 
suicide.
Differential Diagnosis: The occurrence of myotonia soon after
heavy exposure to 2,4-D would be suggestive of poisoning. 2,4,5-T 
produces only mild spasticity  but may produce difficulty in swal­
lowing. In the absence of myotonia, poisoning by solvents and the 
possib ility  of neurological d ise a se  unrelated to chem icals must be 
considered in view of the low toxicity and good safety record of 
the hormone-type herbicides.
Treatment: If poisoning were to occur, for example in attempted 
suicide, treatment would be symptomatic.
Dinitrophenols
Identity: A number of substituted dinitrophenols, alone or as sa lts  
of aliphatic amines (triethanolamine or isopropanol amine) or alka­
lie s  (sodium or ammonium hydroxide), are sold under many trade 
names, frequently with a suffix to indicate the formulation. Repre­
sentative m aterials are a s  follows:
4,6-dinitro-o-cresol (DNOC) 2-sec-butyl-4,6-dinitrophenol
(2-methyl-4,6-dinitrophenol)
689679 O - 63 - 109
H 2 H2 +Ô N H j-C H 2 -C H O H -C H 3
isopropanolamine
2-cyclohexyl-4,6-dinitrophenol sa lt  of 2-sec-amyl-4,6-dinitro-
phenol
Formulations: Dinitrophenols are marketed a s  1.5% to 2.5% solu­
tions in oil and up to 53% water-wettable powders. They are also 
available in the form of 20% sa lts  in 14% oxidized oil. Frequently 
2% sodium chromate is  included in liquid concentrates a s a cor­
rosion inhibitor.
Uses: The substituted dinitrophenols are used, in different formu­
lations, a s  fungicides, in secticides, m iticides, or herbicides. They 
are used extensively in dormant sprays for the control of mites, 
aphids, sca le  in sects, and other p e sts  in overwintering stag es. 
They are useful a s acaricides in greenhouse, field, and orchard. 
In other countries, DNOC has been released by aircraft against 
airborne swarms of grasshoppers. The compounds may be used as 
eradicant herbicides in such' locations as roadsides and right-of- 
ways, or a s se lective  weed killers in fields or pastures, or as 
blossom thinners for tree fruits.
Routes of Absorption: All of the compounds listed  may be ab­
sorbed in toxic amounts by inhalation or ingestion. DNOC and the 
secondary butyl derivative may be absorbed through the skin to a 
dangerous degree while the cyclohexyl derivative i s  not absorbed 
to an appreciable extent by this route.
Pharmacologic Action: All o f the compounds increase the oxidative 
metabolism and therefore the heat production of the body chiefly 
by direct peripheral action.
Dangerous Single and Repeated Doses to Man: The dangerous 
single dose o f DNOC has been estimated to be 2 g. (about 29 mg. 
kg.). No toxic effects were noted by any of five volunteers after
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the ingestion of the first of 5 or more doses of 75 mg. of DNOC 
leading to blood levels of 10 ppm or slightly le s s .  Two volunteers 
who ingested d oses of 75 mg. of DNOC per day for 5 and 7 days, 
respectively, experienced lassitu de, headache, and m alaise.
B ecause DNOC i s  a cumulative poison and i s  excreted very 
slowly by human beings, persons who have suffered any symptoms 
of poisoning should be removed from risk of further absorption for 
a period of at le a st  6 weeks. L e s s  is  known of the toxicity o f the 
other compounds to man but their toxicity to the rat is  sim ilar, as 
shown in the table below.
The threshold limit value for DNOC in air has been se t at
0.2 mg./M 3.
O R A L  T O X I C I T Y  O F  S E L E C T E D  S U B S T I T U T E D  
D I N I T R O P H E N O L S  T O  T H E  R A T
Compound 
(R = 4,6-dinitrophenol)
T  derated  
Acute  
Dosage  
(mg./kg.)
Acute
L D 50
(mg./kg.)
T  olerated 
Concentration  
in Diet  
(ppm)
2-Methyl-R (DNOC) 10 30 100
2-sec-Butyl-R 5 37 100
2-Cyclohexyl-R 30 80 500
Signs and Symptoms of Poisoning in Man: The signs and symptoms 
of confirmed acute DNOC poisoning in man have closely  paralleled 
those of experimental animals and include nausea, gastric d istre ss , 
re stle ssn e ss , sensation of heat, flushed skin, sweating, deep and 
rapid respiration, tachycardia, fever, cyanosis, co llapse , and coma. 
Acute poisoning with DNOC usually runs a rapid course; death or 
almost complete recovery within 24 to 48 hours is  the general rule.
The increase in metabolic rate is  proportional to the dose of 
the toxicant absorbed, and very high lev els (up to 4 times normal) 
may be reached temporarily. However, with high metabolic rates, 
heat production so  exceeds the physiologic capabilities of heat
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dissipation that fatal hyperthermia may result. DNOC is  much more 
effective in raising the body temperature if the temperature o f the 
surroundings i s  22PC. (7 2 °F .) or over. If the external temperature 
is  16°C. (6 1 °F .) or below, increased oxidation and pyrexia are not 
produced. On the contrary, in this situation, DNOC lowers oxida­
tion by greatly diminishing or abolishing shivering, and eventually 
cau se s rapid cooling of the animals. Heat regulation is ,  therefore, 
disturbed in both directions, so a s to exaggerate the detrimental 
effects of external temperature.
The sign s and symptoms of chronic DNOC intoxication may 
include fatigue, r e stle ssn e ss , anxiety, e x cessiv e  sweating, un­
usual thirst, and lo s s  of weight. Yellow staining of the conjunc­
tivae may be noted though staining of skin i s  not n ecessarily  in­
dicative of poisoning. Cataract formation is  another possib le  
sequela of chronic DNOC poisoning.
Laboratory Findings: The most striking laboratory finding is  the 
increased basal metabolic rate (BMR). A te st i s  available  for 
determining the blood and urinary content of DNOC. Repeated daily 
oral d o se s of 75 mg. g ives r ise , after 3 days, to a blood level of 
about 20 ppm. Symptoms appear when the concentration in the blood 
reaches 40 ppm, or more. A case  with a blood level of 70 ppm, termi­
nated fatally. In very cool weather, blood lev els a s  high a s 50 ppm 
may be tolerated without symptoms.
Pathology: In persons who have died from the effect of DNOC, 
yellow staining of the organs, t is su e s , and fluids due to the pres­
ence of the sodium sa lt  of DNOC may be noted. The lungs are con­
gested  and there is  usually some edema and a few petechial hemor­
rhages. There may be sim ilar hemorrhagic changes in the brain and 
gastric  mucosa.
Differential Diagnosis: The symptoms of chronic poisoning from 
substituted dinitrophenols resemble those of hyperthyroidism rather 
closely . BMR determination, of course, i s  of no value in differentia­
ting between these two conditions. An exposure history should pro­
vide some b a s is  for making a distinction. In doubtful c a se s , this 
may be supplemented by urine and blood determinations for DNOC
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content, and by the use of other te sts  for thyroid function such as 
blood protein-bound iodine, and rate of uptake of radioactive iodine 
by the thyroid gland.
Acute poisoning is  so rapid in onset that it will not be con­
fused with hyperthyroidism. It may be confused with other forms of 
poisoning merely because of rapidity and severity. Confusion with 
poisoning by an organic phosphorous compound would be d isastrous.
Treatment: Atropine sulfate is  absolutely contraindicated. The 
poison should be promptly removed from the skin and/or gastro­
intestinal tract with an appropriate alkaline agent. No attempt 
beyond ordinary washing should be made to remove the deeply- 
penetrated, persistent stain from the skin or hair.
Treatment co n sists  of an ice  bath to reduce the patient’ s  fever, 
the administration of oxygen to assure maximal oxygenation of the 
blood, and the infusion of large quantities of isotonic saline to 
replace the fluid and electrolyte lo st by sweating.
It has been claimed that the intravenous injection of 10 ml. 
of a 2.5% solution of sodium methyl thiouracil rapidly reduces the 
BMR in persons in whom the rate of metabolism has been increased 
by DNOC.
Prevention: Applicators should observe all necessary  precautions 
in using dinitrophenols and should have routine periodic checks of 
blood lev els. The significance of different concentrations of DNOC 
in whole blood i s  a s  follows:
0 - 1 0  ppm trivial
11 - 20 appreciable absorption
21 - 30 unsafe
31 - 40 likely to cause some toxicity
41 - 50 dangerous
> 50 critically dangerous
Corresponding values for plasm a or serum are approximately twice 
as high.
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S O L V E N T S
Introduction: Solvents and other carriers may contribute to the 
danger of in secticidal formulations either through their inherent 
toxicity or through their solubilizing action on the so-called  active 
ingredients. In some in stances, c a se s  of poisoning by solutions of 
in sectic id es have been characterized by symptoms and clin ical 
course indistinguishable from those caused by the solvent alone. 
On the other hand, a clin ical course characteristic of the active 
ingredient has been present in other c a se s .
Kerosene
Identity: Kerosene, or coal o il, is  a mixture of principally aliphatic 
hydrocarbons d istilled  from petroleum in the temperature range of 
204° to 315°C. The empirical formula i s  CnH2n+ 2 (Where n ranges 
from approximately 10 to 16). Other petroleum fractions such as 
d iese l fuels Nos. 1 and 2 are closely  related chemically, and much 
of this section pertains to such fractions also.
Formulations: Kerosene is  one o f the most common solvents in 
insecticidal solutions and emulsions, e specia lly  in sprays of the 
household type, which may contain up to 98% kerosene. T his so l­
vent is  usually highly refined and — unlike fuel grade kerosene — 
essen tially  odorless. Other toxic solvents are often included in 
formulations o f in secticides.
Uses: Kerosene is  used as a solvent, diluent, and vehicle in 
sprays for household, agricultural, and public health use. Kerosene 
is  also  commonly used alone as an herbicide, a s a fuel, as an in­
dustrial solvent, and for many other purposes.
Routes of Absorption: Kerosene may be absorbed orally or through 
the respiratory tract. Its dermal absorption i s  not significant for 
system ic poisoning under ordinary conditions of exposure
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Pharmacologic Action: System ically, kerosene acts a s  a narcotic 
producing depression that may or may not be preceded by an excite­
ment phase. At le a s t  in connection with ingestion, depression 
p e r  s e  i s  apparently never fatal although it may be alarming. Liver 
and kidney damage may occur in severe c a se s . Coma and other 
major central nervous system effects are frequently present in 
c a se s  that resu lt from fumes and are serious enough to come to 
medical attention. However, such serious effects are reported in 
only 3% to 6% of c a se s  involving ingestion. In one se rie s  of 204 
c a se s , 4% of the children were sem iconscious but none had con­
vulsions, 40% were lethargic and 28% had gastrointestinal symp­
toms; however, all had respiratory symptoms and 3% died. Ingestion 
o f kerosene has been known to produce rapid death by gross aspira­
tion and occlusion of the respiratory system. Even when death does 
not occur promptly, there i s  abundant evidence that the pneumonia 
commonly seen in children who swallow kerosene usually resu lts 
from aspiration. The aspiration usually occurs at the moment of 
ingestion or a s the result of vomiting within the first hour. The 
ratio of the oral to the intratracheal L D 5Q for kerosene is  approxi­
mately 140:1. Animal experiments prove that kerosene is  absorbed 
from the gastrointestinal tract. Concentrations o f aromatics as high 
a s 140 ppm and of aliphatics as high as 917 ppm were found in 
blood or t is su e s . In spite of this absorption, the lungs of animals 
receiving dosages of 13 m l./kg. or le s s  with precautions to prevent 
aspiration were normal histologically  when the animals were sac ri­
ficed. The lungs o f rats dosed at 18 m l./kg. showed moderate 
changes on sacrifice , and rats killed by 30 to 40 m l./kg. showed 
more marked pathology of the lungs a s  well a s liver and kidney 
changes. Fatal aspiration leads to gro ss hemorrhagic pneumonitis 
most severe in the hilar and dependent portion of the lung in con­
trast to the even distribution of hemorrhage following rapid intra­
venous injection or pulmonary edema following slow intravenous 
injection. It would appear that, in the absence of aspiration, the 
dosage of kerosene necessary  to produce pneumonitis or other 
serious effects i s  greater than that likely to be ingested. Evidence 
on the effect o f mineral oil and vegetable oil on absorption of 
kerosene i s  conflicting.
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Like many other o ils , kerosene is  a local irritant and may 
cause a maculopapular eruption of the exposed skin. The irritation 
tends to increase and later decrease with repeated exposure over a 
long period.
Dangerous Single Dose to Man: Although kerosene i s  a common 
cause o f poisoning especially  in children, the amount taken is  
seldom known. Survival has been reported following the ingestion 
of one liter, but death has followed the ingestion of doses as small 
as 30 ml., e specia lly  after kerosene w as aspirated. The air con­
centration capable o f producing acute symptoms by inhalation is  
not known.
Dangerous Repeated Dose to Man: Chronic intoxication has not 
been reported.
Signs and Symptoms of Poisoning of Man: The use of kerosene 
sprays in closed or poorly ventilated sp aces may lead to fullness 
of the head, headache, blurred vision, d izz in ess, unsteady gait, and 
nausea. More m assive exposure may cause  co llapse , nervous twitch­
ing; and coma before the victim i s  apparently aware of overexposure 
and before he seek s fresh air.
Ingestion frequently resu lts in immediate gagging and coughing 
and thus leads to aspiration of the oil. The initial symptoms are 
followed by deep drow siness. In the more serious c a se s , broncho­
pneumonia may develop in 24 to 36 hoars. Chest signs are likely to 
be few or absent even when X-ray of the chest reveals an extensive 
bronchopneumonia. Liver and kidney damage may be manifest by 
hepatomegaly and by albumin, ce lls , and c a s ts  in the urine.
Laboratory Findings: Leukocytosis and albuminuria or ca sts  
(generally in severe c a se s , only) may be present. It may be pos­
sib le  to recognize kerosene in stomach contents by its  characteris­
tic odor. This odor will be negligible or absent in poisoning by 
deodorized kerosene. X-ray and liver and kidney function te sts  
should be used to follow the progress of v isceral damage.
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Pathology: Bronchopneumonia, visceral congestion, acute pul­
monary edema, and hemorrhage. Evidence of inflammation of the 
upper gastrointestinal tract may be seen in c a se s  that die early.
Differential Diagnosis: The ca se  history will usually establish  the 
d iagnosis. The characteristic odor may or may not be present. 
Where there i s  doubt, poisoning by alcohol and other solvents and 
by a wide range of narcotic agents may be considered as well as 
diabetic coma.
Treatment: The injury caused by inhalation of kerosene fumes 
seldom requires any treatment except prompt removal from exposure.
If kerosene containing no insecticide has been ingested, g a s­
tric lavage may be done mainly a s a precaution again st regurgitation 
and aspiration from the gastrointestinal tract. A recent study has 
shown that gastric  lavage was not harmful to patients but there 
was no conclusive evidence that it was beneficial. This is  en­
couraging in connection with c a se s  in which the ingested kerosene 
was the solvent for an insecticide that should be removed rapidly 
and thoroughly. If attempted, the gastric lavage should be done very 
early before narcosis se ts  in and every other possib le  precaution, 
including use of an intratracheal tube with inflated balloon, should 
be taken so  that the lavage itse lf  does not lead to aspiration of the 
kerosene. Em etics are contraindicated. Oil laxativ es should be 
avoided, especially  if  the kerosene was the vehicle for an in secti­
cide. A salin e  laxative may be helpful. Sedatives and stimulants 
may be used symptomatically in moderation. Antibiotic therapy 
does not benefit kerosene pneumonia as such, but it may be of some 
benefit in preventing bacterial invasion. Oxygen should be used 
promptly if  the patient shows any respiratory difficulty or the 
sligh test cyanosis. Cortisone and related drugs have been used for 
treating chemical pneumonitis caused by kerosene and other o ils , 
but the value of this treatment remains to be determined. There 
seem s to be no doubt that the inflammatory reaction is  suppressed 
and symptoms are relieved, but there is  some indication that this 
merely postpones the removal of oil from the lung and healing of 
the injury. Thus, the value of adrenocortical steroids for the treat­
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ment of kerosene pneumonitis can be decided only after further 
carefully-controlled study. Liver damage may be minimized by the 
use of a diet low in fat and adequate in carbohydrate. The useful­
n ess of lipotrophic drugs has not been investigated in this con­
nection. Kidney involvement is  rarely sufficient to merit special 
treatment and for those rare c a se s  where the kidneys are seriously 
involved the treatment should be the same as for toxic nephritis 
of other etiology.
Kerosene dermatitis requires no special treatment and will 
regress spontaneously if  exposure is  discontinued. C lean lin ess 
will help to prevent its  occurrence.
Chemical Name: A mixture of o—, m—, and p-xylene. (The ortho 
isomer is  predominant in percentage.)
Chemical Formulae:
CH,
CH3
ortho
isomer
CH,
Cl
meta
isomer
CH,
0
CH}
para
isomer
Formulations and Uses: Xylene i s  a common solvent in in secti­
cidal solutions, em ulsifiable concentrates, and emulsions. It is  
extensively used in industry especially  as the main constituent 
of “ solvent naphtha.”
Routes of Absorption: Xylerte is  absorbed when taken orally or 
inhaled by the respiratory tract. Its dermal absorption i s  not sig­
nificant under ordinary conditions o f exposure.
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Pharmacologic Action: Undiluted xylene i s  a severe irritant to 
mucous membranes and delicate skin. Xylene can cause a local 
dermatitis on any type of skin if  used repeatedly. When absorbed, 
it acts as a narcotic and affects the circulating red blood ce lls.
Dangerous Single and Repeated Doses to Man: The sm allest oral 
dose which may prove fatal is  unknown. The threshold limit value 
for xylene in air has been se t at 870 mg./M 3.
Signs and Symptoms of Poisoning in Man: Local application to 
tender skin or to the eyes resu lts in intense burning. Exposure to 
vapors in a poorly ventilated room results in headache, disturbed 
vision, d izzin ess, poor coordination, and nausea. Severe exposure 
may lead to co llapse  and coma. Repeated exposure may lead to 
moderate anemia a s well a s  headache, d izz in ess, m alaise, loss of 
appetite,ready fatigue and later nausea, ch illin ess, and hemorrhage 
from the nasal mucosae. It should be pointed out that commercial 
grades of xylene may be contaminated by appreciable amounts of 
benzene, so  that the inhalation of the vapor may affect the hemat­
opoietic system .
Laboratory Findings: Complete blood studies.including, if n eces­
sary, sternal puncture should be done if chronic xylene poisoning 
is  suspected. M acrocytosis, moderate decrease o f the red ce lls , 
and lymphocytosis are suggestive but not diagnostic.
Differential Diagnosis: D iagnosis is  usually established  by the 
history. If in doubt, alcohol and a wide variety of narcotic agents 
must be considered. Changes in the blood picture must be distin­
guished from sim ilar changes caused by other m aterials and from 
acute leukemia.
Treatment: If the eyes or skin are contaminated, they should be 
thoroughly washed. Two percent butyn sulfate ophthalmic ointment 
may be placed in the eyes immediately after washing to allay pain;
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later cortisone ophthalmic ointment may be used to reduce inflam­
mation. Any analgesic ointment may be applied to the skin.
If xylene has been taken by mouth, an effort should be made to 
remove it by induced vomiting and by gastric  lavage. Oil laxatives 
should be avoided if  the xylene served as a vehicle for an in secti­
cide. Saline laxatives may be used. General care of the patient is 
symptomatic.
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APPENDIX A
C A S E  H I S T O R Y  F O R M *
c « Age :____ Sex:_Occupation:__
Employer:____
Referred by:_
_Mar. Status:_
DO NOT WRITE IN THIS BOX 
Case No.:________________________
Diagnosis:____
Investigatory
_ Address 
Address:
CHIEF COMPLAINT with date and time of onset:_ 
PRESENT ILLNESS:------------------------------
I => 60j sa «
«0 TJ O 41 cO U 
(x  ra u
«
*j  S to
I t i  « 01 «I I XI I
«H U •cs §-s•^0 4)S.^S
<0 p.0) XO 
C 41 «  oc a  
C 3  W1
GEN: Fever,Weight change,Weakness,Fatigability,Sweating,Sleep,Skin,Allergy 
GI: Nausea,Vomiting,Appetite,Taste,Gas,Pain,Stools,Sialorrhea 
NM: Headache,Dizziness,Irritability,Paresthesia,Pains,Twitching,Tremors, 
Fasclculations,Convulsions,Hallucinations,Unconsciousness 
CR: Nasal discharge,Wheeze,Cough,Expectoration,Pain,Tightness,Dyspnea,
Palpi tation,Heart consciousness,Tachycardia,Hypertension,Fainting,Cyanosis 
GU: Urination
EYE: Miosis,Acuity,Depth perception,Double vision,Intensity,Tearing 
PSY: Temperament»Judgment,Affect,Memory,Nervousness,Drowsiness,Insomnia 
PAST ILLNESS (Especially that caused by poisons or of unknown origin):
FAMILY HISTORY:
DOCTOR'S ORIGINAL CLINICAL IMPRESSION:_
TO X IC O LO G Y  C A S E  H ISTO R Y
* T h e  f o r m  i s  s h o w n  i n  r e d u c e d  s i z e .  F u l l - s i z e d  c o p i e s  w i l l  b e  s e n t  t o  c o l l a b o ­r a t i n g  p h y s i c i a n s  w h o  r e q u e s t  t h e m  f r o m  t h e  f o l l o w i n g  a d d r e s s e s .
C o m m u n i c a b l e  D i s e a s e  C e n t e r  A t l a n t a  2 2 ,  G e o r g i a  A t t n :  T o x i c o l o g y  S e c t i o n
U.  S.  P u b l i c  H e a l t h  S e r v i c e  P .  O .  B o x  73  W e n a t c h e e ,  W a s h i n g t o n
U.  S.  P u b l i c  H e a l t h  S e r v i c e  4 4 0 2  N o r t h  S e v e n t h  S t r e e t  P h o e n i x  1 2 ,  A r i z o n a
121
C A S E  H IS T O R Y  FORM (Continued)
PREVIOUS EXPOSURE: Compou ids
No. Seasons No. days this season.
RECENT EXPOSURE: Immediate or Last Other Recent
Compounds
Date and time began 
ended
Duration exposure (hours)
Strength of poison as 
sold? Wettable powder, 
solution, or dust? Final 
strength used? How appl.?
Crop or other use
Route exposure: oral 
dermal
respiratory
mixed
Protective , _ 
clothing: COmplete 
partial
gloves 
shoes or boots
Respirator: type
Ablutions: washing
bathing 
clothes changed
Habits: smoking 
alcohol
Temp, and humidity 
Sweating
Describe any known spill­
age or accident, and sub­
sequent clean up, if any.
Remarks:
2
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C A S E  H IS T O R Y  FORM (Continued)
LABORATORY ANALYSES:
Lab No. SAMPLE DATE HOUR ANALYSIS FOR RESULTS BY
TREATMI
FIRST
3NT AND CLINICAL COURSE:
M D  by
ATTENDI
Home,
ADMITT1
DISCHAJ
DETAIL
CONVAL1
:d BY M.D. of
Jffice, Ho 
2D: Date
Address
spltal
Hour Condition
^GED: Date Condition
3:
ÎSCENCE RECOMMENDATIONS AND RETURN TO WORK:
3
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APPENDIX B
Instructions for obtaining and shipping a fat biopsy for analysis 
for fat soluble compounds.
1. F at from any portion of the body is  su itable. However, when 
performing an operation primarily for the purpose of obtaining a 
biopsy, it is convenient to obtain the fat from the subcutaneous 
tissu e  of the anterior part of the abdomen. It is  more comfortable 
for the patient if the belt line is  avoided for the site  of incision. 
The minor surgical procedure may be done on an outpatient b a sis .
2. The amount of fat should be about 2.5 g. This is  a piece about 
the s iz e  of the tip of a man’s  thumb. The fat should be separated 
from any attached skin or other nonfatty tissu e , blotted with paper 
toweling, and then weighed carefully on a pharmacist’s  balance (or 
one more accurate).
3. Immediately after weighing, the biopsy should be placed into a 
sm all, wide-mouth bottle and frozen. No preservative should be 
used because of interference with certain te s ts , except that 10% 
formalin may be used if chlorinated hydrocarbons are the only com­
pounds for which analysis is  desired. The container should be 
tightly closed and taped and the label filled in with the following 
information:
(a) Name of patient
(b) Weight of sample in grams
(accurate to at le a st two decimal p laces)
(c) Date sample taken
(d) Name of referring physician
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Frozen sam ples should be shipped in dry ice by air. Samples pre­
served with formalin may be shipped by surface mail. Specimens 
should be sent to the nearer of the following add resses:
Communicable D isease  Center 
Atlanta 22, Georgia 
Attn: Toxicology Section
U. S. Public Health Service 
P. 0 . Box 73 
Wenatchee, Washington
609679 0 - 6 3 - 9 125
APPENDIX C
In s t ru c t io n s  for d ra w in g ,  p re p a r in g ,  and s h ip p in g  b lood s a m p le s  
for c h o l in e s t e r a s e  d e te rm in a t io n s .
Blood should be taken by venipuncture in the usual way, using 
sterile  equipment. Heparin is the anticoagulant of choice, and the 
minimal amount to prevent clotting should be used, so as to dilute 
the blood sample a s little a s possib le . Merely wetting the inside 
of the syringe with heparin a s  supplied in the ampule (1,000 units 
per milliliter) is  sufficient. Sodium citrate may be used if heparin 
is unavailable. The blood should be carefully transferred from 
the syringe to a clean, dry 15-ml. graduated centrifuge tube by 
gentle pressure on the plunger. The needle should be removed, and 
the aperture of the syringe should be placed in contact with the 
side of the tube before the blood is  forced out. T hese precautions 
are helpful in preventing hem olysis. Ideally, ten m illiliters of blood 
should be drawn and processed to insure adequate amounts of 
material for cholinesterase an alysis and other te sts  that may be 
indicated.
The collected blood is centrifuged for 15 minutes at 2,000 rpm, 
and the plasma thus separated. The plasm a may now be placed in a 
clean, dry, g la s s  or polyethylene te st  tube of su itable s iz e , closed 
with a tight-fitting, rubber or polyethylene stopper, and plainly 
labeled. The white ce lls  and any remaining plasma at the interface 
in the centrifuge tube are discarded. The remaining red ce lls  are 
transferred to a te st tube, stoppered, and labeled in a manner sim i­
lar to that suggested  for plasma.
The sam ples must be kept refrigerated. For shipment, the 
tubes should be wrapped to prevent breakage. Refrigeration may 
be provided by placing the sam ples between p lastic  bags filled 
with chips of ice. Refrigeration may a lso  be provided by “ refreez- 
an ts”  (water or s ilic a  gel packaged in p lastic  or metal) sold for 
keeping picnic lunches and drinks cold. Before use , refreezants 
must be thoroughly frozen.
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It is ju st as important that the shipping containers be carefully 
insulated and sealed  a s that the sam ples be surrounded by ice.
Never use dry ice for cholinesterase sam ples because the 
sam ples will freeze and the red cell sample will be ruined.
It is recommended that shipments be made by the fa ste st  ava il­
able means of transportation in order to insure adequate refrigera­
tion for the sam ples during the entire period of shipment. P lease  
mark all packages “ P E R I S H A B L E , "  “ R U S H , ”  and “ R E F R I G E ­
R A T E  U P O N  A R R I V A L  _  D O  N O T  F R E E Z E . ”
Samples for analysis should be sent to the c lo se st of the fol­
lowing laboratories:
Communicable D isease  Center U. S. Public Health Service
Atlanta 22, Georgia P- 0 . Box 73
Attn: Toxicology Section Wenatchee, Washington
U. S. Public Health Service 
4402 North Seventh Street 
Phoenix 12, Arizona
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APPENDIX D
I n s t ru c t io n s  fo r  s h ip p in g  s to m ach  c o n te n ts ,  u r in e ,  t i s s u e s ,  or c e r ­
ta in  o th e r  m a t e r ia ls  fo r  to x ic o lo g ic a l  e x a m in a t io n .
If the nature of the toxicant is  unknown, it may be expedient 
to do a b ioassay , and formalin or other preservatives (even volatile 
ones) may interfere with the procedure. In such instances, sp ec i­
mens for routine toxicological study may be frozen and shipped with 
dry ice. Packages should be marked “ P E R I S H A B L E , ”  “ R U S H , ”  
and “ F R E E Z E  ON A R R I V A L . ”  They should be shipped by the 
fa ste st means of transportation available to one of the addresses 
given below.
Each sample of an organ or tissu e  should be i n a separate
jar.
It is usually satisfactory  to preserve urine with a few drops 
of 10% formalin and ship the specimen by ordinary mail. In ca se  of 
doubt, urine too may be shipped under refrigeration. (Of course, 
liquid in g la s s  cannot be shipped with dry ice because freezing of 
the liquid may break the g la s s .)
Samples of in secticides suspected  of being the cause  of poi­
soning should be shipped in a completely separate package from 
blood, tissu e , or other biological specim ens because of the p o ss i­
bility of vapor contamination. If clothing or other objects suspected 
of being contaminated by in secticides are to be shipped, they should 
be put in a third package; if there is any possib le difference be­
tween the sam ples, they should be sealed  in g la s s  ja rs. Ordinary 
p lastic  wrapping may not be sufficient to prevent cross-contamina­
tion.
Communicable D isea se  Center 
Atlanta 22, Georgia 
Attn: Toxicology Section
U. S. Public Health Service 
P. 0 . Box 73 
Wenatchee, Washington
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APPENDIX E
A R T IF IC IA L  R ESP IR A TIO N
U nless the apneic victim is  in a toxic atmosphere, do not 
waste time moving him. Start artificial respiration at once. The 
mouth-to-mouth (or mouth-to-nose) technique of artificial respiration 
is the only one that requires no equipment and will still overcome 
the airway resistance that may be present in poisoning by organic 
phosphorus insecticides a s a result of bronchial constriction and 
excessive  secretion. No matter why breathing has stopped, this 
technique allows the rescuer to get a better idea of the volume and 
pressure needed to inflate the victim’s  lungs than can be gotten 
by other methods. Timing tends to be correct automatically with 
the mouth-to-mouth method, because the nonbreathing adult needs 
about the same volume of air as the rescuer breathes at the normal 
rate (12 to 16 per minute), while the infant or very young child 
requires a sm aller volume delivered at a slightly higher rate (about 
20 per minute).
When a person is unconscious and stops breathing, the base 
of the tongue tends to press again st the back of the pharynx and 
block the p assage  of air from either the nose or mouth into the 
lungs. To clear the upper airway, wipe out the mouth with your 
finger covered by your handkerchief or your shirt. Roll the victim 
onto his back. P lace  both your hands at the angles of his lower
jaw and lift it so  that it juts out and the head tilts back (F ig . 1).
You may do the same thing by putting your thumb in his mouth, 
grasping the jav^ and pulling it forward.
Having cleared the airway, pinch the victim ’s finger so  that 
your fingernail is driven in hard enough to cause sharp pain in a 
normal person. This may cause the victim to gasp  and start breath­
ing again. If this maneuver fa ils  and if the victim is a child, place 
your mouth over his mouth and nose and blow into him gently so
that the chest is  inflated to about the normal degree (F ig . 2).
Remove your mouth to take fresh air and to let the victim breath 
out. As you remove your mouth, turn your ear to listen for air being
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passively  exhaled by the victim. Repeat the active inflation and 
passive  deflation of the victim 20 times per minute.
If the victim is  adult, place your mouth over either his nose 
or mouth and pinch the other opening closed with the fingers of 
one hand. (You can blow between his teeth even though his jaws 
are closed .) You will have to blow harder to get enough air into 
an adult, e specially  a heavily muscled one. Insofar a s possib le , 
keep the jaw jutting out while artific ia l respiration progresses.
If there seem s to be resistan ce to your blowing, recheck the 
position of the jaw. A child may be held up by the ankles (F ig . 3) 
or hung with his abdomen over one of your arms (F ig . 4) while 
you pat him sharply on the back in the hope of dislodging any 
obstructing matter. This effort should la s t  only a moment. Wipe 
out the mouth again and continue artificial respiration.
If obstruction is  s t ill  present after the jaw has been rechecked 
and if the victim is too heavy to lift, he may be rolled onto his 
side and struck several times between the shoulder blades in the 
hope of dislodging foreign matter. Clean out the mouth and continue 
artificial respiration.
If the victim vomits, turn the head quickly to the sid e . Clear 
out the mouth and continue artific ia l respiration a s  soon a s pos­
sib le . Those who do not wish to contact the victim directly may 
cover his mouth with a cloth. This will not interfere very much 
with the exchange of air.
If someone comes to  help, send him to call the police for an 
ambulance equipped for mechanical artificial respiration.
If the victim begins' to  breathe for himself, try to time your 
blowing to match his rate of breathing and help his natural inspira­
tion. As his breathing becomes stronger, stop helping but watch 
very closely  le st he stop again. Keep the person as quiet as 
possib le .
If the victim does not start to breath promptly, do not despair. 
Remember that some poisoned people who required artificial respira­
tion for many hours survived without permanent injury.
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F I G U R E  1. T i l t  the head back and 
l ift  the jaw forward before g iv in g  
a r t i f i c i a l  re sp irat io n.
F I G U R E  2. B low  into the c h i l d 's  
mouth and nose  about 20 times a 
minute (12-16 for ad ults)  ho ld in g  the 
head b a ck  and the chin up.
F I G U R E  3. Invert the infant .and pat 
him on the b a ck  if there is  something  
caught in the w indpipe.
F I G U R E  4. H old  an older c h i ld  over  
your arm to d is lo d g e  an obstruction  
to breathing.
F i g u r e s  on a r t i f i c i a l  re sp ira t io n  by  c o u r t e s y  o f  the A m e r ic a n  R e d  C r o s s .
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SUMMARY
1. Don’t waste time moving the victim unless he is actually in a 
toxic atmosphere.
2. Quickly clear the mouth and throat.
3. T ilt head back as far a s  possib le .
4. L ift lower jaw forward.
5. Pinch the patient sharply to see  if he will gasp  and breathe.
If this fa ils ,
6. open your mouth wide and blow into the victim’s mouth and 
nose (or one of them with the other squeezed shut) until you 
see  the chest rise .
7. Listen for exhalation.
8. Repeat (No. 6 and 7) 12 to 16 times per minute for adults or 
20 per minute for small children.
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LIST O F  M A N U F A C T U R E R S
1. Agricultural Chemical Company, Phoenix, Arizona.
2. Amchem Products, Inc., Agricultural Chem icals D ivision, 
Ambler, Pennsylvania.
3. American Cyanamid Company, Agricultural Chem icals D ivision, 
30 Rockefeller P laza , New York 20, New York.
4. American Potash and Chemical Corporation, Agricultural Chem­
ic a ls  D ivision, 3000 West 6th Street, L o s Angeles 54, C a li­
fornia.
5. Bayer Farbenfabriken, Bayerwork, Leverkusen, Germany.
6. California Chemical Company, Ortho D ivision, L u cas  and Ortho 
Way, Richmond, California.
7. Chemagro Corporation, Hawthorn Road, K an sas City 20, Mis­
souri.
8. Chipman Chemical Company, Bound Brook, New Je rsey .
9. C iba, L td ., B a se l, Switzerland.
10. Commercial Solvents Corporation, 260 Madison Avenue, New 
York 16, New York.
11. Dow Chemical Company, Midland, Michigan.
12. E . I. du Pont de Nemours and Company, Inc., G rasse lli Chemi­
ca ls  Department, Wilmington 98, Delaware.
13. F iso n s P e st  Control L td ., Harston, Cambridge, England.
14. Geigy Agricultural Chem icals, P o st Office Box 430, Yonkers, 
New York.
15. Hercules Powder Company, Inc., Agricultural Chem icals Divi­
sion, Wilmington 99, Delaware.
16. Imperial Chem icals Industries L td ., Curzon Street, London Wl, 
England.
17. Monsanto Chem icals Company, Organics D ivision, 800 North 
Lindberg B lvd ., St. Lou is 24, M issouri.
18. Montecatini, Via F . Turati 18, Milan, Ita ly ..
19. Motomco, Inc., 89 Terminal Avenue, Clark, New Je rse y .
20. Norda E sse n tia l Oil and Chemical Company, 601 West 26th 
Street, New York, New York.
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21. Rohm and H aas Company, Washington Square, Philadelphia 5, 
Pennsylvania.
22. Shell Chemical Corporation, Agricultural Chem icals D ivision, 
110 West 51st Street, New York 20, New York.
23. Standard Agricultural Chem icals, Inc., Hoboken, New Jersey .
24. Stauffer Chemical Company, 380 Madison Avenue, New York 17, 
New York.
25. Thompson Hayward Chemical Company, K an sas City, M issouri.
26. Union Carbide Chem icals Company, 30 E a s t  42nd Street, New 
York 17, New York.
27. V elsico l Chemical Corporation, 330 E a s t  Grand Avenue, Chi­
cago 11, Illinois.
Names and addresses of manufacturers whose trade name 
products are mentioned in this Handbook are provided for the con­
venience of the physician. Manufacturers are often good sources of 
recent and detailed information on the toxicology of their products. 
It may sometimes be necessary  for a physician to get in touch with 
one of them without delay.
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INDEX
Insofar a s  po ssib le , common or standard names have been 
used in the text of th is Handbook. However, some containers for 
p estic id es are so  labeled that only the chemical name or the trade 
name of the principal active ingredient is  given. Chemical names and 
important trade names of compounds mentioned in the text are 
listed  in the following index so  the Handbook will be of use to 
physicians in emergencies. In most in stances, the form of chemical 
name favored by C h e m ic a l  A b s t r a c t s  has been used. Unfortunately, 
limitation of space  makes it im possible to include a ll relevant trade 
names or all important variants of chemical names. A number a s so c ­
iated with each trade name below indicates a company in the pre­
ceding l is t  that is  concerned. Main headings in the text are printed 
in bold type in the index.
Aldrin (see  related compound dieldrin) ..............................................  62
A l l e t h r i n ........................................................................................................  74
3-Allyl-2-methyl-4-oxo-2-cyclopenten-l-yl
chrysanthemumate (allethrin )...........................................................  74
2-sec-Amyl-4-6-dinitrophenol (isopropanolamine) .......................... 109
A r s e n i c ........................................................................................................... 101
Arti f i c ia l  respiration (appendix E ) .......................................................  129
Azinphos-methyl (Guthion <g>-7) ...........................................................  30
Bayer L 13/59 (trichlorofon)..................................................................  42
Bayer 21/199 (Co-Ral ® -7 )..................................................................... 24
Bayer 22/190 (Chorthion ® -7)................................................................  24
Bayer 8169 (demeton)................................................................................ 27
Bayer 17147 (Guthion ® -7) ....................................................................  30
Baytex ®-7 (fenchion).............................................................................  13
Benzahex (BHC) ......................................................................................... 50
Benzene hexachloride (BHC) ................................................................  50
B H C  ...............................................................................................................  50
2,2,Bis-(p-chlorophenyl)-l,l,l-trichloroethane (D D T)................... 58
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Botanical in se c tic id e s .............................................................................  74
Bulan ® -io  (see  Dilan ® -io ) ..............................................................  67
2-sec-Butyl-4,6-dinitrophenol (dinitrobutylphenol) .......................  109
Carbamate in secticides ...........................................................................  44
Carbaryl ........................................................................................................  44
2-Carbomethoxy-l-methylvinyl dimethyl phosphate
(Phosdrin © -22) ..................................................................................  38
Carbophenothion (see  organic phosphorus in secticides) ............  13
C ase history form (appendix A) ...........................................................  121
CD-68 (chlordane)......................................................................................  55
Chlordan (chlordane) .................................................................................  55
Chlordane......................................................................................................  55
Chlorinated camphene (toxaphene).......................................................  71
Chlorinated hydrocarbon in secticides ................................................  47
Chlorobenzilate <©-14 (see  related compound DDT) .....................  58
2-Chloro-2-diethylcarbamoyl-l-methylvinyl dimethyl
phosphate (phosphamidon) ................................................................ 13
Chlorophenothane (DDT) .........................................................................  58
Chlorophenoxy herbicides .......................................................................  106
Chlorothion (Chlorthion ® -7) .............................................................. 24
Chlorthion ® -7 ......................................................................................... 24
Clinical te s ts  .............................................................................................  6
Coal oil (kerosene)....................................................................................  114
Compound 42 (warfarin) ...........................................................................  85
Compound 269 (endrin) ...........................................................................  68
Compound 497 (dieldrin) .........................................................................  62
Compound 1080 (sodium fluoroacetate) .............................................. 79
Compound 3422 (parathion) ..................................................................... 35
Compound 3911 (phorate).........................................................................  37
Compound 3956 (toxaphene) ...................................................................  71
Compound 4049 (m alathion)..................................................................... 31
Compound 4124 (dicapthon) ..................................................................  13
Co-Ral ®-7 .................................................................................................. 24
Coumachlor (see  related compound warfarin) ................................ 85
Coumafene (warfarin) ................................................................................ 85
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Coumafuryl (see  related compound warfarin).....................................  85
2-Cyclohexyl-4,6-dinitrophenol (dinitrocyclo-
hexylphenol)........................................................................................... 109
2.4-D (see chlorophenoxy herbicides) ................................................  106
Dalmatian insect flowers (pyrethrum) ..................... :.......................... 74
DBD (Guthion®-7) ....................................................................................  30
DDA (see  related compound DDT) ....................................................  58
DDD (TDE) .................................................................................................. 58
DDE (see  related compound DDT) ....................................................  58
DDT ...............................................................................................................  58
DDVP ........................................................ ....................................................  25
Delnav ® -is  (see organic phosphorus insecticides) ...................  13
Demeton ........................................................................................................  27
Deobase (kerosene) ..................................................................................  114
Diazinon ® -i4  ...........................................................................................  29
Dibrom ®-6 (naled) ..................................................................................  25
l,2-Dibromo-2,2-dichloroethyl dimethyl phosphate
(n aled)......................................................................................................  25
Dicapthon (see organic phosphorus insecticides) .......................... 13
l,l-Dichloro-2,2-bis(p-chlorophenyl) ethane
tetrachlorodiphenylethane (TDE) ..................................................  58
2.4-Dichlorophenoxyacetic acid (2,4-D) ...........................................  106
Dichlorvos (D D V P)....................................................................................  25
Dicophane (DDT)......................................................................................... 58
Dieldrin..........................................................................................................  62
D iesel oil (see  related kerosene) ..................................................... 114
0,0-D iethyl 0-(3-chloro-4-methyl-2-oxo-2H-l- benzopyran-
7-yl)phosphorothioate (C o-R al® -7) ..............................................  24
0,0-D iethyl p-chlorophenylmercaptomethyl dithio-
phosphate (carbophenothion) ...........................................................  13
0,0-Diethyl 0-[2-(ethylthio)ethylJphosphorothioate plus 
0,0-diethyl S-[2-(ethylthio)ethylJphosphorothioate
(demeton).................................................................................................. 27
0,0-Diethyl 0-(2-isopropyl-4-methyl-6-pyrimidinyl)
phosphorothioate (Diazinon ® -14) ..................................................  29
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0,0-D iethyl S-(methylthio-ethyl) phosphorodithioate
(phorate) .................................................................................................. 37
0,0-D iethyl O-(p-nitrophenyl) phosphorothioate
(parathion)...............................................................................................  35
Dilan ® -io  .................................................................................................. 67
Dimecron ®-9 (phosphamidon).............................................................. 13
Dimethoate (see  organic phosphorus in secticides) .......................  13
Diraethylbenzene (xylene) .......................................................................  118
0,0-Dimethyl O-(m-chloro-p-nitrophenyl) phosphorothioate
(Chlorthion ® -7)....................................................................................  24
0,0-Dimethyl 0-(2-chloro-4-nitrophenyl) thiophosphate
(dicapthon) .............................................................................................  13
0,0-Dimethyl S-(l,2-dicarbethoxyethyl) phosphoro­
dithioate (m alathion)...........................................................................  31
0,0-Dimethyl 2,2-dichlorovinyl phosphate (D D VP).......................  25
0,0-Dimethyl S-(N-methylcarbamoylmethyl) phosphoro­
dithioate (dim ethoate).........................................................................  13
0,0-Dimethyl O-(p-nitrophenyl) phosphorothioate
(methyl parathion).................................................................................  34
0,0-Dimethyl S-(4-oxo-l,2,3-benzotriazin-3 (4H)-ylmethyl
phosphorodithioate (Guthion ®-7) ..................................................  30
Dimethyl parathion (methyl parathion) ...............................................  34
0,0-Dimethyl-2,2,2-trichloro-l-hydroxyethyl phosphonate
(trichlorofon) ........................................................................................ 42
0,0-Dimethyl 0-(2,4,5-trichlorophenyl) phosphorothioate
(ronnel) ....................................................................................................  13
Dinitrobutylphenol (see  dinitrophenols) ............................................ 109
Dinitrocresol (DNOC)................................................................................ 109
Dinitrocyclohexylphenol (see  dinitrophenols)i................................  109
4,6-Dinitro-o-cresol (DNOC)..................................................................  109
Dinitrophenols.............................................................................................  109
Dinoseb (dinitrobutylphenol)................................................................... 109
Dipterex ®-7 (trichlorofon) ..................................................................  42
'Disodium ethylene bisdithiocarbamate (nabam )..............................  90
Di-Syston ®-7 (sulfur analog of demeton).......................................... 27
Dithane D-14 ® -2i (nabam) ................................................................... 90
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Dithane-Manganese ® -2i (m aneb).........................................................  90
Dithane Z-78 ® -2i (zineb) ..................................................................... 90
Dithiocarbamates ....................................................................................... 90
DNBP (dinitrobutylphenol) ....................................................................  109
DNC (DNOC) ...............................................................................................  109
DNOC (see  dinitrophenols)......................................................................  109
DNOCHP (dinitrocyclohexylphenol)..................................................... 109
DNOSBP (dinitrobutylphenol) ................................................................  109
DNSBP (dinitrobutylphenol) ..................................................................  109
DNTP (parathion) ......................................................................................  35
DSE (nabam).................................................................................................. 90
Dylox ®-7 (trichlorofon) .........................................................................  42
E-600 (paraoxon)......................................................................................... 35
E-601 (methyl parathion) ..........................................................................  34
E-605 (parathion) ......................................................................................  35
E-1059 (demeton) ......................................................................................  27
E-3314 (heptachlor) ..................................................................................  70
Elgetol 30 ®-2 3 (DNOC) .........................................................................  109
Endrin ........................................................................................................... 68
EPN (see  organic phosphorus in se c tic id e s).....................................  13
Ethion (see  organic phosphorus in secticides) ................................. 13
Ethyl 4,4'-dichlorobenzilate (Chlorobenzilate ® -m ) ................... 58
0-Ethyl O-p-nitrophenyl phenyl phosphonothioate
(EPN) ......................................................................................................  13
Fenthion (see  organic phosphorus in secticides) ............................  13
Ferbam (see  dithiocarbam ates)..............................................................  90
Fermate ® -12 (ferbam) ...........................................................................  90
Ferric dimethyldithiocarbamate (ferbam)............................................ 90
Folidol ® -s (parathion) .........................................................................  35
Fuel oil (see  related kerosene) ............................................................. 114
Fumarin ®-2 (coumafuryl)....................................................................... 85
Fun gicides.................................................................................................... 90
G-24480 (Diazinon ® . 14) .........................................................................  29
Gammexane ® - i6 (BHC) .........................................................................  50
Gesapon ® -14 (D D T)................................................................................. 58
Gesarex ® - i4 (DDT) ................................................................................  58
Gesarol ® - i 4 (DDT) ................................................................................. 58
139
Guesarol ® -i4  (DDT) .............................................................................  58
Gusathion <©-7 (Guthion @ -7) .............................................................. 30
Guthion <g)-7 ................................................................................................ 30
HCH (BHC) .......... .......................................................................................  50
HEOD (dieldrin) ......................................................................................... 62
Heptachlor ....................................................................................................  70
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